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Abstract 
 
Metabolism is key for life and involves the interplay of anabolic and catabolic reactions within a cell to 
meet the required energy needs. Each cell, tissue and organ possesses a unique metabolic profile that 
all contribute to systemic energy homeostasis and disturbances at any level profoundly affect whole 
body metabolism. The complex integration of metabolism takes place at different levels including 
adjustments in gene transcription. Over the last 20 years, transcriptional coregulators have emerged 
as important players in the regulation of gene expression and the field is constantly expanding 
identifying new coregulator proteins and their metabolic functions. The peroxisome proliferator-
activated receptor γ coactivator-1 (PGC-1) family includes the three family members termed PGC-1α, 
PGC-1β and PGC-related coactivator. They have been implicated to play important roles in oxidative 
metabolism and mitochondrial homeostasis in a variety of different tissues including skeletal muscle 
and kidney. Thus, during the course of this thesis, we studied the physiological and pathophysiological 
effects of PGC-1α- and PGC-1β-specific ablation in these two organs in four different projects. 
In the first project, we assessed the role of PGC-1α in skeletal muscle in response to chronic ketogenic 
diet feeding. Ketogenic diets have gained more and more attention as therapeutic strategies in the 
treatment of metabolic diseases and other pathological disorders. However, the mode of action is still 
poorly understood, particularly upon chronic administration. Next to liver, brain, and heart, skeletal 
muscle is one of the main players involved in the regulation of physiological and pathophysiological 
ketosis. Thus, we studied the effects of 12 weeks of ketogenic diet feeding in wildtype (WT) and PGC-
1α muscle-specific knockout mice (PGC-1α MKO). Importantly, muscle PGC-1α was essential to 
increase oxygen consumption and transcript levels of genes involved in fatty acid oxidation as well as 
to maintain exercise performance upon ketogenic diet feeding. Therefore, we elucidated a new role 
for muscle PGC-1α in the regulation of physiological adaptations to chronic ketogenic diet 
administration.  
In the second project, we studied the PGC-1α-dependent transcriptional changes in skeletal muscle 
upon acute bouts of exercise and chronic exercise training. Skeletal muscle is a highly plastic organ 
with an enormous capacity to adapt its metabolism to different energy needs. Interestingly, many of 
these metabolic changes, especially in response to exercise, are known to be mediated by PGC-1α. 
Thus, we performed acute time-course and chronic exercise experiments with WT and PGC-1α MKO 
mice and defined the PGC-1α-dependent and -independent transcriptional changes. Thereby, we 
identified the WT time-course-specific and acute core exercise responses and could demonstrate that 
PGC-1α is substantially involved in the regulation of these adaptations in skeletal muscle. Furthermore, 
while the acute exercise response involved many transcriptional changes, chronic exercise training 
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exerted only minor adaptations in gene expression levels. Thus, we elucidated new important aspects 
of PGC-1α in the regulation of skeletal muscle exercise physiology.  
The third project was aimed at determining the role of PGC-1β in skeletal muscle in response to fasting. 
Skeletal muscle constitutes the largest protein reservoir of the body and its catabolism is the main 
source of amino acids for hepatic gluconeogenesis during energy deprived conditions. Thus, skeletal 
muscle emerges as one of the key players in the whole body response to fasting, yet, the complex 
regulation of skeletal muscle metabolism upon energy deprivation is still poorly understood. Thus, we 
evaluated the involvement of PGC-1β in the control of fasting-induced skeletal muscle adaptations in 
WT and PGC-1β MKO mice. Interestingly, 24 h of fasting induced only a partial muscle mass loss in PGC-
1β MKO animals, which was characterized by reduced myostatin mRNA levels, a blunted induction of 
atrophy markers gene expression and absent activation of AMP-dependent and cAMP-dependent 
protein kinases in comparison to WT animals. Furthermore, PGC-1β MKO mice exhibited increased 
transcriptional activity of the nuclear factor of activated T-cells, cytoplasmic 1 (Nfatc1) and showed 
elevated PGC-1α expression levels. Thus, our data suggest that PGC-1β might inhibit Nfatc1 
transcriptional activity during fasting-induced muscle atrophy. These data shed new light on the 
complex regulation of skeletal muscle metabolism under energy deprived conditions and revealed 
PGC-1β as an important player in the control of fasting.  
The fourth project of this thesis assessed the function of PGC-1α in podocyte and kidney metabolism. 
Glomerular filtration is the first step in urine production and involves different types of cells including 
podocytes, which are part of the glomerular filtration barrier that contributes to the prevention of 
protein loss from the primary filtrate. Mitochondrial dysfunction has been implicated to trigger 
podocyte injury, which eventually progresses to the development of chronic kidney disease. However, 
mitochondrial function and its contribution to podocyte disorders are still poorly understood. Thus, 
we studied the role of PGC-1α in podocyte metabolism under basal and stress-induced conditions in 
WT and PGC-1α podocyte-specific knockout mice (PGC-1α PKO). The mild increase in glomerular 
basement membrane thickness in PGC-1α PKO animals did not result in any functional deficits and 
young and aged PGC-1α PKO mice showed unchanged kidney and podocyte function under basal and 
stress-induced conditions in comparison to WT animals. Therefore, we concluded that PGC-1α is not 
mandatory for normal podocyte function in-vivo. 
In summary, this thesis describes new aspects of PGC-1α and PGC-1β in the regulation of skeletal 
muscle and kidney metabolism. Moreover, we identified new molecular pathways and mechanisms by 
which these two coactivators exert their biological functions. Finally, our results might serve as 
cornerstone in the development of future therapeutic strategies for the treatment of metabolic 
disorders and other disease conditions. 
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Abbreviations 
 
AD activation domain  
AMPK AMP-dependent protein kinase 
ATF2 activating transcription factor 2  
BAT brown adipose tissue  
β-OHB β-hydroxybutyrate  
CaMK calcium/calmodulin-dependent protein kinase 
CBP CREB binding protein  
CKD chronic kidney disease 
CnA calcineurin A 
CREB cAMP-response element binding protein 
EGFR epidermal growth factor receptor  
EMT epithelial–mesenchymal trans-differentiation  
EPO erythropoietin 
ER estrogen receptor  
ERK extracellular‐signal‐regulated kinase  
ERRα estrogen-related receptor α 
FFAR3 free fatty acid receptor 3  
FoxO3 forkhead box O 3 
GBM glomerular basement membrane  
GCN5 general control of amino-acid synthesis 5 
GO gene ontology 
GPR G-protein coupled receptor 
HBM HCF-binding motif 
HCAR2 hydroxycarboxylic acid receptor 2 
HCF host cell factor  
HDAC histone deacetylase  
HFD high fat diet 
HSF heat shock transcription factor 
Hsp heat shock protein 
IGF-1 insulin-like growth factor-1 
ISMARA integrated motif activity response analysis  
KD ketogenic diet 
LXR liver-X receptor  
MAFbx muscle atrophy F-box  
MAPK mitogen-activated protein kinase  
MEF2 myocyte enhancer factor 2  
MH malignant hyperthermia 
MKO muscle-specific knockout mice 
mTOR mammalian target of rapamycin  
MuRF-1 muscle RING finger-1 
MyHC myosin heavy chain 
NAD nicotinamide adenine dinucleotide  
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NAM nicotinamide 
Nfatc1 nuclear factor of activated T-cells, cytoplasmic 1 
NF-κB nuclear factor-kappaB 
PCr phosphocreatine 
PGC-1 PPARγ coactivator-1  
PKA cAMP-dependent protein kinase 
PKO podocyte-specific knockout mice 
PPAR peroxisome proliferator-activated receptor  
PRC PGC-related coactivator  
RAAS renin-angiotensin-aldosterone system 
RRM RNA-recognition motif 
RS Arg/Ser-rich domain  
SIRT1 sirtuin 1 
SRC-1 steroid receptor coactivator-1  
SREBP sterol regulatory element-binding protein  
TF transcription factor 
TNF tumor necrosis factor 
TWEAK TNF-like weak inducer of apoptosis  
UCP1 uncoupling protein 1  
VEGF vascular endothelial growth factor 
WT wildtype 
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1. Introduction  
 
1.1 Metabolism and energy homeostasis 
Metabolism is key for life and describes a highly organized network of chemical reactions to provide a 
continual input of free energy in living organisms. This energy is derived from the environment and is 
required to meet three main purposes: a) the execution of mechanical work in muscle contractions 
and cellular movements, b) the active transport of molecules and ions, and c) the synthesis of 
biomolecules. Phototrophs like plants obtain this energy through photosynthesis in which they convert 
light energy into chemical energy. Animals are categorized as chemotrophs that obtain energy by the 
oxidation of molecules generated by photosynthetic organisms. 
Metabolism consists of energy-yielding and energy-requiring reactions that are interdependent on 
each other to convert a particular molecule into another one. There are many defined metabolic 
pathways in a cell (Figure 1), which generally can be categorized into catabolic and anabolic reactions. 
Catabolism transforms fuels into cellular energy while anabolic reactions rely on energy produced 
during catabolism to build complex molecules or to generate high energy states. Thus, whole body 
metabolism is regulated by energy intake and energy expenditure and integrates all cells, tissues and 
organs to meet the required energy needs.  
 
 
Figure 1 – The metabolic pathways (from the Kyoto Encyclopedia of Genes and Genomes) 
Metabolism consists of a network of metabolic pathways, which convert molecule A into molecule B by 
linking series of chemical reactions. 
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1.2 Coregulators and their role in metabolism  
The complex integration of internal and external cues takes place at different levels ranging from 
metabolic specializations of individual organs, to allosteric interactions and covalent modifications of 
proteins to adjustments of gene expression levels. Gene transcription is a highly regulated process in 
which the coordinated interaction between coregulators and transcription factors (TF) controls the 
expression of target genes. Coregulators thereby expand the complexity of the transcriptional 
regulation and function as metabolic sensors to ensure the fine-tuning of transcriptional events 
(Spiegelman and Heinrich 2004, Lonard and O'Malley B 2007, Mouchiroud, Eichner et al. 2014). 
Coregulators are not able to directly bind to the DNA themselves but interact with a variety of different 
TFs to induce expression of target genes. They can be broadly categorized into coactivators and 
corepressors promoting or inhibiting gene transcription, respectively, even though some coregulator 
proteins harbor both abilities (Lonard and O'Malley B 2007). In addition, some coregulators possess an 
intrinsic enzymatic activity to modify histones and thereby change the nature of the chromatin 
structure while others serve as recruiting platforms for different molecules to build large 
transcriptional complexes. Furthermore, coregulators are highly regulated and can be the primary 
target of hormonal control and signal transduction pathways (Spiegelman and Heinrich 2004). To date, 
over 450 different coregulator proteins have been identified showing pleiotropic functions in the 
control of tissue-specific and whole body metabolism (Malovannaya, Lanz et al. 2011).  
 
1.2.1 The PGC-1 family of transcriptional coactivators  
The peroxisome proliferator-activated receptor γ (PPARγ) coactivator-1 (PGC-1) family consists of the 
three family members PGC-1α, PGC-1β and PGC-related coactivator (PRC) (Figure 2) and over the last 
twenty years, their regulation and biological function in tissue-specific and whole body metabolism 
have been studied in greatest detail (Puigserver, Wu et al. 1998, Andersson and Scarpulla 2001, 
Kressler, Schreiber et al. 2002, Lin, Puigserver et al. 2002).  
PGC-1α, the first family member described, was discovered as a cold-responsive protein interacting 
with PPARγ to induce uncoupling protein 1 (UCP1) expression and thus regulating adaptive 
thermogenesis in brown adipose tissue (BAT) (Puigserver, Wu et al. 1998). PGC-1α belongs to the class 
of coactivators without intrinsic enzymatic activity but it has been shown to bind several histone 
acetyltransferase-harboring proteins such as cAMP-response element binding protein (CREB) binding 
protein (CBP), p300 and steroid receptor coactivator-1 (SRC-1), which acetylate histones and thereby 
remodel chromatin structures to facilitate gene activation (Puigserver, Adelmant et al. 1999). In 
addition, the C-terminal region of PGC-1α serves as a docking platform for proteins of the mediator 
complex (Wallberg, Yamamura et al. 2003). PGC-1α is a master integrator of external stimuli such as 
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fasting and exercise and is especially important in metabolic organs like the liver, brain, BAT, kidney 
and skeletal muscle (Puigserver, Wu et al. 1998, Larrouy, Vidal et al. 1999). Furthermore, PGC-1α is 
essential for mitochondrial function and oxidative phosphorylation, which are crucial for fatty acid 
oxidation and cellular energy metabolism (Lin, Handschin et al. 2005). In addition, PGC-1α is also vitally 
for tissue-specific metabolic actions such as the above mentioned adaptive thermogenesis in BAT 
(Puigserver, Wu et al. 1998, Tiraby, Tavernier et al. 2003), hepatic gluconeogenesis and ketogenesis 
(Herzig, Long et al. 2001, Yoon, Puigserver et al. 2001, Rhee, Inoue et al. 2003) and the switch from 
glycolytic fast-twitch muscle fibers towards more oxidative slow-twitch fibers in skeletal muscle (Lin, 
Wu et al. 2002). 
Even though PGC-1β shares extensive sequence identities with PGC-1α, especially in the N-terminal 
activation domain (AD) and the C-terminal RNA binding domain (RRM) (Figure 2), its role in regulating 
metabolism is less well studied and understood (Kressler, Schreiber et al. 2002, Lin, Puigserver et al. 
2002). PGC-1β was originally identified as a protein interacting with nuclear receptors like PPARα and 
estrogen receptor α (ERα) as well as with host cell factor (HCF) and was thus implicated in the 
regulation of hepatic fasting, viral infection and cell proliferation (Kressler, Schreiber et al. 2002, Lin, 
Puigserver et al. 2002). Like PGC-1α, PGC-1β is involved in mitochondrial biogenesis and cellular 
respiration in different tissues and fasting induces its expression in the liver (Lin, Puigserver et al. 2002, 
Lin, Tarr et al. 2003, St-Pierre, Lin et al. 2003). Furthermore, hepatic PGC-1β expression is also induced 
upon short-term high fat diet (HFD) feeding to coactivate the sterol regulatory element-binding protein 
(SREBP) and liver-X receptor (LXR) families of transcription factors regulating de novo lipogenesis and 
lipoprotein secretion (Lin, Yang et al. 2005). 
The third member of the PGC-1 family, PRC, is ubiquitously expressed and induced upon the initiation 
of cell proliferation. Furthermore, PRC is able to respond to metabolic stress by promoting the 
expression of genes involved in inflammation, proliferation and metabolic reprogramming and has 
been described as a mitochondrial biogenesis regulator (Andersson and Scarpulla 2001, Vercauteren, 
Pasko et al. 2006, Vercauteren, Gleyzer et al. 2009, Philp, Belew et al. 2011, Gleyzer and Scarpulla 
2013).  
As this thesis is aimed at elucidating the role of the PGC-1 family of transcriptional coactivators in 
skeletal muscle and kidney metabolism, the remainder of the introduction will focus on the regulation 
of PGC-1α and –β in these two tissues.
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Figure 2 – The PGC-1 family of transcriptional coactivators  
Gene structure of the three PGC-1 family members PGC-1α, -β and PRC. Conserved domains/motifs are 
indicated including the activation domain (AD), LXXLL motifs, host cell factor (HCF)-binding motif 
(HBM), Arg/Ser-rich domain (RS) and RNA-recognition motif (RRM) (Lin, Puigserver et al. 2002). 
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1.3 Skeletal muscle metabolism 
Skeletal muscle is one of the most abundant and metabolically active tissues in mammals, accounting 
for approximately 40-50% of total body mass. Its main purpose is to generate force in order to facilitate 
movement of the body. Skeletal muscle is composed of myofibers with different functional and 
metabolic characteristics, e.g. slow-oxidative and fast-glycolytic fibers. Oxidative fibers appear red in 
color and are characterized by slow-twitch properties and a high mitochondrial number, oxidative 
capacity and resistance to fatigue. Slow fibers are also referred to as type I fibers, which mainly express 
the myosin heavy chain-I (MyHC-I) (Schiaffino and Reggiani 2011). The hallmarks of glycolytic fibers are 
a low mitochondrial number and endurance as well as fast-twitch contraction kinetics and high peak 
force. Fast fibers are distinguished as type IIA, IIB and IIX fibers specifically expressing MyHC-IIA, MyHC-
IIB and MyHC-IIX, respectively, in rodents while MyHC-IIB is missing in human muscles (Schiaffino and 
Reggiani 2011). Moreover, type IIA fibers show intermediate properties between slow type I and fast 
type IIB/X fibers (Schiaffino and Reggiani 2011). These differences in fiber types facilitate a high degree 
of muscle plasticity to ensure the tight regulation of a variety of activities, from supporting the skeleton 
to stand upright, to performing explosive movements as during a sprint. Furthermore, external stimuli, 
such as the specific training of muscle tissue, can change the composition of fiber types, which is 
reflected by the fact that successful endurance athletes have relatively more slow-twitch fibers while 
the muscles of sprinters are predominantly composed of fast-twitch fibers (Costill, Daniels et al. 1976, 
Fink, Costill et al. 1977, Saltin, Henriksson et al. 1977). 
Therefore, cellular metabolism within muscle tissue must be precisely regulated in order to ensure 
sufficient supply of energy for muscle movements.  ATP is the main immediate free-energy donor 
during muscle contractions, however, intracellular ATP stores in human skeletal muscle are rather 
small (5-6 mM) (Sahlin, Tonkonogi et al. 1998). Accordingly, immediately available ATP is quickly 
depleted upon the onset of exercise and must continually be re-synthesized to ensure prolonged 
muscle contractions.  
At high exercise intensities, also referred to as anaerobic metabolism, ATP is primarily regenerated 
through the breakdown of phosphocreatine (PCr) and muscle glycogen (Figure 3). Creatine kinase 
catalyzes the reaction in which PCr and ADP interact to yield creatine and ATP. Glycogen breakdown is 
much more complex and regulated by glycogen phosphorylase, which gets phosphorylated and 
activated by the action of phosphorylase kinase and dephosphorylated and inactivated by protein 
phosphatase 1 (Johnson 2009). The released glucose enters glycolysis and is converted to pyruvate, 
which ultimately is further oxidized to lactate by the action of lactate dehydrogenase (Westerblad, 
Bruton et al. 2010). The accumulation of lactate thus only occurs when oxygen availability is low and 
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the demand of ATP is high. The resulting lactate can then be converted back to glucose in the liver in 
a process known as the Cori cycle, which shifts the metabolic burden of the muscle to the liver. 
In contrast to anaerobic metabolism, the generation of ATP through the complete oxidation of 
carbohydrates and lipids to CO2 relies on sufficient oxygen supply and occurs at a much slower rate 
(Figure 3). In addition, amino acids from the breakdown of muscle proteins can be used for aerobic 
metabolism, however, this contributes only minor to the overall energy metabolism in skeletal muscle, 
especially, when carbohydrates are available (Lemon and Mullin 1980). Oxidative metabolism mainly 
uses glucose (from intramuscular glycogen stores but also from the circulation) and free fatty acids 
(from intramuscular and adipose tissue triglyceride stores) for the conversion into acetyl-CoA, which 
is then fed into the citric acid cycle inside the mitochondrial matrix. This cycle is important to generate 
NADH and FADH2 in order to build a proton gradient across the inner mitochondrial membrane. The 
release of energy from the diffusion of protons back into the mitochondrial matrix is coupled to ATP 
production through the ATP synthase enzyme (Westerblad, Bruton et al. 2010). In contrast to 
anaerobic metabolism, which only yields 3 ATP molecules per glucose molecule, oxidative metabolism 
releases around 38 molecules of ATP per glucose molecule and is thus much more energy efficient 
(Egan, Hawley et al. 2016).  
At rest, skeletal muscle only contributes to around 20-30% of the whole body energy expenditure, 
however, during maximal physical activity, oxygen consumption can dramatically increase up to 90% 
of the whole body oxygen uptake (Zurlo, Larson et al. 1990). Not surprisingly, muscle tissue thus shows 
an enormous capacity to adapt to different energy needs and substantially contributes to the 
regulation of whole body energy metabolism. 
 
 
Figure 3 – Energy substrates and pathways as a function of exercise intensity in human leg muscles 
during upright cycling 
At high exercise intensities phosphocreatine (PCr) and lactate are major contributors of ATP production 
while carbohydrate and fat oxidation become more important at moderate or low exercise intensities, 
respectively (Sahlin 1986, Westerblad, Bruton et al. 2010).  
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Skeletal muscle not only ensures movement and thus plays a major role in whole body energy 
expenditure but it also constitutes one of the largest energy stores in form of triglycerides, glycogen 
and proteins. These energy stores are of crucial importance during increased energy expenditure, as 
described above during exercise, but also during decreased energy intake, as during periods of fasting. 
If blood glucose and insulin concentrations drop, glucagon gets released from the pancreas to trigger 
hepatic glycogenolysis and gluconeogenesis to liberate de-novo produced glucose from the liver 
(Briant, Salehi et al. 2016). Consequently, the reduction in glucose availability and insulin release lead 
to an increase in lipolysis in white adipose tissue and fatty acid oxidation in skeletal muscle, 
respectively (Holness and Sugden 1990). If fasting is prolonged, liver glycogen stores get depleted and 
hepatic gluconeogenesis is solely fueled by glycerol from lipolysis in adipose tissue as well as from the 
catabolism of muscle proteins, ensuring whole body glucose homeostasis (Longo and Mattson 2014). 
Furthermore, the liver starts to produce ketone bodies like β-hydroxybutyrate (β-OHB) and 
acetoacetate in a process called ketogenesis (Krebs 1966). The use of circulating ketone bodies by 
extra-hepatic tissues, such as skeletal muscle and the brain, largely diminishes the need of glucose, 
which minimizes the loss of muscle protein and functionality and maintains cognitive function (Longo 
and Mattson 2014). Ketone bodies, as carbohydrates and fatty acids during oxidative metabolism, get 
metabolized to acetyl-CoA, which is fed into the citric acid cycle to generate energy for cellular 
processes.  
Thus, skeletal muscle emerges as a tissue with pleiotropic functions in whole body metabolism, ranging 
from the production of force to generate movements, to substrate handling to adapt to a variety of 
different energy needs.  
 
1.3.1 Skeletal muscle plasticity  
Skeletal muscle is a highly plastic tissue and shows enormous potential to adapt its contractile and 
metabolic properties according to external stimuli. Different pathological conditions like cancer, heart, 
liver or renal failure, chronic obstructive pulmonary disease and AIDS profoundly contribute to the 
phenotype of skeletal muscle. Muscle wasting or atrophy is a common feature of these diseases, which 
also occurs during non-pathological conditions such as aging or fasting (Glass and Roubenoff 2010, 
Bonaldo and Sandri 2013). Atrophy is defined as a decrease in muscle size due to cellular shrinkage, 
which includes the loss of organelles, cytoplasm and proteins. Muscle mass strongly depends on 
protein and cell turnover and is the net result between protein synthesis and degradation. Accordingly, 
muscle atrophy occurs when the balance is shifted towards increased proteolysis, which is tightly 
regulated by different cell signaling cascades (Bonaldo and Sandri 2013, Egerman and Glass 2014). 
Importantly, the progression of the above mentioned diseases is strongly associated with excessive 
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muscle mass loss, which is a poor prognostic indicator ultimately increasing morbidity and mortality 
(Glass and Roubenoff 2010, Bonaldo and Sandri 2013). Thus, preservation of muscle mass, metabolism 
and aerobic fitness is fundamental for health and normal organ function and in fact, physical activity 
has been shown to lower the risk of different metabolic diseases including obesity or type 2 diabetes 
but also of cancer or skeletal muscle wasting (Haskell, Lee et al. 2007, Colberg, Sigal et al. 2010, Egan 
and Zierath 2013). Therefore, physical activity is another stimulus that largely contributes to skeletal 
muscle remodeling and whole body homeostasis.  
Exercise-induced alterations in muscle phenotype include changes in contractile protein and function 
(e.g. MyHC composition), mitochondrial and metabolic adaptations as well as modifications of signal 
transduction pathways and transcriptional responses (Green, Helyar et al. 1992, Adams, Hather et al. 
1993, Spina, Chi et al. 1996, Benziane, Burton et al. 2008, Kupr, Schnyder et al. 2017, Schnyder, Kupr 
et al. 2017). It is believed that each acute exercise bout elicits a transient peak in the expression level 
of certain genes, which over time cumulatively increases protein content and enzyme activity and 
finally results in improved exercise performance and whole body metabolism (Figure 4) (Egan and 
Zierath 2013). However, it is important to note that different exercise modalities, e.g. endurance 
versus resistance, but also the frequency, intensity and duration of the training lead to different 
metabolic and molecular skeletal muscle adaptations (Coffey, Shield et al. 2006, Coffey, Zhong et al. 
2006).  
Endurance training is characterized as a low-load exercise modality, which is performed during a long 
period of time and during which energy is derived through oxidative metabolism of carbohydrates and 
fatty acids. Thus, endurance training effectively modifies and increases muscle capillarisation, 
mitochondrial metabolism, oxidative function, lactate tolerance and anaerobic and endurance 
capacity (Egan and Zierath 2013). On the other hand, resistance training, also known as hypertrophy 
exercise, imposes a high-load demand on muscular contraction but only for a short period of time. This 
leads to a higher muscle mass with increased muscle fiber size, strength and power as well as to an 
elevation of the basal metabolic rate (Egan and Zierath 2013). Thus, resistance exercise is thought to 
be an effective therapeutic strategy for the treatment of muscle wasting (Glass and Roubenoff 2010, 
Egan and Zierath 2013). Furthermore, even though both exercise modalities exert health promoting 
effects, a combination of both, endurance and resistance training, emerges as the most effective in 
the treatment of metabolic diseases such as insulin resistance, obesity, the metabolic syndrome or 
type 2 diabetes (Sigal, Kenny et al. 2007, Davidson, Hudson et al. 2009).  
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Figure 4 – Skeletal muscle adaptations to acute and chronic exercise training 
Acute exercise bouts result in the transient increase in mRNA expression levels of exercise-responsive 
genes. Upon chronic exercise training these repeated peaks in expression changes cumulate and lead 
to a modest but gradual accumulation of protein, which over time results in improved exercise 
performance and whole body metabolism (Egan and Zierath 2013). 
 
1.3.2 Regulation of PGC-1α/β expression and activity in skeletal muscle metabolism  
Skeletal muscle adaptations to external stimuli are often coordinated at the gene expression level, in 
which the PGC-1 family plays a prominent role controlling skeletal muscle metabolism and plasticity 
(St-Pierre, Lin et al. 2003). Importantly, endurance and resistance exercise are able to stimulate the 
expression of the full-length PGC-1α1 and the PGC-1α4 isoform, respectively (Pilegaard, Saltin et al. 
2003, Ruas, White et al. 2012), indicating that different exercise regimens can induce various PGC-1α 
isoforms with specific biological functions (Miura, Kai et al. 2008, Ruas, White et al. 2012, Wen, Wu et 
al. 2014). Interestingly, many of the exercise-induced pathways converge on PGC-1α to either increase 
its expression, protein stability or transcriptional activity, which makes it a master regulator of skeletal 
muscle plasticity (Correia, Ferreira et al. 2015). PGC-1α expression is regulated by calcium signaling via 
the action of the calcium/calmodulin-dependent protein kinase IV (CaMKIV) and calcineurin A (CnA), 
which involves the two transcription factors CREB and myocyte enhancer factor 2 (MEF2) (Wu, 
Kanatous et al. 2002, Handschin, Rhee et al. 2003). Furthermore, mRNA levels of PGC-1α are increased 
through the activation of the p38 mitogen-activated protein kinase (p38 MAPK) involving the 
downstream transcription factor activating transcription factor 2 (ATF2) and the AMP-dependent 
protein kinase (AMPK), which is largely dependent on the function of the PGC-1α protein (Akimoto, 
Pohnert et al. 2005, Jager, Handschin et al. 2007). In addition, exercise not only controls the expression 
of PGC-1α through different pathways but also its post-translational modifications. For example, 
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transcriptional activity of PGC-1α is enhanced by phosphorylation through p38 MAPK (Puigserver, Rhee 
et al. 2001) and AMPK (Jager, Handschin et al. 2007) and deacetylation through sirtuin 1 (SIRT1) (Canto, 
Gerhart-Hines et al. 2009), whereas the acetylase general control of amino-acid synthesis 5 (GCN5) 
counteracts the activation by SIRT1 (Lerin, Rodgers et al. 2006). Furthermore, acute exercise in human 
skeletal muscle has been shown to hypomethylate the promoters of PGC-1α and other exercise-
responsive genes, indicating that dynamic changes in DNA methylation can also contribute to gene 
activation (Barres, Yan et al. 2012). Moreover, other upstream regulators of PGC-1α expression and 
protein activity have been identified, however, their role in exercise-mediated control of PGC-1α has 
not been studied so far (Fernandez-Marcos and Auwerx 2011, Kupr and Handschin 2015). In addition, 
PGC-1β expression is not affected or even reduced by exercise training, demonstrating that even 
though PGC-1α and –β share extensive sequence similarities, their role and biological function are 
clearly distinct (Koves, Li et al. 2005, Mortensen, Plomgaard et al. 2007). 
Interestingly, while only PGC-1α is controlled by exercise-induced signaling cascades, both PGC-1 
family members seem to contribute to the maintenance of skeletal muscle mass. Accordingly, disuse 
muscle atrophy in old individuals leads to marked reduction in the expression levels of PGC-1α and –β 
(Suetta, Frandsen et al. 2012). Even though the mechanisms that lead to this downregulation of PGC-
1 expression are poorly understood, the tumor necrosis factor (TNF)-like weak inducer of apoptosis 
(TWEAK) has been shown to significantly reduce the mRNA levels of PGC-1α by binding to Fn14, a 
member of the TNF-receptor superfamily (Hindi, Mishra et al. 2014). If this pathway also leads to the 
downregulation of PGC-1β expression remains to be elucidated by future studies.  
 
1.3.3 PGC-1α/β in the regulation of skeletal muscle plasticity  
As described, regulation of PGC-1 expression and activity is tightly controlled by a variety of pathways 
that profoundly contribute to skeletal muscle plasticity. Both coactivators have been implicated in 
regulating skeletal muscle oxidative metabolism, e.g. overexpression of PGC-1α and PGC-1β drives the 
formation of slow-twitch MyHC type I and IIA or MyHC type IIX fibers, respectively (Lin, Wu et al. 2002, 
Arany, Lebrasseur et al. 2007), while the knockout of either PGC-1 family member results in a shift 
towards more fast-twitch glycolytic fibers (Handschin, Chin et al. 2007, Rowe, Patten et al. 2013, Gali 
Ramamoorthy, Laverny et al. 2015). In addition, both PGC-1 coactivators are of crucial importance for 
the expression of genes involved in oxidative phosphorylation and single as well as total ablation of 
PGC-1α/β in skeletal muscle drastically diminishes mitochondrial respiration resulting in severe defects 
in exercise capacity (Handschin, Chin et al. 2007, Rowe, Patten et al. 2013, Gali Ramamoorthy, Laverny 
et al. 2015). On the other hand, overexpression of either PGC-1 family member results in improved 
oxidative capacity and increased exercise performance (Lin, Wu et al. 2002, Arany, Lebrasseur et al. 
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2007, Lee, Leone et al. 2017). Furthermore, PGC-1α and –β are involved in the regulation of 
angiogenesis, through coactivation of estrogen-related receptor α (ERRα), inducing the expression of 
vascular endothelial growth factor (VEGF) (Arany, Foo et al. 2008, Chinsomboon, Ruas et al. 2009, 
Rowe, Jang et al. 2011). Thus, even though only PGC-1α seems to be controlled by exercise, both 
coactivators profoundly contribute to skeletal muscle oxidative capacity and endurance performance. 
In addition, PGC-1α has been described to be involved in a variety of other processes regulating skeletal 
muscle plasticity, such as calcium and lipid handling (Summermatter, Baum et al. 2010, 
Summermatter, Thurnheer et al. 2012) as well as glycogen, lactate and ketone body homeostasis 
(Wende, Schaeffer et al. 2007, Summermatter, Santos et al. 2013, Svensson, Albert et al. 2016), while 
the role of PGC-1β in these contexts has not been studied so far.  
PGC-1 coactivators are not only important for mitochondrial and oxidative metabolism but also 
contribute to the maintenance of skeletal muscle mass. Muscle-specific overexpression of PGC-1α4, a 
recently identified isoform of the PGC-1α family, leads to hypertrophy and increased muscle strength 
while it reduces muscle mass loss caused by hindlimb suspension or cancer cachexia (Ruas, White et 
al. 2012). It does so by activating the expression of insulin-like growth factor-1 (IGF-1) and suppressing 
myostatin gene transcription (Ruas, White et al. 2012). Moreover, it also stimulates the expression of 
G protein-coupled receptor 56 (GPR56) and its ligand collagen III, inducing mammalian target of 
rapamycin (mTOR) signaling, which promotes cellular hypertrophy in cultured myotubes (White, 
Wrann et al. 2014). Furthermore, overexpression of PGC-1α or –β in skeletal muscle has been shown 
to protect from fiber atrophy and proteolysis mainly by reducing forkhead box O 3 (FoxO3) and nuclear 
factor-kappaB (NF-κB)-dependent transcription of target genes (Sandri, Lin et al. 2006, Brault, 
Jespersen et al. 2010). Importantly, FoxO transcription factors activate the expression of two essential 
E3 ubiquitin ligases, muscle atrophy F-box (MAFbx) and muscle RING finger-1 (MuRF-1), so called 
atrogenes, that have been identified as key regulators of muscle atrophy (Bodine, Latres et al. 2001, 
Gomes, Lecker et al. 2001, Sandri, Sandri et al. 2004, Stitt, Drujan et al. 2004). Even though 
overexpression of PGC-1α and PGC-1β protects against muscle wasting, the loss of either PGC-1 family 
member does not increase the propensity for muscle atrophy. For example, muscle-specific PGC-1α 
knockout mice are not more susceptible to denervation-induced fiber atrophy showing unchanged 
muscle weights and atrogenes expression compared to control mice (Handschin, Chin et al. 2007). Also, 
ablation of PGC-1β specifically in muscle tissue does not affect muscle mass or myofiber structure and 
cross-sectional area (Gali Ramamoorthy, Laverny et al. 2015). 
To conclude, PGC-1 coactivators are versatile proteins that substantially contribute to skeletal muscle 
plasticity being involved in mitochondrial and oxidative metabolism as well as protein degradation 
through transcriptional activation and repression.  
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1.4 Kidney metabolism 
The kidneys are two bean-shaped organs lying in the abdominal cavity at each side of the spine. They 
are essential for whole body metabolism regulating blood pressure, acid-base balance, electrolyte 
homeostasis and the excretion of waste products such as urea. The renal cortex is the outer zone of 
the kidney and the renal medulla is the inner zone. Each kidney is composed of around 900’000 – 1 
Mio. of nephrons, the functional unit of the kidney (Bertram, Douglas-Denton et al. 2011). A nephron 
consists of the glomerulus and the associated tubule that connects to the collecting duct. The 
glomerulus is the basic filtering unit of the nephron, which is composed of a network of capillaries that 
is surrounded by the Bowman’s capsule into which the blood plasma is filtered (Figure 5). Blood enters 
the glomerular capillaries from an afferent arteriole and leaves through an efferent arteriole. 
Capillaries are lined by fenestrated endothelial cells that allow the free filtration of plasma and solutes 
while larger molecules, such as red blood cells, cannot pass through. The endothelium is followed by 
the glomerular basement membrane (GBM), a specialized extracellular matrix, that represents another 
filtration barrier for bigger proteins like albumin (Miner 2012, Suh and Miner 2013). Podocytes sit on 
the opposite side of the GBM forming large projections, the so called foot processes, connected by the 
slit diaphragm. These three-layered structure facilitates the efficient flow of water and small solutes 
into the Bowman’s space while the retention of bigger molecules and proteins is ensured. The 
glomerulus also contains mesangial cells that have contractile and phagocytic properties.  
 
 
Figure 5 – The glomerulus and the composition of the glomerular filtration barrier 
Schematic representation of the glomerulus and the glomerular filtration barrier. Blood enters the 
glomerulus through an affarent arteriole and leaves through an efferent arteriole. It is filtered through 
a barrier composed of three layers: the fenestrated endothelium, the glomerular basement membrane 
(GBM) and the podocytes with foot processes (Leeuwis, Nguyen et al. 2010). 
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The ultrafiltrate, produced by the glomerulus, passes into the tubules where its volume and content is 
altered by reabsorption or secretion. Most solute and water reabsorption occurs in the proximal tubule 
consisting of the proximal convoluted and the proximal straight tubule that connect the Bowman’s 
capsule to the loop of Henle (Curthoys and Moe 2014). Sodium transport at the apical membrane is 
passive and often coupled to chloride, glucose or amino acid symport as well as to hydrogen ion 
antiport (Aronson and Sacktor 1975, Bobulescu and Moe 2006). Importantly, apical H+-secretion 
generates bicarbonate that exits the basolateral membrane by a sodium-bicarbonate cotransport, 
which substantially contributes to the whole body acid-base balance (Boron and Boulpaep 1983, 
Schmitt, Biemesderfer et al. 1999). At the basolateral membrane, the export of sodium is actively 
driven by Na+-K+-ATPases while water moves osmotically with the reabsorbed solutes so that the 
proximal fluid remains almost isoosmotic to plasma (Curthoys and Moe 2014). Potassium is reabsorbed 
para- and transcellularly by the activity of a luminal K+-pump (Giebisch 1998). The straight proximal 
tubule connects to the loop of Henle composed of the thin descending limb, the thin ascending limb 
and the thick ascending limb. The thin descending limb is permeable to water but not to 
sodiumchloride while the thin ascending limb is permeable to sodiumchloride but not to water. These 
differences in permeability allow the generation of a concentrated medullary interstitium and produce 
a diluted fluid. The final reabsorption of sodium and potassium takes place in the thick ascending limb 
of the loop of Henle as well as in the distal tubule and the collecting ducts. Thus, excreted urine is 
formed by three main processes: glomerular filtration, tubular reabsorption and tubular secretion. 
In total, about 99% of the filtered sodium and water is being reabsorbed, mostly by active transport, 
which requires a lot of energy in form of ATP (O'Connor 2006). Thus, it is not surprising that the kidneys 
are second to the heart in terms of oxygen consumption and mitochondrial number (O'Connor 2006, 
Parikh, Yang et al. 2015). Especially, segments of the nephron with a high abundance of Na+-K+-
ATPases, such as the proximale tubule and the thick ascending limb of Henle’s loop, are densely packed 
with mitochondria (Parikh, Yang et al. 2015). Furthermore, the proximal tubule mainly relies on 
oxidative phosphorylation to generate energy and emerges as the only place where gluconeogenesis 
occurs as evidenced by the presence of gluconeogenic enzymes (Vandewalle, Wirthensohn et al. 1981). 
On the other hand, more distal nephron segments have been shown to produce large amounts of 
lactate suggesting that anaerobic glycolysis may contribute substantially to the production of ATP in 
these parts of the kidney (Bagnasco, Good et al. 1985, Soltoff 1986). Thus, kidney is an important player 
in the regulation of whole body glucose homeostasis by using glucose as an energy substrate for 
aerobic and anaerobic metabolism, by reabsorbing glucose from the primary filtrate and by releasing 
de-novo produced glucose from renal gluconeogenesis (Gerich 2010).  
Next to its role in fluid, salt and glucose homeostasis, the kidney is an important endocrine organ and 
secretes various hormones such as renin, erythropoietin (EPO), 1,25 dihydroxy vitamin D3, kallikrein 
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and eicosanoids. Furthermore, the kidney is also the primary target of various hormones like 
aldosterone, angiotensin and vasopressin (Sahay, Kalra et al. 2012). The renin-angiotensin-aldosterone 
system (RAAS) is essential in the control of blood pressure and begins with the release of renin from 
the juxtaglomerular apparatus in the kidney, whenever there is a drop in blood pressure or body fluid 
volume. Renin leads to the cleavage of angiotensinogen to angiotensin I and via the angiotensin 
converting enzyme to angiotensin II. The latter leads to vasoconstriction of capillaries and the release 
of aldosterone from the adrenal cortex, which increases sodium and water retention in the nephron 
(Brewster and Perazella 2004). Furthermore, angiotensin II promotes the feeling of thirst and leads to 
the liberation of vasopressin from the brain, which increases the rate of water reabsorption by the 
distal tubule and the collecting duct through exocytosis of the water channel molecule aquaporin 
(Nielsen, DiGiovanni et al. 1993). All of these pathways of the RAAS finally lead to an increase in blood 
pressure and thereby contribute to the regulation of whole body homeostasis.  
EPO is another important hormone that is mainly synthesized in the kidney, which controls erythrocyte 
differentiation (Jacobson, Goldwasser et al. 2000, Foley 2008). Because of its stimulating effect on red 
blood cell production, recombinant human EPO has been produced for the use in therapeutic settings, 
however, it has also been misused in sports in the form of doping (Salamin, Kuuranne et al. 2017).  
Thus, the kidney is a highly active organ that substantially contributes to whole body metabolism and 
homeostasis.  
 
1.4.1 Kidney plasticity  
The kidney is a highly complex organ with a huge number of different cell types and disturbances in 
metabolic function and cellular homeostasis in either of them can contribute to the development and 
progression of a variety of pathological conditions. Regardless of the cause, kidney diseases are 
characterized by a loss of kidney function and are generally classified into acute, which develop within 
seven days, and chronic kidney diseases (CKD), which develop over three or more months (Levey, 
Coresh et al. 2003, Mehta, Kellum et al. 2007). CKD is an emerging health problem in the Western 
World and several risk factors including race, gender, age, family history but also diabetes and 
hypertension can contribute to the development of CKD (Snyder and Pendergraph 2005, Kazancioglu 
2013). Nowadays, it is believed that in response to injury, renal cells can undergo an epithelial–
mesenchymal trans-differentiation (EMT), meaning, that they regress from an adult, mature 
phenotype to an embryonic one. This phenotypic change, together with inflammatory processes and 
remodeling of the extracellular matrix, is involved in tissue scarring and the progression of CKD (El-
Nahas 2003, El Nahas 2003). Furthermore, oxidative stress and mitochondrial dysfunction have been 
observed in patients with CKD suggesting that mitochondria are also involved in the development and 
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progression of CKD (Granata, Zaza et al. 2009, Small, Coombes et al. 2012). In fact, mitochondrial 
dysfunction, due to a decrease in mitochondrial DNA copy number, loss of mitochondrial membrane 
potential and reduced ATP production, is an early event in aldosterone-induced podocyte injury (Su, 
Dhoopun et al. 2013). The latter is known to induce proteinuria that eventually induces tubular 
epithelial cell apoptosis and EMT, which finally progresses to CKD (Nangaku 2004). Emerging evidence 
suggest that mitochondrial dysfunction, for example through increased oxidative stress, might be 
involved in many other renal diseases as in diabetic nephropathy, a CKD initiated by diabetes mellitus 
(Kdoqi 2007, Che, Yuan et al. 2014, Higgins and Coughlan 2014, Granata, Dalla Gassa et al. 2015). 
However, future studies are needed to determine the impact of mitochondrial dysfunction on renal 
physiology and pathophysiology. To conclude, CKD develops and progresses through different 
mechanisms involving phenotypic changes in renal cells, inflammation, extracellular matrix remodeling 
and mitochondrial dysfunction.  
 
1.4.2 Regulation of PGC-1α expression and activity in kidney metabolism 
Mitochondrial function and oxidative respiration are essential for kidney metabolism, which is also 
reflected by the high basal expression of PGC-1α (Puigserver, Wu et al. 1998, Larrouy, Vidal et al. 1999). 
As in many other pathological conditions in different organs, PGC-1α expression is downregulated, for 
example in patients with CKD, which seems to negatively correlate with plasma levels of 
malondialdehyde, a product of oxidative stress-induced lipid damage (Zaza, Granata et al. 2013, 
Elsayed, Nassra et al. 2017). Furthermore, aldosterone-induced podocyte injury decreases PGC-1α 
mRNA levels and induces mitochondrial damage (Yuan, Huang et al. 2012). Sepsis-associated acute 
kidney injury promotes renal dysfunction and suppresses PGC-1α leading to the downregulation of 
oxidative phosphorylation genes (Tran, Tam et al. 2011). In addition, transient local induction of 
ischemia impairs renal function, induces renal steatosis and reduces PGC-1α expression (Tran, 
Zsengeller et al. 2016). As in skeletal muscle, the inflammatory cytokine TWEAK has been shown to 
decrease renal PGC-1α expression through NF-κB activation and histone deacetylation leading to 
impaired mitochondrial function (Ruiz-Andres, Suarez-Alvarez et al. 2016). Furthermore, PGC-1α 
expression also seems to be regulated by extracellular‐signal‐regulated kinase 1/2 (ERK1/2) that 
phosphorylates FoxO3a/1 inactivating and preventing it from increasing PGC-1α expression (Collier, 
Whitaker et al. 2016). Interestingly, ERK1/2 is stimulated by epidermal growth factor receptor (EGFR), 
which itself has been shown to be transactivated by TWEAK (Rayego-Mateos, Morgado-Pascual et al. 
2013). Thus, TWEAK seems to be a potent negative regulator of PGC-1α expression in different tissues 
including skeletal muscle and kidney.  
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As downregulation of PGC-1α expression and reduced protein activity are evident in many renal 
diseases, numerous studies focused on the prevention of this deregulation to improve mitochondrial 
and kidney functions. Fenofibrate treatment ameliorates diabetic nephropathy through activation of 
the AMPK-PGC-1α axis in db/db mice and renal lipotoxicity and hypertension through stimulation of 
the PPARα-FoxO3a-PGC-1α pathway in HFD fed rats, respectively (Chung, Lim et al. 2012, Hong, Lim et 
al. 2014). Moreover, resveratrol, a proposed SIRT1 activator, has been shown to protect from 
aldosterone-induced podocyte injury, renal lipotoxicity and mesangial cell glucotoxicity by activating 
PGC-1α (Yuan, Huang et al. 2012, Kim, Lim et al. 2013). Thus, PGC-1α is an essential player in 
mitochondrial homeostasis and oxidative metabolism in renal physiology and stimulation of PGC-1α 
activity and expression shows potential in the treatment of different kidney pathologies.  
 
1.4.3 PGC-1α in the regulation of kidney plasticity 
Even though PGC-1α is important for kidney metabolism and homeostasis, it seems to be dispensable 
for basal renal function, however, necessary for the recovery from different kidney disorders. For 
example, global– and proximal tubule-specific PGC-1α knockout mice show an impaired ability to 
recover from sepsis-induced acute kidney injury (Tran, Tam et al. 2011). Furthermore, overexpression 
of PGC-1α or SIRT1 in podocytes protects from aldosterone-induced cell damage, depletion and 
mitochondrial dysfunction (Yuan, Huang et al. 2012, Zhao, Yuan et al. 2016). In addition, inducible 
nephron-specific PGC-1α knockout mice show a mild salt-losing phenotype with elevated urinary 
sodium excretion and display impaired renal steatosis upon HFD treatment (Svensson, Schnyder et al. 
2016). Recently, PGC-1α has been shown to regulate renal nicotinamide adenine dinucleotide (NAD) 
biosynthesis (Tran, Zsengeller et al. 2016). Following ischemia, global PGC-1α knockout mice exhibited 
exacerbated renal function, lipid accumulation and tubular injury, which could be prevented by the 
supplementation with nicotinamide (NAM), a precursor for the synthesis of NAD (Tran, Zsengeller et 
al. 2016). Furthermore, overexpression of PGC-1α in tubular epithelial cells blunted the response to 
ischemia and better preserved kidney function (Tran, Zsengeller et al. 2016). These results clearly 
demonstrate that PGC-1α is a potent mediator of renal stress resistance and strongly suggest that PGC-
1α might be a valuable target in the treatment of renal diseases.  
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2. Aims of the thesis 
 
Coregulator proteins have emerged as important players in the control of gene transcription and exert 
essential cellular functions as metabolic sensor and effector proteins. During this thesis, we particularly 
focused on the regulation of the PGC-1 family of transcriptional coactivators and their role in tissue-
specific metabolism and plasticity. Using different mouse knockout models, molecular biology 
techniques including mRNA sequencing and cell culture approaches, we elucidated the role of PGC-1α 
and PGC-1β in skeletal muscle metabolism under various stress conditions. Furthermore, we 
determined the function of PGC-1α in podocyte biology and its contribution to renal physiology. Thus, 
during the course of my thesis, we tried to achieve the following aims: 
 
1. Define the role of PGC-1α in the regulation of muscle and whole body metabolism in response to 
long-term ketogenic diet feeding. 
Ketogenic diets have emerged as potent therapeutic interventions in the treatment of epilepsy as well 
as of metabolic disorders such as obesity or type 2 diabetes. Furthermore, PGC-1α has recently been 
identified as an important modulator of systemic ketone body homeostasis through the regulation of 
ketolytic gene expression in skeletal muscle. This prompted us to conduct a follow-up study in order 
to elucidate the role of muscle PGC-1α in the regulation of the physiological adaptations to a long-term 
ketogenic diet, which is described in chapter 3 of this thesis.  
 
2. Elucidate the acute time-course specific and chronic transcriptional changes upon exercise and 
their dependence on skeletal muscle PGC-1α. 
PGC-1α is an important key player in mediating exercise-induced skeletal muscle adaptations. As a 
transcriptional coactivator, PGC-1α is thus required for the expression of target genes. In chapter 4 of 
this thesis, we defined the acute time-course and chronic transcriptional changes induced by exercise 
and the involvement of PGC-1α in these contexts.  
 
3. Determine if PGC-1β is involved in the fasting response in skeletal muscle and thereby elucidate 
how PGC-1β expression is regulated. Furthermore, define the PGC-1β-dependent and –independent 
fasting response in skeletal muscle and whole body metabolism. 
PGC-1β is known to be an essential regulator of mitochondrial metabolism in different tissues including 
skeletal muscle. Contrary to PGC-1α, PGC-1β expression is largely unaffected by different stimuli such 
as exercise or cold exposure. Nevertheless, fasting and short-term high fat feeding induce hepatic PGC-
1β mRNA levels. Thus, we evaluated if PGC-1β expression in skeletal muscle is also affected by fasting 
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and if so, how. Furthermore, we defined the PGC-1β-dependent fasting response in skeletal muscle 
and whole body metabolism, which is described in chapter 5 of this thesis.  
 
4. Define the role of PGC-1α in podocyte physiology and its function in stress-induced kidney 
metabolism. 
Podocytes are highly specialized kidney cells participating in the renal filtration process. Recently, 
mitochondrial dysfunction in podocytes and other kidney cells has been implicated to contribute to 
the development and progression of kidney malfunction and diseases. Since PGC-1α is an essential 
regulator of oxidative metabolism and mitochondrial homeostasis in different tissues including the 
kidney, we determined its role in podocyte metabolism under basal and stress-induced conditions. The 
results of this study can be found in chapter 6 of this thesis.  
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Abstract 
Skeletal muscle adaptations to acute bouts of exercise or chronic exercise training are complex and 
involve profound changes in muscle and whole body metabolism. One of the known key players in 
mediating the transcriptional responses to exercise in muscle tissue is the peroxisome proliferator-
activated receptor γ coactivator-1α (PGC-1α). In this study, we highlight the PGC-1α-dependent and -
independent time-course transcriptional changes upon an acute bout of exercise using control (WT) 
and muscle-specific PGC-1α knockout (MKO) mice. We identified the WT time-course-specific and 
acute core exercise responses using RNA sequencing and showed that PGC-1α is important for the 
exercise-induced acute- and heat-stress response in skeletal muscle. Furthermore, the comparison of 
the acute and chronic exercise-induced transcriptional changes revealed only little overlap between 
the two conditions suggesting that the acute and chronic transcriptional responses to exercise are 
clearly distinct from each other. Thus, our study adds new aspects to the complex regulation of skeletal 
muscle exercise physiology and the important role of PGC-1α in this context.  
 
Abbreviations 
AP-1, activator protein 1 complex; ATF, activating transcription factor; CaMK, Ca2+/calmodulin-
dependent protein kinase; DE, differentially expressed; Egr1, early growth response 1; FC, fold change; 
FDR, false discovery rate; GO, gene ontology; HS, horse serum; HSF, heat shock factor; Hsp, heat shock 
protein; ISMARA, integrated motif activity response analysis; Maf, proto-oncogene c-Maf; MAPK, 
mitogen-activated protein kinase; MHC, myosin heavy chain; MKO, muscle-specific PGC-1α knockout 
mice; Nr4a3, nuclear receptor subfamily 4 group A member 3; PCA, principal component analysis; PGC- 
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1α, peroxisome proliferator-activated receptor γ coactivator-1α; SEM, standard errors of the means; 
SRF, serum response factor; WT, control mice 
 
Introduction 
Skeletal muscle is a highly plastic organ and substantially contributes to whole body energy 
metabolism, especially during strenuous exercise. Nowadays, the latter is considered to be part of a 
healthy lifestyle and is widely accepted as a therapeutic strategy to counteract different metabolic 
diseases such as obesity or type 2 diabetes (Haskell, Lee et al. 2007, Colberg, Sigal et al. 2010). 
Furthermore, regular exercise has been shown to exert beneficial effects in the treatment of cancer or 
other muscle wasting diseases like sarcopenia (Haskell, Lee et al. 2007, Egan and Zierath 2013). 
Multiple pathways coordinate the complex metabolic changes in response to exercise and numerous 
molecular regulators involved in skeletal muscle exercise physiology have been elucidated (Gabriel and 
Zierath 2017). Interestingly, many of the exercise-induced molecular changes converge on the 
peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α), a master regulator of 
mitochondrial biogenesis and oxidative metabolism (Lin, Handschin et al. 2005), to increase its 
expression (Wu, Kanatous et al. 2002, Handschin, Rhee et al. 2003, Akimoto, Pohnert et al. 2005, Jager, 
Handschin et al. 2007), protein stability (Puigserver, Rhee et al. 2001, Jager, Handschin et al. 2007, 
Canto, Gerhart-Hines et al. 2009) or hypomethylate its promotor (Barres, Yan et al. 2012). PGC-1α itself 
interacts with a variety of different transcription factors to promote many of the exercise-induced 
transcriptional changes in mitochondrial metabolism, angiogenesis and β-oxidation (Catoire, Mensink 
et al. 2012, Egan and Zierath 2013). Even though skeletal muscle exercise metabolism and the role of 
PGC-1α in this context have been largely explored, the complete picture of exercise-induced skeletal 
muscle changes is still unclear. Nevertheless, it is believed that each bout of acute exercise elicits 
alterations in mRNA levels, which over time accumulate and lead to the increased abundance of 
proteins, finally resulting in improved exercise performance and skeletal muscle metabolic functions 
(Yang, Creer et al. 2005, Gabriel and Zierath 2017, Robinson, Dasari et al. 2017). Yet, the time-course 
of the acute exercise-induced transcriptional changes and their contributions to the chronic training-
induced skeletal muscle adaptations have not been explored so far. Thus, we performed a time-course 
study with control (WT) and muscle-specific PGC-1α knockout mice (MKO) using mRNA sequencing. 
Only a small fraction of differentially expressed (DE) genes overlapped between all of the different 
time points in WT animals, which we identified as the acute core exercise response. Interestingly, MKO 
animals showed a different pattern of DE genes during the time-course and a much smaller core 
exercise response. Importantly, stress-induced transcripts seemed to be dependent on skeletal muscle 
PGC-1α, especially genes belonging to the family of heat shock proteins. Thus, our data demonstrate 
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that PGC-1α is important for the induction and perpetuation of the acute time-course and heat-stress 
response in skeletal muscle. Furthermore, chronic exercise training of WT and MKO mice only resulted 
in a small amount of DE genes with a minimal overlap with the acute time-course. These results suggest 
that chronic exercise training might lead to an increase in protein rather than transcript levels and 
demonstrate that the acute and chronic transcriptional exercise responses are clearly distinct from 
each other. Thus, for the first time, we characterize the acute and chronic core exercise responses and 
the dependence of skeletal muscle PGC-1α and thereby solidify its key role in exercise and muscle 
physiology. 
 
Material and Methods 
Mice and training protocols 
Experiments were performed with the approval of the Swiss authorities on adult male mice (15-20 
weeks old). Mice had free access to food and water and were housed in a conventional facility with a 
12 h light/12 h dark cycle. The PGC-1α muscle-specific knockout (MKO) mice used in this study were 
generated as described previously (Svensson, Albert et al. 2016) and floxed littermates were used as 
controls (WT).  
For the time-course study mice were acclimatized to treadmill running (Columbus Instruments) as 
described in Table 1 of the Supplemental Material. Two days after acclimatization, the test started at 
0 m/min for 5 min, 5 m/min for 5 min and 8 m/min for 5 min with a 5° incline and the speed was 
increased 2 m/min every 15 min until exhaustion. Blood lactate and glucose were measured from tail 
blood with a lactate plus meter (Nova Biomedical, Labor-Systeme Flükiger AG) or glucose meter (Accu-
Chek, Roche), respectively, before and after the treadmill test. Immediately, 4 h 6 h and 8 h after the 
test mice were killed by CO2 and tissues collected. Sedentary mice were not exposed to any treadmill 
running.  
For chronic training mice were acclimatized to treadmill running and treadmill training was carried out 
five times a week for four weeks as described in Table 2a and b of the Supplemental Material. 
Endurance capacity of the mice was determined on an open treadmill as described above. VO2max was 
measured in a closed treadmill (Columbus Instruments) and the test started at 0 m/min for 5 min and 
10 m/min for 3 min with a 15° incline and the speed was increased 2 m/min every 2 min until 
exhaustion. Chronically trained mice were killed by CO2 18 h after the last training session and organs 
were removed. 
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mRNA sequencing and analysis 
Total RNA was isolated from Quadriceps muscle with TRI reagent (T9424, Sigma) according to the 
manufacturer’s instructions. RNA concentration was measured with a NanoDrop OneC 
spectrophotometer (Thermo Scientific). 7500 ng RNA was further purified with the direct-zol RNA 
MiniPrep Kit (R2050, Zymo Research) according to the manufacturer’s instructions. For RNAseq library 
preparation 1 µg of purified RNA was used and libraries prepared with the TruSeq RNA library Prep Kit 
(Illumina) according to the manufacturer’s instructions. Single read sequencing was performed with a 
HighSeq 2500 machine (50 cycles, Illumina). Fastq files were mapped to the mouse genome (mm10) 
and RNAseq and statistical analysis performed with the CLC Genomics Workbench Software (Qiagen).  
Differentially expressed genes were pictured in a Venn diagram with the use of the interactiVenn web-
based tool (Heberle, Meirelles et al. 2015). Gene ontology (GO) analysis was executed by the usage of 
GeneCodis (Carmona-Saez, Chagoyen et al. 2007, Nogales-Cadenas, Carmona-Saez et al. 2009, Tabas-
Madrid, Nogales-Cadenas et al. 2012). Only GO terms with at least five mapped genes were considered 
to be enriched and GO list was summarized using REVIGO with an allowed similarity of 0.5 (Supek, 
Bosnjak et al. 2011). Enriched GO terms were furthermore sorted by enrichment (calculated by: 
(Support/List Size)/(Reference Support/Reference size)). Integrated motif activity response analysis 
(ISMARA) was used to predict enriched transcription factor binding motifs (Balwierz, Pachkov et al. 
2014). 
 
Cell culture 
C2C12 myoblasts were grown in proliferation medium (DMEM, 10% FetalClone Serum [FCS, 
SH30066.03, GE Healthcare Life Sciences], 1% Penicillin/Streptomycin [15140122, Thermo Scientific]) 
until confluency and then medium was switched to differentiation medium (DMEM, 2% horse serum 
[HS, 16050122, Thermo Scientific]) for 4 days. Myotubes were infected with si-Scr or si-PGC-1α for 24 
h. For serum shock experiments cells were treated with DMEM containing 50% HS for 15 min, 30 min, 
1 h, 2 h or 4 h and RNA was harvested as described below. For heat shock experiments cells were put 
at 42 °C for 15 min, 30 min, 1 h, 2 h or 4 h and RNA was harvested as described below.  
 
RNA isolation and real-time qPCR 
Total RNA was isolated from C2C12 mytubes with 1 mL TRI reagent (T9424, Sigma) according to the 
manufacturer’s instructions. RNA concentration was measured with a NanoDrop OneC 
spectrophotometer (Thermo Scientific), treated with DNase I (18068015, Thermo Scientific) and then 
reverse transcribed using hexanucleotide mix (11277081001, Sigma) and SuperScript II reverse 
transcriptase (18064022, Thermo Scientific). The level of relative mRNA was quantified by real-time 
PCR on a Light Cycler 480 II system (Roche) using Fast Start Essential DNA Green Master mix 
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(06924204001, Roche). The analysis of the mRNA was performed by the comparative CT method using 
TATA binding protein (TBP) as endogenous control. Primer sequences are listed in Table 3 of the 
Supplemental Material. 
 
Statistical analysis 
Values are expressed as means ± standard errors of the means (SEM) and statistical significance was 
determined with unpaired two tailed t-tests using Excel software. P values <0.05 were considered 
statistically significant. Significant differences between WT and MKO mice or between untreated (Ctrl) 
and treated cells, respectively, are indicated by an asterisk (*). Significant differences between pre- 
and post-acute exercise, si-Scr and si-PGC-1α treated cells and sedentary and chronically trained mice, 
respectively, are indicated by a hashtag (#). 
 
Results 
PGC-1α substantially contributes to gene expression changes after acute treadmill running 
To elucidate transcriptional changes after an acute bout of exercise a time-course study was 
performed. Thus, control (WT) and muscle-specific PGC-1α knockout mice (MKO) were run on an open 
treadmill until exhaustion and then killed 0 h, 4 h, 6 h or 8 h after the exercise test. As expected, MKO 
animals ran significantly less (Fig. 1A) and showed higher post-lactate levels (Fig. 1B) than WT mice, 
which is in accordance with the current literature (Handschin, Chin et al. 2007, Summermatter, Santos 
et al. 2013). Furthermore, treadmill running increased blood lactate (Fig. 1B) and glucose (Fig. 1C) 
levels in WT and MKO animals compared to sedentary animals indicative that the mice indeed reached 
exhaustion.  
Quadriceps muscles were used for RNAseq analysis and principal component analysis (PCA) was 
conducted. WT and MKO animals were clearly distinct from each other clustering at different points 
on the PC-3 axis (Fig. 1D). Furthermore, the different time points of the acute exercise time-course 
distributed along the axes of PC-1 and -2, being more dispersed in WT than in MKO animals (Fig. 1D). 
Interestingly, the 6 h time point clustered the farthest away from the sedentary mice, which was also 
reflected in the highest total number of differentially expressed (DE) genes over the time-course in WT 
and MKO animals (Fig. 1E). Moreover, MKO animals showed substantially less DE genes than WT 
animals (854 versus 1339) suggesting that PGC-1α contributes to many of the gene expression changes 
induced after acute treadmill running (Fig. 1E-G). Venn diagram representation of DE genes clearly 
revealed 56 and 25 overlapping genes in WT (Fig. 1F) and MKO (Fig. 1G) animals, respectively (Supp. 
Fig. 1). The overlapping 56 DE genes in WT animals were thus defined as the acute core exercise 
response. These data suggest that PGC-1α is not only important for the determination of the amount 
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of DE genes after acute treadmill running but might also be essential for the acute core exercise 
response in skeletal muscle.  
 
PGC-1α is involved in the acute core exercise response in skeletal muscle 
To characterize the acute core exercise response, we performed gene ontology (GO) analysis on the 
56 and 25 DE genes, respectively, and identified five overrepresented categories in WT animals (Fig. 
2A) while we could not find any enriched GO category in MKO mice. The top overrepresented category 
in WT animals was “cellular response to calcium ion” with an enrichment of over 200 and associated 
genes of the Fos and Jun gene families (Fig. 2A and B). Interestingly, these genes associated also to 
other GO terms of the five identified categories related to the control of gene transcription and 
apoptotic processes (Fig. 2B). Furthermore, the second top overrepresented category, “response to 
stress”, involved genes of the heat shock protein (Hsp) family, of which some also associated to 
another category “negative regulation of apoptotic processes” (Fig. 2B). Thus, the acute core exercise 
response in WT animals mainly involves the transcriptional regulation of target genes due to calcium 
ions and stress. Moreover, PGC-1α seems to contribute to this stress-induced transcriptional 
regulation indicated by the reduced number of DE genes associated to the acute core exercise 
response in MKO animals.  
We also assessed the time point specific GO categories of WT and MKO animals excluding the core 
exercise response. Immediately after the exercise test (0 h), DE genes of WT animals clustered into 
categories involved in immunity, hypoxia, inflammation, transcription and signal transduction (Fig. 2C 
and Supp. Fig. 2A), while DE genes of MKO animals clustered into categories related to the WT core 
exercise response like “cellular response to calcium”, “regulation of apoptotic process” or “response 
to stress” next to categories involved in immunity, inflammation and transcription (Fig. 2D and Supp. 
Fig. 2B). These results suggest that PGC-1α might not be important for the induction of the exercise-
induced acute stress response but rather for the perpetuation of gene transcription over time. At the 
4 h time point of the time-course, DE genes in WT animals associated to different categories than at 
the 0 h time point like “glucose metabolic process”, “angiogenesis”, “fatty acid metabolic process” or 
“actin cytoskeleton organization” (Fig. 2E and Supp. Fig. 2A). Interestingly, “response to stress”, one of 
the GO terms of the acute core exercise response, also appeared in the overrepresented categories of 
the 4 h time point suggesting that certain members of the Hsp family seem to be important throughout 
the time-course while others cluster at a given time point (Fig. 2E and Supp. Fig. 2A). The two top GO 
terms of MKO animals were related to glucose metabolism and angiogenesis, as it was also seen in WT 
mice, followed by “protein homooligomerization” and transcriptional regulation (Fig. 2F Supp. Fig. 2B). 
These categories again differed from the ones of WT animals, which was also the case at the 6 h time 
point. WT animals showed enriched GO terms related to cell growth, inflammation and wound healing 
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while MKO animals showed “heart development”, “regulation of cell proliferation” and “regulation of 
ion transmembrane transport” as top overrepresented categories with very low enrichments (Fig. 2G, 
H and Supp. Fig. 2A, B). At the 8 h time point only one GO term could be identified for both genotypes, 
“regulation of transcription, DNA-templated” (Supp. Fig. 2A and B). These data demonstrate that the 
time-courses of WT and MKO animals are clearly distinct from each other and suggest that PGC-1α 
might be important for the acute core exercise response as well as for the timely regulation of 
transcription of target genes.  
 
MKO animals show different expression patterns of genes associated to the acute core exercise 
response 
We next assessed the time-course gene expression patterns of genes associated to the acute core 
exercise response. Fos (Fig. 3A) and Jun (Fig. 3B) of the category “cellular response to calcium ion” 
showed very similar patterns between WT and MKO animals, however, Fos was significantly lower 
expressed at the 6 h time point in MKO compared to WT animals (Fig. 3A). Candidates of the second 
top GO term of the acute core exercise response, “response to stress”, depicted a blunted induction 
of gene expression in MKO animals. Hsp90aa1 was significantly lower expressed at time points 0 h, 6 
h and 8 h (Fig. 3C) while Hspa1b showed reduced transcript levels at time points 6 h and 8 h (Fig. 3D) 
in MKO compared to WT animals. The same pattern was observed for the early growth factor 1 (Egr1), 
a gene that is involved in transcriptional regulation (Fig. 3E). On the other hand, nuclear receptor 
subfamily 4 group A member 3 (Nr4a3) seemed to be negatively regulated by PGC-1α in sedentary 
mice and at the 6 h time point, even though its transcript levels peaked at the same point in WT and 
MKO animals (Fig. 3F). Taken together, these results demonstrate that PGC-1α is indeed important for 
the perpetuation of transcription of genes belonging to the acute core exercise response.  
Integrated motif activity response analysis (ISMARA) was conducted to identify enriched transcription 
factor binding motifs. Serum response factor (SRF) was one of the top candidates of predicted 
transcription factors, which showed increased transcriptional activity immediately after the exercise 
test, however, there was no difference between WT and MKO animals (Fig. 3G) (Rose, Kiens et al. 
2006). Interestingly, Egr1, Fos and Hsp90aa1 are predicted to be target genes of SRF (data not shown) 
(Chai and Tarnawski 2002), which would correlate with our gene expression data and suggest that SRF 
is one of the first transcription factors to be activated after an acute bout of exercise to regulate the 
stress response. Furthermore, also Jun (Fig. 3H) and Fos (3I) were predicted to have increased 
transcriptional activity immediately after and at the 4 h time point, respectively, but again 
independently of PGC-1α. Thus, Fos and Jun of the acute core exercise response not only show induced 
mRNA levels but also increased transcriptional activity at target gene promoters.  
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Serum and heat shock experiments in C2C12 myotubes cannot mimic the complex acute core exercise 
response  
As we identified the acute core exercise response to be a stress response and SRF as one of the early 
induced predicted transcription factors, we tried to mimic this response in differentiated C2C12 
myotubes. SRF is known to be induced by a variety of different factors including serum (Chai and 
Tarnawski 2002). Thus, we treated C2C12 myotubes with 50% horse serum (HS) for different periods 
of time. Serum shock significantly induced mRNA levels of Fos, Jun, Egr1, Nr4a3 and PGC-1α at different 
time points, while the transcript levels of Hsp90aa1 were not affected and the ones of Hspa1b were 
even reduced (Fig. 4A). Thus, serum shock of cells can only limited mimic transcriptional changes 
observed after acute exercise in-vivo. We further assessed the dependence on PGC-1α in this context 
and serum shocked cells for 15 min to analyze the time-course expression of the SRF target genes. Si-
RNA treatment against PGC-1α led to a 50% reduction in PGC-1α mRNA levels, however, this 
downregulation had no effect on any of the SRF target genes like Fos (Fig. 4B and data not shown).  
As we did not observe an upregulation of Hsp after serum shock we tried to mimic the exercise-induced 
heat-stress response with another stimulus. As the name of the Hsp already suggests, their expression 
is induced upon heat-stress (Salo, Donovan et al. 1991). Thus, we put C2C12 myotubes at 42 °C for 
different periods of time and analyzed gene expression changes. Fos, Jun, Nr4a3 and PGC-1α were 
mildly induced after prolonged heat-stress while the mRNA levels of Egr1 continually decreased over 
time (Fig. 4C). However, Hsp90aa1 and Hspa1b were nicely induced already after 30 min and 1 h, 
respectively, of heat-stress (Fig. 4C). We again performed a knockdown experiment of PGC-1α to 
evaluate its role in the heat-stress response (Xu, Ma et al. 2016). As upon serum shock, si-RNA 
treatment against PGC-1α had no effect on the induction of Hspa1b or other target genes of the acute 
core exercise response (Fig. 4D and data not shown). Nevertheless, mRNA levels of Hspa1b were 
significantly lower in si-PGC-1α compared to si-Scr treated C2C12 myotubes in control conditions (Ctrl) 
and at the 4 h time point suggesting that PGC-1α might be important for basal Hsp expression (Fig. 
4D). These data demonstrate that the acute core exercise response in-vivo is a combination of different 
external triggers and stimuli that is too complex to be mimicked by one single factor in a system in-
vitro.  
 
Chronic exercise training shows little overlap with the acute-induced time-course transcriptional 
changes 
As described in the introduction, chronic exercise adaptations are believed to be the cumulative result 
of changes caused by acute bouts of exercise (Egan and Zierath 2013). Thus, we chronically trained WT 
and MKO mice on a treadmill five times a week for a total of five weeks to analyze and compare the 
transcriptome to the acute time-course transcriptional changes. Both, WT and MKO animals 
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significantly improved their endurance exercise capacity (Fig. 5A) as well as their maximal oxygen 
consumption (VO2max) (Fig. 5B) in a PGC-1α-independent manner. RNAseq analysis revealed only 138 
DE genes in WT and 41 DE genes in MKO animals, respectively, upon chronic exercise training 
compared to 1339 DE genes in WT and 854 DE genes in MKO animals, respectively, upon an acute bout 
of exercise (Fig. 5D and E, Fig. 1F and G). The three top GO terms in chronically trained WT animals 
were all related to peptide metabolism and included genes of the myosin heavy chain (MHC) class II 
antigen family as well as of the serine protease inhibitor family (Fig. 5C) while for chronically trained 
MKO animals no enriched GO terms were found. Also, only a small fraction of the chronically-induced 
DE genes overlapped with any of the acute time point transcriptional changes in both WT and MKO 
animals (Fig. 5D and E). GO analysis of these overlapping genes identified only one enriched category 
in WT and MKO animals related to transcriptional regulation (Fig. 5F and G). Interestingly, Nr4a3 and 
Fos of the acute core exercise response also seemed to be chronically regulated, however, in different 
directions (Fig. 5F). While both genes were significantly induced after an acute bout of exercise, their 
expression upon chronic exercise training was reduced compared to sedentary mice (data not shown). 
Thus, these data demonstrate that the acute and chronic transcriptional exercise responses are very 
distinct from each other and show little overlap in their transcriptome.  
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Figure 1. PGC-1α substantially contributes to gene expression changes after acute treadmill running  
A) Distance until exhaustion of acutely treadmill run WT and MKO mice (n=24). 
B-C) Pre- and post-lactate (B) and –glucose (C) blood levels of acutely treadmill run WT and MKO mice 
(n=24). 
D) Principal component analysis in Quadriceps muscle of WT and MKO mice killed 0 h, 4 h, 6 h, or 8 h 
after the acute treadmill test (n=5).  
E) Total differentially expressed (DE) genes in Quadriceps muscle of WT and MKO mice killed 0 h, 4 h, 
6 h, or 8 h after the acute treadmill test compared to sedentary mice with a false discovery rate (FDR) 
< 0.01 and a log2 fold change (FC) < -0.6 and > 0.6 (n=5).  
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F-G) Venn diagram of DE genes in Quadriceps muscle of WT (F) and MKO (G) mice killed 0 h, 4 h, 6 h, 
or 8 h after the acute treadmill test compared to sedentary mice with a FDR < 0.01 and a log2FC < -0.6 
and > 0.6 (n=5).  
* indicating significant differences between WT and MKO mice; # indicating significant differences 
between pre- and post-acute exercise. 
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Figure 2. PGC-1α is involved in the acute core exercise response in skeletal muscle  
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A-B) Gene ontology (GO) analysis of the acute core exercise response and associated genes (B) in 
Quadriceps muscle of WT animals compared to sedentary mice with a FDR < 0.01 and a log2FC < -0.6 
and > 0.6 (n=5).  
C-H) GO analysis of differentially expressed (DE) genes in Quadriceps muscle of WT and MKO animals 
0 h (C, D), 4 h (E, F) and 6 h (G, H) after the treadmill test compared to sedentary mice with a FDR < 
0.01 and a log2FC < -0.6 and > 0.6 (n=5).  
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Figure 3. MKO animals show different expression patterns of genes associated to the acute core 
exercise response 
A-F) mRNAseq time-course expression levels of Fos (A), Jun (B), heat shock protein 90aa1 (Hsp90aa1) 
(C), Hspa1b (D), early growth response 1 (Egr1) (E) and nuclear receptor subfamily 4 group A member 
3 (Nr4a3) (F) in Quadriceps muscle of WT and MKO animals compared to sedentary mice with a FDR < 
0.01 and a log2FC < -0.6 and > 0.6 (n=5).  
G-I) ISMARA predictions of enriched transcription factor binding motifs like serum response factor 
(SRF) (G), Junb_Jund (H) and Fos (I) in Quadriceps muscle of WT and MKO animals (n=5). 
* indicating significant differences between WT and MKO mice. 
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Figure 4. Serum and heat shock experiments in C2C12 myotubes cannot mimic the complex acute 
core exercise response  
A) Gene expression of Fos, Jun, early growth response 1 (Egr1), nuclear receptor subfamily 4 group A 
member 3 (Nr4a3), PGC-1α, heat shock protein 90aa1 (Hsp90aa1) and Hspa1b relative to TATA binding 
protein (TBP) in C2C12 myotubes after serum shock for 15 min, 30 min, 1 h, 2 h or 4 h (n=3).  
B) Time-course gene expression of PGC-1α and Fos after 15 min of serum shock in C2C12 myotubes 
treated with control si-RNA (si-Scr) or si-RNA targeting PGC-1α (si-PGC-1α) (n=3).  
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C) Gene expression of Fos, Jun, early growth response 1 (Egr1), nuclear receptor subfamily 4 group A 
member 3 (Nr4a3), PGC-1α, heat shock protein 90aa1 (Hsp90aa1) and Hspa1b relative to TATA binding 
protein (TBP) in C2C12 myotubes after heat shock for 15 min, 30 min, 1 h, 2 h or 4 h (n=3). 
D) Time-course gene expression of PGC-1α and Hspa1b after 30 min of heat shock in C2C12 myotubes 
treated with control si-RNA (si-Scr) or si-RNA targeting PGC-1α (si-PGC-1α) (n=3). 
* indicating significant differences between untreated (Ctrl) and treated cells; # indicating significant 
differences between si-Scr and si-PGC-1α treated cells. 
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Figure 5. Chronic exercise training shows little overlap with the acute-induced time-course 
transcriptional changes.  
A) Distance until exhaustion of sedentary and chronically trained WT and MKO mice (n=6). 
B) Maximal oxygen consumption (VO2max) of sedentary and chronically trained WT and MKO mice 
(n=6). 
C) Gene ontology (GO) analysis of the chronic exercise response with associated genes in Quadriceps 
muscle of WT animals compared to sedentary mice with a FDR < 0.01 and a log2FC < -0.6 and > 0.6 
(n=5). 
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D-E) Venn diagram of differentially expressed (DE) genes in Quadriceps muscle of WT (D) and MKO (E) 
mice chronically trained or killed 0 h, 4 h, 6 h, or 8 h after the acute treadmill test compared to 
sedentary mice with a FDR < 0.01 and a log2FC < -0.6 and > 0.6 (n=5).  
F-G) Gene ontology (GO) analysis of the overlap of DE genes of chronically and acutely run WT (F) or 
MKO (G) mice in Quadriceps muscle with a FDR < 0.01 and a log2FC < -0.6 and > 0.6 (n=5). 
* indicating significant differences between WT and MKO mice; # indicating significant differences 
between sedentary and chronically trained mice. 
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Supplemental Figure 1. PGC-1α substantially contributes to gene expression changes after acute 
treadmill running 
List of genes associated to the acute core exercise responses in Quadriceps muscle of WT and MKO 
animals compared to sedentary mice with a FDR < 0.01 and a log2FC < -0.6 and > 0.6 (n=5).  
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Supplemental Figure 2. PGC-1α is involved in the acute core exercise response in skeletal muscle 
A) Gene ontology (GO) analysis of the acute time-course exercise response with associated genes in 
Quadriceps muscle of WT animals compared to sedentary mice with a FDR < 0.01 and a log2FC < -0.6 
and > 0.6 (n=5).  
B) Gene ontology (GO) analysis of the acute time-course exercise response with associated genes in 
Quadriceps muscle of MKO animals compared to sedentary mice with a FDR < 0.01 and a log2FC < -0.6 
and > 0.6 (n=5). 
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Discussion 
Regular exercise is widely accepted as a strategy in the prevention, management and treatment of 
many metabolic and chronic diseases such as hypertension, cardiovascular diseases, type 2 diabetes 
and sarcopenia (Haskell, Lee et al. 2007, Colberg, Sigal et al. 2010). Many of the exercise-induced 
benefits in whole body metabolism are mediated by profound metabolic and molecular changes in 
skeletal muscle (Egan and Zierath 2013). These adaptations include changes in the contractile 
apparatus (Adams, Hather et al. 1993, Widrick, Stelzer et al. 2002), mitochondrial and metabolic 
function (Green, Helyar et al. 1992, Spina, Chi et al. 1996), signaling cascades (Benziane, Burton et al. 
2008) and transcriptional responses (Pilegaard, Saltin et al. 2003). One of the most important mediator 
of the transcriptional adaptations to exercise is PGC-1α (Catoire, Mensink et al. 2012, Egan and Zierath 
2013). For the first time, we now defined the transcriptional acute core exercise response and 
identified PGC-1α as an essential player in the perpetuation of this response over time. Furthermore, 
the acute and chronic transcriptional responses to exercise are clearly distinct from each other 
suggesting that chronic exercise training leads to changes in protein rather than mRNA expression 
levels.  
It is well established that elevated cytoplasmic calcium concentrations after neuronal stimulation 
activate different signaling cascades such as the Ca2+/calmodulin-dependent protein kinases (CaMK) 
(Gehlert, Bloch et al. 2015). Thus, it is not surprising that the top GO term of the acute core exercise 
response was identified to be “cellular response to calcium ion”. Also, the associated genes of the Fos 
and Jun gene family have been shown to be induced after exercise in human skeletal muscle 
(Puntschart, Wey et al. 1998), most likely through the activation of CaMKs and mitogen-activated 
protein kinases (MAPK) (Carrasco, Riveros et al. 2003). Interestingly, PGC-1α expression is also known 
to be induced by CaMKIV and the p38 MAPK (Wu, Kanatous et al. 2002, Akimoto, Pohnert et al. 2005) 
and seems to be involved in the perpetuation of Fos gene expression over time. Furthermore, PGC-1α 
has been shown to interact with the activator protein 1 complex (AP-1), a transcription factor 
composed of different proteins belonging to the Fos, Jun, proto-oncogene c-Maf (Maf) and activating 
transcription factor (ATF) gene families (Shaulian and Karin 2002), to induce transcription of target 
genes (Baresic, Salatino et al. 2014). It is conceivable that some of the exercise-induced gene 
expression changes are regulated by the AP-1 complex, which could explain why MKO animals show a 
different time-course expression pattern and a reduced number of DE genes. Thus, it would be 
interesting to perform knockdown studies of the two AP-1 complex members Fos and Jun to identify 
PGC-1α/AP-1-dependent target genes that are involved in the acute response to exercise.  
SRF was predicted to have increased transcriptional activity immediately after the exercise bout (Rose, 
Kiens et al. 2006), which could also be due to increased cytoplasmic calcium concentrations and 
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activated CaMK. At least in-vitro it was shown that SRF is a substrate of CaMKII, which phosphorylates 
it at Ser103 and Thr160 leading to its translocation to the nucleus (Fluck, Booth et al. 2000). These in-vitro 
data suggest that the predicted increased activity of SRF could be also caused by an elevation of 
cytoplasmic calcium concentrations and would indicate that SRF activation upon exercise is calcium-
dependent, not only in-vitro but also in-vivo. Therefore, future studies could elucidate the acute 
exercise response and the activation of SRF under conditions in which calcium release from the 
sarcoplasmic reticulum is blocked (e.g. by blocking the ryanodine receptor) or in which CaMK activity 
is disabled. Furthermore, SRF could be a potential new transcriptional partner of PGC-1α and thus, as 
for Fos and Jun, SRF knockdown studies would help in identifying SRF/PGC-1α-dependent target genes.  
The acute core exercise response also included the GO term “response to stress” in which Hsp family 
members clustered. Hsp, which have been shown to be upregulated upon an acute bout of exercise in 
different tissues including skeletal muscle, are chaperones that help to correctly fold newly synthesized 
proteins or to prevent protein aggregation (Henstridge, Febbraio et al. 2016). Interestingly, Hsp are 
not only regulated by heat-stress but also by other physiological stressors such as energy depletion, 
hypoxia or acidosis, all of which are induced by exercise (Kregel 2002). Moreover, it cannot be excluded 
that increased cytoplasmic calcium concentrations could also lead to an induction of Hsp, even though 
experimental data for this hypothesis are missing. Thus, it is difficult to dissect if upon an acute bout 
of exercise Hsp are only induced due to heat-stress caused by the mechanical contraction or due to a 
combination of the different stressors mentioned above. However, one could perform exercise 
training in a temperature controlled environment to prevent overheating of the muscle and thereby 
elucidate if Hsp are only induced by heat-stress or other factors. Nevertheless, PGC-1α seems to be 
substantially involved in the Hsp response upon exercise given the reduced induction and perpetuation 
of Hsp90aa1 and Hspa1b expression in MKO animals. Recently, PGC-1α has been shown to interact 
with heat shock factor-1 (HSF-1) to induce transcription of Hsp genes (Xu, Ma et al. 2016), which could 
explain the different response in MKO animals. However, knockdown of PGC-1α in C2C12 myotubes 
did not lead to a defect in Hsp transcriptional induction. These data suggest that either the induced 
heat-stress was to weak, even though Hsp expression was significantly induced, or that the C2C12 
myotubes system was not chosen wisely because basal mRNA expression of PGC-1α is too low. 
Therefore, either primary cells or in-situ experiments would be more suitable systems to study the 
heat-stress response. 
Finally, the acute and chronic transcriptional responses were clearly distinct from each other, even 
though theoretically it is believed that induced transcript levels after each bout of acute exercise would 
result in a sustained increase in mRNA expression after chronic training (Egan and Zierath 2013). 
However, it is possible that the chronic exercise groups would have already shown changes in protein 
rather than transcript levels, which we did not assess in this study. Thus, mass spectrometry analysis 
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of the chronically trained animals should be conducted and compared to the transcriptional changes 
of the acute time-course. Furthermore, it would be interesting to perform a time-course analysis of 
chronically trained mice and compare that to the acute time-course. These data would give insights in 
how close the acute and chronic time-course responses are to each other and whether chronic exercise 
training leads to adaptations that would blunt the response to each acute exercise bout in order to 
reduce the exercise-induced stress.  
To conclude, our data highlight the acute and chronic exercise responses and the dependency of PGC-
1α in these contexts, especially its function in the acute core exercise response, which solidifies its key 
role in exercise and muscle metabolism. Furthermore, new exciting questions regarding the acute and 
chronic exercise time-courses arose, which will hopefully be answered in future studies to contribute 
to the elucidation of the complex biology of exercise.    
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Supplemental Material 
Table 1. Acclimatization protocol for treadmill running of the acute time course study at 5° inclination. 
Day 1 
5 min  
0 m/min 
5 min  
5 m/min 
5 min  
8 m/min 
10 min  
10 m/min     
Day 2 
5 min  
0 m/min 
5 min  
5 m/min 
5 min  
8 m/min 
15 min  
10 m/min 
5 min  
12 m/min   
Day 3 
5 min  
0 m/min 
5 min  
5 m/min 
5 min  
8 m/min 
15 min  
10 m/min 
5 min  
12 m/min 
2 min  
14 m/min 
Day 4 
5 min  
0 m/min 
5 min  
5 m/min 
5 min  
8 m/min 
15 min  
10 m/min 
10 min  
12 m/min 
2 min  
14 m/min 
Day 5 
5 min  
0 m/min 
5 min  
5 m/min 
5 min  
8 m/min 
15 min  
10 m/min 
10 min  
12 m/min 
5 min  
14 m/min 
 
Table 2a. Acclimatization protocol for treadmill running of chronically trained mice. 
Day 1 
0° 
inclination 
5 min  
0 m/min 
5 min  
5 m/min 
5 min  
8 m/min 
5 min  
10 m/min 
Day 2 
5° 
inclination 
5 min  
0 m/min 
5 min  
5 m/min 
5 min  
8 m/min 
5 min  
10 m/min 
 
Table 2b. Training protocol for chronic treadmill exercise. 
   Day 1  Day 2 Day 3 Day 4 Day 5 
Week 1 10 m/min 10.5 m/min 11 m/min 11.5 m/min 12 m/min 
Week 2 12.5 m/min 13 m/min 13.5 m/min 14 m/min 14.5 m/min 
Week 3 15 m/min 15.5 m/min 16 m/min 16.5 m/min 17 m/min 
Week 4 17.5 m/min 18 m/min 18.5 m/min Rest Exercise test 
Week 5 Exercise test 18.5 m/min 18.5 m/min Sacrifice   
 
Table 3. qPCR primer sequences. 
Gene Name Forward primer Reverse primer 
Egr1 GAGCACCTGACCACAGAGTC   CGAGTCGTTTGGCTGGGATA   
Fos TACTACCATTCCCCAGCCGA GCTGTCACCGTGGGGATAAA 
Hsp90aa1 CGACGATGAGCAGTATGCCT   TCCACGACCCATTGGTTCAC   
Hspa1b GTGCACTGTACCAGGGGATTAT   CCCAGGCTACTGGAACACTG   
Jun TGGGCACATCACCACTACAC TCTGGCTATGCAGTTCAGCC 
Nr4a3 CTGCTGCTTCGCCTATCCC   GCAGGGCATATCTGGAGGGT   
PGC‐1α AGCCGTGACCACTGACAACGAG  GCTGCATGGTTCTGAGTGCTAAG 
TBP TGCTGTTGGTGATTGTTGGT CTGGCTTGTGTGGGAAAGAT 
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Abstract 
Skeletal muscle accounts for around 40-50% of total body weight and serves as the largest protein 
reservoir of the body. As such, protein catabolism from muscle tissue is of crucial importance when 
energy supply is restricted, as during fasting conditions, to maintain de-novo production of glucose in 
the liver. Thus, skeletal muscle emerges as one of the key players in the whole body response to energy 
deprivation. However, the complex regulation of skeletal muscle metabolism upon fasting is still poorly 
understood. We now assessed the role of the peroxisome proliferator-activated receptor γ 
coactivator-1β (PGC-1β) in skeletal muscle of male wild type control (WT) and PGC-1β muscle-specific 
knockout (MKO) mice upon 24 h of fasting. Interestingly, MKO animals are partially protected from the 
fasting-induced muscle atrophy even though PGC-1β expression is downregulated in muscle of WT 
mice after a 24 h energy deprivation phase. Moreover, MKO animals show significantly reduced 
myostatin mRNA levels, a blunted induction of atrophy markers gene expression and absent activation 
of AMP-dependent and cAMP-dependent protein kinases. The increased transcriptional activity of the 
nuclear factor of activated T-cells, cytoplasmic 1 (Nfatc1) and the concomitant elevation of PGC-1α 
mRNA levels provide evidence for the blunted fasting response in MKO animals and suggest that PGC-
1β acts as an inhibitor for Nfatc1 activity. Thus, these data highlight the complex regulation of muscle 
metabolism under fasting conditions and reveal PGC-1β as an important regulator in the control of 
fasting.  
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Abbreviations 
AMPK, AMP-dependent protein kinase; ATP5A, ATP synthase 5 alpha; BSA, bovine serum albumin; β-
OHB, β-hydroxybutyrate; BW, body weight; CaMK, Ca2+/calmodulin-dependent protein kinase; CEE, 
chicken embryo extract; COX, cytochrome oxidase; Cox4i1, cytochrome C oxidase subunit 4 isoform 1; 
Cox5B, cytochrome C oxidase subunit 5B; CPT-cAMP, 8-(4-chlorophenylthio)adenosine 3',5'-cyclic 
monophosphate; CRE, cAMP response element; Creb, cAMP response element binding protein; CSA, 
cross sectional area; CytC, cytochrome C; DE, differentially expressed; DMSO, dimethyl sulfoxide; EDL, 
Extensor digitorum longus muscle; FC, fold change; FDR, false discovery rate; FoxO, forkhead box O; 
GO, gene ontology; HS, horse serum; HSA, human skeletal actin; IBMX, 3-isobutyl-1-methylxanthine; 
ISMARA, integrated motif activity response analysis; MAFbx, muscle atrophy F-box; March1, 
membrane associated ring-CH-type finger 1; Mettl11b, methyltransferase like 11B; minFeret, minimal 
fiber feret; MKO, PGC-1β-specific muscle knockout; Mstn, myostatin; MuRF-1, muscle RING finger 1; 
NDUFB8, NADH dehydrogenase 1 beta subcomplex subunit 8; NEFA, non-esterified fatty acid; Nfatc1, 
nuclear factor of activated T-cells, cytoplasmic 1; Nos1, nitric oxide synthase 1; PGC-1, peroxisome 
proliferator-activated receptor γ coactivator-1; PKA, cyclic AMP-dependent protein kinase; Pomk, 
protein-O-mannose kinase; RER, respiratory exchange ratio; SDH, succinate dehydrogenase; SDHB, 
mitochondrial succinate dehydrogenase iron-sulfur subunit; SEM, standard errors of the means; 
Sh3kbp1, SH3 domain containing kinase binding protein 1; TA, Tibialis anterior muscle; TBP, TATA-
binding protein; TGF, transforming growth factor; UQCRC2, mitochondrial cytochrome b-c1 complex 
subunit 2; WT, wild type control 
 
Introduction 
Sufficient energy supply is key for life and multiple mechanisms have evolved over billions of years to 
ensure energy homeostasis even during fasting or starvation. Lately, different forms of fasting (e.g. 
intermittent or periodic) have gained more and more attention as approaches to counteract weight 
gain and obesity (Varady and Hellerstein 2007, Harvie, Pegington et al. 2011). Furthermore, emerging 
evidence suggests that fasting could even be protective against a variety of different pathological 
conditions such as diabetes, cancer or neurodegeneration, at least in rodent models (Pedersen, 
Hagemann et al. 1999, Halagappa, Guo et al. 2007, Lee, Raffaghello et al. 2012). As an adaptive 
hypometabolic response to energy deprivation, fasting involves the complex interplay between all 
organs of the body in a temporal highly organized manner. Initially, blood glucose concentration drops 
consequently leading to the release of glucagon from the pancreas, which mainly acts on the liver to 
release glucose into the circulation by triggering glycogenolysis and gluconeogenesis (Briant, Salehi et 
al. 2016). Furthermore, the reduced blood insulin levels lower the entry of glucose into adipose tissue 
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and muscle resulting in increased lipolysis and fatty acid oxidation, respectively (Holness and Sugden 
1990). These early metabolic changes all contribute to the maintenance of blood glucose levels and 
ensure the proper functioning of organs mainly relying on glucose as an energy fuel like red blood cells 
or the brain. If fasting is prolonged, liver glycogen stores get depleted so that the only source of glucose 
comes from gluconeogenesis, which is fueled by glycerol from lipolysis in adipose tissue as well as from 
the catabolism of muscle proteins (Longo and Mattson 2014). Hence, the fasting-induced muscle 
breakdown will necessitate a loss of function resembling other catabolic conditions such as 
denervation or cancer cachexia (Mitch and Goldberg 1996). However, during fasting, muscle loss is 
limited to a minimum by the production of ketone bodies in a process called ketogenesis in the liver 
(Krebs 1966). Released ketone bodies can be used by extra-hepatic tissues such as skeletal muscle and 
brain, which largely diminishes the need of glucose and consequently minimizes the loss of muscle 
protein and functionality. Thus, skeletal muscle is one of the most important players in the regulation 
of whole body energy homeostasis during fasting. Even though the fasting response in skeletal muscle 
has been extensively studied at the level of protein modifications and post-translational changes (de 
Lange, Farina et al. 2006, de Lange, Moreno et al. 2007) only very few studies focused on the 
transcriptional regulation, especially on a transcriptome-wide level (Fong, Moldawer et al. 1989, Wu, 
Inskeep et al. 1999, Hildebrandt and Neufer 2000, Jagoe, Lecker et al. 2002). Moreover, the 
involvement of coregulator proteins, which are able to control the transcription of target genes by 
interacting with different transcription factors without possessing an intrinsic DNA binding side 
themselves (Schnyder, Kupr et al. 2017), is still unknown. The peroxisome proliferator-activated 
receptor γ coactivator-1β (PGC-1β) belongs to the PGC-1 family of transcriptional coactivators 
(Kressler, Schreiber et al. 2002, Lin, Puigserver et al. 2002) and has been implicated to play a role in 
skeletal muscle mitochondrial homeostasis, angiogenesis and fiber type determination (Arany, 
Lebrasseur et al. 2007, Zechner, Lai et al. 2010, Rowe, Jang et al. 2011, Gali Ramamoorthy, Laverny et 
al. 2015). Furthermore, hepatic PGC-1β mRNA levels are induced upon fasting (Lin, Tarr et al. 2003) 
and liver-specific PGC-1β knockout mice show a blunted fasting-refeeding response (Chambers, Chen 
et al. 2012). Given the important role of skeletal muscle in the whole body response to energy 
deprivation and the fact that PGC-1β is an important regulator of skeletal muscle metabolism, we 
wondered if muscle PGC-1β might be also involved in the fasting response. Thus, the aim of our study 
was to elucidate the role of PGC-1β in the regulation of fasting on a transcriptome-wide level using 
wild type control (WT) and PGC-1β muscle-specific knockout (MKO) mice. Our data show that PGC-1β 
is substantially involved in the response to energy deprivation even though its expression in WT mice 
is downregulated upon fasting most likely through cAMP-inducing pathways. Surprisingly, MKO mice 
were partially protected from the fasting response and showed a blunted induction of myostatin 
(Mstn) and atrophy markers gene expression and reduced activation of AMP-dependent protein kinase 
5. PGC-1β is involved in the response to fasting-induced skeletal muscle atrophy by inhibiting Nfatc1 activity 
66 
 
(AMPK) and cAMP-dependent protein kinase (PKA). We identified increased transcriptional activity of 
the nuclear factor of activated T-cells, cytoplasmic 1 (Nfatc1) in MKO animals leading to increased PGC-
1α expression, which resulted in the blunted induction of the fasting-induced muscle atrophy. Thus, 
our results shed new light on the complex transcriptional network after energy deprivation and 
identified PGC-1β and Nfatc1 as novel players in the fasting response in skeletal muscle.  
 
Material and Methods 
Animal housing and PGC-1β muscle-specific knockout mouse generation 
Mice had free access to food and water and were housed in a conventional facility with a 12 h light/12 
h dark cycle. Experiments were performed with the approval of the Swiss authorities on adult male 
mice (10 weeks or older). For the knockout confirmation (Fig. 1E and F) 3-4 weeks old male and female 
mice were used. PGC-1β muscle-specific knockout (MKO) animals were generated as follows. PGC-
1βloxP/loxP animals were purchased from the Jackson Laboratory (B6.129X1-Ppargc1b tm1.1Dpk/J, strain 
number 012378; (LAI, LEONE ET AL. 2008)) and crossed with human skeletal actin (HSA)-Cre transgenic 
mice to generate MKO mice. PGC-1βloxP/loxP animals without Cre expression were used as wild type 
control (WT) mice. Genotyping was performed from tail biopsies by PCR using specific primer pairs to 
detect the presence of the loxP sites, which resulted in amplicons of ~500 bp (WT allele, 318 bp). 
Specific primer pairs to detect Cre recombinase resulted in amplicons of 100 bp in MKO mice.  
 
In vivo analysis 
To determine PGC-1 gene expression after maximal endurance performance mice were acclimatized 
to treadmill running (Columbus Instruments) as described in Table 1 of the Supplemental Experimental 
Procedures. Two days after acclimatization, the test started at 5 m/min for 5 min and 8 m/min for 5 
min with a 5° incline and the speed was increased 2 m/min every 15 min until exhaustion. 4 h after the 
exercise test mice were killed by CO2 and Quadriceps muscles removed.  
All mice were fed a normal chow diet. For fasting experiments food was withdrawn from the mice in 
the morning and 24 h later mice were killed by CO2 and organs removed 
Body composition of the mice was determined using an EchoMRI-100TM analyzer (EchoMRI Medical 
Systems).  
For indirect calorimetry mice were placed in a CLAMS system (Columbus Instruments) for four days (2 
days acclimatization, 2 days measurement) to assess their VO2 consumption and respiratory exchange 
ratio (RER). For body temperature measurements anipills (Phymep S.a.r.l.; REF: 01101, LOT: 15-03,1 
(DL 01-2017)) were implanted into the intraperitoneal cavity two weeks before CLAMS measurements. 
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Blood analysis 
Blood analysis was carried out in the morning of ad-libitum fed or 24 h fasted animals. Blood glucose 
and ketone bodies were measured from tail blood with a glucose meter (Accu-Chek, Roche) or a ketone 
body meter (Precision Xtra, Abbott Laboratories), respectively. Plasma was obtained from whole 
blood, which was collected in microvette tubes (Sarstedt) and centrifuged at 2000 g for 10 min. Non-
esterified fatty acids (NEFA) were measured in plasma using a NEFA-Kit (HR Series NEFA-HR(2), Wako 
Diagnostics) according to the manufacturer’s instructions.  
 
Primary cell culture 
For the establishment of primary cell cultures, single fibers of 3 weeks old male WT mice were isolated 
as described in the Supplemental Experimental Procedures. Primary myoblasts were differentiated at 
around 60-70% confluency using differentiation medium (DMEM Glutamax, 4% HS, 1% P/S, 1% CEE) 
for 3 days. The next day, cells were serum starved with low glucose medium (D6046, Sigma) for 16 h 
before treatment of the different compounds for 6 h. Compounds used were forskolin (100 µM, F3917, 
Sigma), 8-(4-chlorophenylthio)adenosine 3',5'-cyclic monophosphate (CPT-cAMP, 100 µM, C3912, 
Sigma), 3-isobutyl-1-methylxanthine (IBMX, 1 mM, I5879, Sigma). All compounds were diluted in 
dimethyl sulfoxid (DMSO, 1%, D2650, Sigma).  
 
Skeletal muscle stainings 
Freshly isolated Gastrocnemius muscles were placed in 8% tragacanth (G1128, Sigma) and frozen in 
liquid nitrogen cooled isopentane before cutting 10 µm cryo-cross-sections. 
Succinate dehydrogenase (SDH) staining: sections were exposed to 50 mM sodium succinate (S2378, 
Sigma) in 0.1 M phosphate buffer in the presence of 0.5 mg/ml nitroblue tetrazolium (N5514, Sigma) 
for 30 min at 37 °C. Then, sections were washed with ddH2O, dehydrated with ethanol and mounted 
with histomount (008030, Thermo Scientific).  
Cytochrome oxidase (COX) staining: slides were exposed to 0.5 mg/ml 3,3’-Diaminobenzidine 
tetrahydrochloride hydrate (D5637, Sigma), 0.2 mg/ml cytochrome c (C2506, Sigma) and 0.125 mg/ml 
catalase (C40, Sigma) in PBS for 1h at 37 °C. Then slides were washed with ddH2O, dehydrated with 
ethanol and mounted with histomount (008030, Thermo Scientific). 
Fiber typing was carried out as described in the Supplemental Experimental Procedures. Whole 
sections were pictured using a slide scanner (Axio Scan.Z1, Zeiss). For minFeret measurements and 
fiber type counting, square pictures from total sections were cropped out (mean of two pictures in the 
oxidative part of the muscle, one in the glycolytic part of the muscle). For minFeret determination a 
Fiji script was used as described in the Supplemental Experimental Procedures.  
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mRNA sequencing and analysis 
mRNA sequencing library preparation was carried out as described in the Supplemental Experimental 
Procedures. Fastq files were mapped to the mouse genome (mm10) and RNAseq and statistical 
analysis performed with the CLC Genomics Workbench Software (Qiagen).  
Differentially expressed (DE) genes were pictured in a Venn diagram with the use of the eulerAPE 
drawing tool (Micallef and Rodgers 2014). Gene ontology (GO) analysis was executed by the usage of 
GeneCodis (Carmona-Saez, Chagoyen et al. 2007, Nogales-Cadenas, Carmona-Saez et al. 2009, Tabas-
Madrid, Nogales-Cadenas et al. 2012). Only GO terms with at least 5 mapped genes were considered 
to be enriched and GO list was sorted according to corrected hypergeometric p-value. The top ten of 
enriched GO terms (Table 3-7 in the Supplemental Experimental Procedures) were furthermore sorted 
by enrichment (calculated by: (Support/List Size)/(Reference Support/Reference size)). Integrated 
motif activity response analysis (ISMARA) was used to predict enriched transcription factor binding 
motifs (Balwierz, Pachkov et al. 2014).  
 
RNA isolation and real-time qPCR 
Total RNA was isolated from powdered Quadriceps and Gastrocnemius muscles or two pieces of liver 
with FastPrep tubes (MP Biomedicals) and TRI reagent (T9424, Sigma) according to the manufacturer’s 
instructions. Total RNA from primary myotubes was isolated using the RNeasy Micro Kit (74004, 
Qiagen) according to the manufacturer’s instructions (without DNase treatment). RNA concentration 
was measured with a NanoDrop OneC spectrophotometer (Thermo Scientific). RNA was treated with 
DNase I (18068015, Thermo Scientific) and then reverse transcribed using hexanucleotide mix 
(11277081001, Sigma) and SuperScript II reverse transcriptase (18064022, Thermo Scientific). The level 
of relative mRNA was quantified by real-time PCR on a StepOnePlus system (Applied Biosystems) using 
Fast SYBR green PCR master mix (4385612, Thermo Scientific) or on a Light Cycler 480 II system (Roche) 
using Fast Start Essential DNA Green Master mix (06924204001, Roche), respectively. The analysis of 
the mRNA was performed by the comparative CT method using TATA binding protein (TBP) and 18S as 
endogenous controls. Primer sequences are listed in Table 2 of the Supplemental Experimental 
Procedures. 
 
Protein isolation and Western blotting 
Powdered tissue samples were homogenized with a polytron device in 300 μl of ice-cold lysis buffer 
(50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 0.5 mM EGTA, 1% NP-40 substitute, 150 mM NaCl, 0.2% Na-
deoxycholate, 1 mM DTT, fresh protease and phosphatase inhibitor cocktail, 10 mM nicotinamide). 
Samples were then shaken at 1300 rpm for 30 min at 4 °C, subsequently centrifuged at 13000 g for 10 
min at 4 °C, and the protein concentration of the supernatant was determined by the Bradford assay 
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(5000006, Bio-Rad). Equal aliquots of protein were boiled for 5 min in Laemmli sample buffer (250 mM 
Tris-HCl, pH 6.8, 8% SDS, 40% glycerol, 0.01% bromophenol blue, and 20% β-mercaptoethanol). 
Samples were separated on SDS-polyacrylamide gels and then transferred to nitrocellulose 
membranes. Membranes were blocked for 1 h in 5% bovine serum albumin (BSA) in Tris-buffered saline 
and Tween 20 (TBST) before overnight incubation at 4 °C with the appropriate primary antibody diluted 
in TBST (1:1000 dilution). Primary antibodies used are listed in the Supplemental Experimental 
Procedures. Following incubation, membranes were washed with TBST before incubation with an 
appropriate peroxidase-conjugated secondary antibody diluted in TBST (1:10’000 dilution). Antibody 
binding was detected using the enhanced chemiluminescence horseradish peroxidase (HRP) substrate 
detection kit (32106, Pierce). Quantification of Western blots was performed with the ImageJ software. 
 
Glycogen isolation 
Around 10 mg of powdered Gastrocnemius muscle were homogenized on ice in 200 µl water using a 
polytron device. Then samples were boiled for 5 min in order to inactivate enzymes. After 
centrifugation for 5 min at 13000 rpm supernatant was moved to new tube and glycogen content 
measured using a glycogen assay kit (ab65620, Abcam) according to the manufacturer’s instructions.  
 
Statistical analysis 
Values are expressed as means ± standard errors of the means (SEM). Statistical significance was 
determined with unpaired two tailed t-tests using Excel software and p < 0.05 was considered as 
significant. Significant differences between fed WT and fed MKO mice and fasted WT and fasted MKO 
mice, respectively, are indicated by an asterisk (*). Significant differences between fed and fasted WT 
and fed and fasted MKO mice, respectively, are indicated by a hashtag (#). 
 
Results 
PGC-1β expression is downregulated in skeletal muscle upon fasting 
The regulation of peroxisome proliferator-activated receptor γ coactivator-1 β (PGC-1β) expression in 
skeletal muscle is still largely unexplored. While PGC-1α mRNA levels are known to increase after an 
acute exercise bout, PGC-1β expression levels seem to be unaffected by exercise (Meirhaeghe, Crowley 
et al. 2003, Koves, Li et al. 2005), which we confirmed in our study (Fig. 1A). Moreover, hepatic PGC-
1α and –β expression levels have been shown to increase upon fasting (Lin, Puigserver et al. 2002) (Fig. 
1B) whereas in skeletal muscle, we observed unchanged PGC-1α mRNA levels contrary to significantly 
reduced PGC-1β levels after a 24 h fasting stimulus (Fig. 1C). These results demonstrate that PGC-1 
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expression levels upon fasting are regulated differently in liver and skeletal muscle and suggest that 
PGC-1β might indeed be involved in the fasting response in skeletal muscle.  
PGC-1α expression in liver and skeletal muscle is known to be controlled by cAMP-dependent 
pathways (Herzig, Long et al. 2001, Handschin, Rhee et al. 2003). To evaluated if PGC-1β mRNA levels 
are also controlled by cAMP signaling, we treated primary myotubes with forskolin, 8-(4-
chlorophenylthio)adenosine 3',5'-cyclic monophosphate (CPT-cAMP) or 3-isobutyl-1-methylxanthine 
(IBMX) to increase intracellular cAMP levels (Totsuka, Ferdows et al. 1983, Parsons, Ramkumar et al. 
1988, Bartsch, Zorn-Kruppa et al. 2003). Interestingly, all three compounds suppressed PGC-1β mRNA 
levels by around 50% while PGC-1α expression, as expected, was highly induced (Fig. 1D). These results 
indicate that PGC-1β expression seems to be controlled and downregulated by cAMP-inducing 
pathways and highlight that PGC-1α and –β might be controlled by the same pathway in a different 
way. 
To further explore the role of muscle PGC-1β in the regulation of fasting, we generated PGC-1β muscle- 
specific knockout mice (MKO) by crossing HSA-Cre transgenic mice with floxed PGC-1β mice (Lai, Leone 
et al. 2008), which deleted exons 4-6 of the PGC-1β gene specifically in skeletal muscle while other 
tissues were unaffected by the knockout (Fig. 1E). Furthermore, there was no compensatory increase 
in PGC-1α expression detected and various mitochondrial target genes like cytochrome C (CytC), 
cytochrome C oxidase subunit 4 isoform 1 (Cox4i1) and cytochrome C oxidase subunit 5B (Cox5B) were 
downregulated in the muscles of MKO animals (Fig. 1F). PGC-1β ablation resulted only in a minor 
reduction in the protein levels of the mitochondrial NADH dehydrogenase 1 beta subcomplex subunit 
8 (NDUFB8) while the other mitochondrial complexes like ATP synthase 5 alpha (ATP5A), mitochondrial 
cytochrome b-c1 complex subunit 2 (UQCRC2) and mitochondrial succinate dehydrogenase iron-sulfur 
subunit (SDHB) were not differently expressed between MKO and WT mice (Fig. 1G and H). 
Nevertheless, MKO mice showed a reduction in oxidative capacity as measured by the activity of the 
two mitochondrial enzymes succinate dehydrogenase (SDH) and cytochrome oxidase (COX) (Fig. 1I and 
J), which has already been shown by other studies (Zechner, Lai et al. 2010, Gali Ramamoorthy, Laverny 
et al. 2015). 
Taken together, our data demonstrate that muscle PGC-1β is an important regulator of mitochondrial 
gene expression and oxidative capacity and confirm the results obtained by other groups (Zechner, Lai 
et al. 2010, Gali Ramamoorthy, Laverny et al. 2015).  
 
PGC-1β MKO animals preserve body weight and lean mass upon 24 h of fasting 
Since we were interested in the fasting response and the role of PGC-1β in this context we fasted WT 
and MKO mice for 24 h and measured different blood parameters. As expected, glucose plasma levels 
dropped after 24 h of fasting (Longo and Mattson 2014) but no differences between MKO and WT mice 
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were observed (Fig. 2A). Concomitantly, non-esterified fatty acid (NEFA) (Fig. 2B) and ketone body, 
specifically β-hydroxybutyrate (β-OHB) (Fig. 2C), plasma levels were significantly elevated after 24 h of 
fasting but again no genotype differences could be detected. Furthermore, mice were put in a CLAMS 
system to monitor the oxygen consumption rate (VO2) (Fig. 2D), respiratory exchange ratio (RER) (Fig. 
2E) and body temperature (Fig. 2F). Fasting significantly reduced all of these three parameters 
independently of skeletal muscle PGC-1β. Next, body composition of ad-libitum fed and 24 h fasted 
mice was evaluated by EchoMRI. There was no difference between MKO and WT mice under normal 
feeding conditions (Fig. 2G), however, after 24 h of fasting MKO animals showed an increased body 
weight (BW), due to increased lean mass and total water content in comparison to their WT fasted 
counterparts (Fig. 2H). These results demonstrate that the whole body response to energy deprivation 
was not different between MKO and WT mice while the fasting induced muscle atrophy seemed to be 
dependent on skeletal muscle PGC-1β.  
 
Muscle PGC-1β is necessary for the fasting-induced fiber atrophy 
To further explore the fasting-induced muscle atrophy we measured individual muscle weights. 
Gastrocnemius (Fig. 3A) and Soleus (Fig. 3B) muscles of fasted MKO animals were significantly heavier 
compared to fasted WT mice. Furthermore, WT animals showed a fasting-induced decrease in muscle 
mass, which was only observed in Tibialis anterior (TA) muscle but not in Gastrocnemius or Soleus 
muscles in the fasted MKO animals (Fig. 3A-C). To evaluate if the preserved muscle mass in fasted MKO 
animals also correlated with an increase in cross sectional area (CSA) of single fibers we analyzed the 
minimal fiber ferets (minFeret) in Gastrocnemius muscle cross-sections. Oxidative fibers (in the center 
of the muscle) were not different between the genotypes in fed (Fig. 3D) and fasted (Fig. 3F) conditions. 
However, energy deprivation induced a slight right shift of the minFeret curve in WT animals (Supp. 
Fig. 1A) leading to a lower percentage of very small fibers and to a higher percentage of middle sized 
fibers. This effect was completely absent when comparing fasted MKO with fed MKO animals (Supp. 
Fig. 1B). Glycolytic fibers (at the edge of the muscle) of fed MKO and fed WT mice were not different 
(Fig. 3G) but fibers between fasted MKO and fasted WT animals (Fig. 3H). MKOs showed a lower 
percentage of small to middle sized fibers, however, a higher percentage of big fibers (Fig. 3H). When 
we compared fasted WT and fed WT animals (Supp. Fig. 1C), we actually observed a left shift of the 
minFeret curve towards smaller fibers in fasted animals, which we did not detect between fasted MKO 
and fed MKO mice (Supp. Fig. 1D). We also analyzed the proportion of fiber types between the 
different groups but did not detect any differences (Supp. Fig. 1E). These data demonstrate that fasted 
WT animals showed a shift in fiber CSA with a higher percentage of middle sized oxidative fibers and a 
lower percentage of big glycolytic fibers, which was not the case in fasted MKO animals. Together with 
the conserved muscle mass in fasted MKO mice these results suggest that muscle PGC-1β might be 
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necessary for the fasting-induced muscle atrophy and could thus explain why MKO animals show a 
reduced fasting response in skeletal muscle regarding lean mass.  
 
Fasted MKO mice show a reduced induction of myostatin and atrophy markers gene expression 
Since PGC-1β is an important transcriptional coactivator we investigated the transcriptional changes 
between 24 h fasted WT and MKO animals by RNA sequencing (RNAseq) and subjected all differentially 
expressed (DE) genes with a false discovery rate (FDR) < 0.05 and a fold change (FC) ± 1.2 to gene 
ontology (GO) analysis. The top overrepresented GO categories were “electron transport chain”, 
“transforming growth factor (TGF)-β receptor signaling pathway” and “cell differentiation” (Fig. 4A, 
Supp. Fig. 2). Interestingly, TGF-β signaling and in particular the associated DE gene myostatin (Mstn) 
have been implicated to induce muscle atrophy by activating the ubiquitin proteolytic system 
(McFarlane, Plummer et al. 2006, Mendias, Gumucio et al. 2012). Furthermore, Mstn is a well 
characterized negative regulator of skeletal muscle mass (McPherron, Lawler et al. 1997). In our 
RNAseq data Mstn was significantly reduced in fasted MKO compared to fasted WT mice suggesting a 
downregulation of Mstn induced TGF-β signaling. Indeed, we could confirm by qPCR that Mstn 
expression was significantly lower in fasted MKO mice while being upregulated in fasted WT compared 
to fed WT animals (Fig. 4B). Moreover, the induction of two important ubiquitin ligases involved in 
muscle atrophy (Bodine, Latres et al. 2001), muscle RING finger 1 (MuRF-1) and muscle atrophy F-box 
(MAFbx), was blunted in fasted MKO animals (Fig. 4B). Furthermore, the lower expression in MuRF-1 
and MAFbx correlated with a reduced ubiquitination of proteins in fasted MKO animals (Fig. 4C and D). 
Transcriptional induction of MuRF-1 and MAFbx is known to be controlled by forkhead box O (FoxO) 
transcription factors (Sandri, Sandri et al. 2004), which includes the three family members FoxO1, 
FoxO3, and FoxO4 (Ho, Myatt et al. 2008). Moreover, dephosphorylation of FoxO transcription factors 
leads to their nuclear entry and the transcriptional induction of target genes (Ramaswamy, Nakamura 
et al. 2002). mRNA levels of all three FoxO members were upregulated upon fasting independently of 
skeletal muscle PGC-1β (Fig. 4E). Nevertheless, the phosphorylation of FoxO3a was significantly higher 
in fed and fasted MKO animals, however, also total FoxO3a protein levels were induced in fasted MKO 
compared to fasted WT mice (Fig. 4F and G). Thus, the ratio of phosphorylated to total FoxO3a protein 
was significantly lower upon fasting but not different between the genotypes (Fig. 4G). These data 
suggest that the reduced fasting-induced muscle atrophy might be a consequence of the absent and 
blunted induction of Mstn, MuRF-1 and MAFbx gene expression, respectively.  
 
MKO mice show reduced activation of AMPK and PKA upon fasting 
Recently, Mstn has been shown to activate the AMP-dependent protein kinase (AMPK), an important 
cell energy sensor, to regulate glucose and glycogen homeostasis in skeletal muscle (Chen, Ye et al. 
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2010). AMPK is sensitive to the intracellular AMP:ATP ratio and upon its phosphorylation the catalytic 
subunit gets activated to switch on catabolic pathways generating ATP while turning off anabolic 
pathways consuming ATP, respectively (Hardie 2007). Thus, we evaluated AMPK activity in fed and 
fasted WT and MKO animals. Total AMPK protein levels were increased in fed MKO mice while being 
significantly lower in fasted MKO animals in relation to their fed counterparts (Fig. 5A and B). 
Moreover, the phosphorylation of AMPK was higher in fasted WT compared to fed WT mice resulting 
in a significantly increased phosphorylated to total AMPK ratio (Fig. 5A and B). This increase was 
completely absent with the ablation of PGC-1β demonstrating that fasted MKO animals suffer less 
from energy stress than their fasted WT counterparts. Furthermore, the absent activation of AMPK 
provides another possible explanation for the reduced muscle atrophy in fasted MKO animals.  
As described before, Mstn regulates glucose and glycogen homeostasis by promoting glycolysis and 
inhibiting glycogen synthesis through the activation of AMPK in muscle cells (Chen, Ye et al. 2010). 
Furthermore, the AMPK complex has been shown to bind glycogen (Hudson, Pan et al. 2003, Polekhina, 
Gupta et al. 2003), which also regulates its activity, being repressed when muscle glycogen is high 
(Wojtaszewski, Jorgensen et al. 2002, Wojtaszewski, MacDonald et al. 2003). Since AMPK activation 
was absent in fasted MKO animals we evaluated if glycogen levels were also different between the 
groups. Indeed, fasted MKO animals showed significantly higher total glycogen levels in Gastrocnemius 
muscle compared to fasted WT animals (Fig. 5C). These results suggest that in addition to the 
regulation by Mstn, the absent activation of AMPK might furthermore be due to the increased glycogen 
content in fasted mice with ablated muscle PGC-1β expression.   
An important regulator of glycogen content in skeletal muscle is the cAMP-dependent protein kinase 
(PKA) (Bishop and Larner 1969). Total PKA protein levels were significantly increased in fasted mice 
independent of PGC-1β and the phosphorylation of PKA in fed MKO and fasted WT mice was induced 
(Fig. 5A and D). Fasted MKO animals showed a reduced phosphorylation of PKA resulting in a lower 
ratio of phosphorylated to total PKA protein levels, which in fasted WT mice was increased compared 
to their fed counterparts (Fig. 5A and D). These data indicate that besides AMPK also activation of PKA 
was absent in fasted MKO animals providing a possible explanation for the observed increased 
glycogen content.  
We further investigated the effects of reduced PKA signaling in fasted MKO animals by analyzing the 
activity of a cAMP-PKA target protein, cAMP response element binding protein (Creb) (Shaywitz and 
Greenberg 1999). Creb is being phosphorylated at a particular site (Ser133), which is required for 
transcriptional induction of target genes (Shaywitz and Greenberg 1999). Total Creb protein levels 
were increased in fed MKO and fasted WT animals and surprisingly, phosphorylation of Creb was 
significantly higher in fasted MKO animals compared to their fed MKO and fasted WT counterparts 
(Fig. 5A and E). Accordingly, the ratio of phosphorylated to total Creb protein tended to be induced in 
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fasted MKO mice (Fig. 5A and E). These data suggest that the increase in Creb phosphorylation is most 
likely due to the action of another kinase, since PKA signaling was reduced in fasted MKO animals.  
 
Nfatc1 activity is increased in fasted MKO animals 
Creb is known to be phosphorylated by a variety of other kinases including the Ca2+/calmodulin-
dependent protein kinases (CaMK) (Shaywitz and Greenberg 1999). Interestingly, the activity of 
CaMKIIα seemed to be higher in fasted MKO compared to fasted WT mice (Fig. 6A and B). Total 
CaMKIIα protein levels were significantly lower in MKO animals in relation to their WT controls and 
fasting decreased the protein content of CaMKIIα in WT and MKO animals (Fig. 6A and B). However, 
phosphorylation of CaMKIIα was strongly induced in fasted MKO animals, which resulted in a massive 
increase in the ratio of phosphorylated to total CaMKIIα protein levels (Fig. 6A and B). These results 
indicate that the increase in Creb signaling could be due to the higher activity of CaMKIIα and suggest 
that Ca2+/calmodulin-dependent signaling might be increased in fasted MKO animals.  
To assess if other downstream targets of Ca2+/calmodulin-dependent signaling were induced in fasted 
MKO animals, we performed integrated motif activity response analysis (ISMARA) with our RNAseq 
data. Indeed, we identified the nuclear factor of activated T-cells, cytoplasmic 1 (Nfatc1), a known 
target protein of the phosphatase calcineurin (Semsarian, Wu et al. 1999), as top transcription factor 
with predicted increased activity in fasted MKO compared to fasted WT animals (Fig. 6C). Interestingly, 
PGC-1α belonged to the predicted ISMARA Nfatc1 target genes, next to protein-O-mannose kinase 
(Pomk), membrane associated ring-CH-type finger 1 (March1), SH3 domain containing kinase binding 
protein 1 (Sh3kbp1), methyltransferase like 11B (Mettl11b) and nitric oxide synthase 1 (Nos1). Except 
for March1, we could confirm that the predicted Nfatc1 target genes indeed showed increased 
expression in fasted MKO animals (Fig. 6D). These data suggest that PGC-1β might act as a inhibitor for 
Nfatc1 activity leading to muscle atrophy upon energy deprivation.  
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Figure 1. PGC-1β expression is downregulated in skeletal muscle upon fasting 
A) Gene expression of PGC-1β and PGC-1α relative to TATA-box binding protein (TBP) in Quadriceps 
muscle of sedentary or exercised mice (n=5-6).   
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B-C) Gene expression of PGC-1β and PGC-1α relative to 18S in liver (B) and Gastrocnemius muscle (C) 
of ad-libitum fed or 24 h fasted mice (n=5-6).   
D) Gene expression of PGC-1β and PGC-1α relative to 18S in primary myotubes of WT mice treated 
with forskolin, 8-(4-chlorophenylthio)adenosine 3',5'-cyclic monophosphate (CPT-cAMP) or 3-isobutyl-
1-methylxanthine (IBMX) for 6 h (n=3).  
E) Gene expression of PGC-1β relative to TATA-box binding protein (TBP) or 18S in different muscles 
and other tissues of WT and PGC-1β MKO mice (n=3-4). 
F) Gene expression of PGC-1β, mitochondrial target genes and PGC-1α relative to TATA-box binding 
protein (TBP) or 18S in Gastrocnemius muscle of WT and MKO mice (n=3-6). 
G-H) Protein levels of different mitochondrial chain complexes (F) in Gastrocnemius muscle of WT and 
MKO mice and representative immunoblots (G) (n=5-6). As a loading control eukaryotic elongation 
factor 2 (eEF2) was used.  
I-J) Representative succinate dehydrogenase (SDH) and cytochrome oxidase (COX) stainings of 
Gastrocnemius muscle cross-sections (I) of WT and MKO mice and corresponding quantification (H) 
(n=4-5).  
* indicating significant differences between sedentary and exercised mice, fed and fasted mice, 
untreated (DMSO) and treated cells and WT and MKO mice, respectively. 
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Figure 2. MKO animals preserve body weight and lean mass upon 24h fasting 
A-C) Plasma glucose (A), non-esterified fatty acids (NEFA) (B) and β-hydroxybutyrate (β-OHB) (C) levels 
of ad-libitum fed or 24 h fasted mice (n=5-8). 
D-F) Average oxygen consumption rate (VO2) (D), respiratory exchange ratio (RER) (E) and body 
temperature (F) measured during nighttime by indirect calorimetry over a 48 h period in ad-libitum 
fed or 24 h fasted mice (n=7-8). 
H-I) Body composition measured by EchoMRI of ad-libitum fed or 24 h fasted mice with an initially 
identical body weight (n=6-7). 
* indicating significant differences between WT and MKO mice; # indicating significant differences 
between fed and fasted conditions.  
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Figure 3. PGC-1β is necessary for the fasting-induced fiber atrophy 
A-C) Gastrocnemius (A), Soleus (B) and Tibialis anterior (TA) (C) muscle weights of ad-libitum fed or 24 
h fasted mice (n=4-6). 
D-G) Minimal fiber ferrets (minFerret) of oxidative (D and E) and glycolytic (F and G) Gastrocnemius 
muscle cross-sections of ad-libitum fed (D and F) or 24 h fasted (E and G) mice (n=4-6). 
* indicating significant differences between WT and MKO mice; # indicating significant differences 
between fed and fasted conditions.  
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Figure 4. Fasted MKO mice show reduced induction of myostatin and atrophy markers gene 
expression 
A) Gene ontology (GO) analysis of differentially expressed (DE) genes between fasted MKO vs. fasted 
WT mice (n=3-5). 
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B) Gene expression of PGC-1β, myostatin (Mstn), muscle RING finger 1 (MuRF-1) and muscle atrophy 
F-box (MAFbx) relative to 18S in Gastrocnemius muscle of ad-libitum fed or 24 h fasted mice (n=5-6). 
C-D) Representative immunoblot of ubiquitinylated proteins (C) in Gastrocnemius muscle of ad-libitum 
fed or 24 h fasted mice and corresponding quantification (D) (n=5-6). Equal loading was verified by 
ponceau staining of the membranes.  
E) Gene expression of forkhead box O (FoxO) transcription factors 1, 3 and 4 relative to 18S in 
Gastrocnemius muscle of ad-libitum fed or 24 h fasted mice (n=5-6).  
F-G) Representative immunoblots of total and phosphorylated forkhead box O 3a (FoxO3a) proteins 
(F) in Gastrocnemius muscle of ad-libitum fed or 24 h fasted mice and corresponding quantifications 
(G) (n=3-6). As a loading control eukaryotic elongation factor 2 (eEF2) was used. 
* indicating significant differences between WT and MKO mice; # indicating significant differences 
between fed and fasted conditions.  
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Figure 5. MKO mice show reduced activation of AMPK and PKA upon fasting 
A-B and D-E) Representative immunoblots of total and phosphorylated AMP-dependent protein kinase 
(AMPK), cAMP-dependent protein kinase (PKA) and cAMP response element binding protein (Creb) 
protein levels (A) in Gastrocnemius muscle of ad-libitum fed or 24 h fasted mice and corresponding 
quantifications (B, D and E) (n=5-6). As a loading control eukaryotic elongation factor 2 (eEF2) was 
used. 
C) Total glycogen content in Gastrocnemius muscle of ad-libitum fed or 24 h fasted mice (n=5-6). 
* indicating significant differences between WT and MKO mice; # indicating significant differences 
between fed and fasted conditions.  
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Figure 6. Nfatc1 activity is increased in fasted MKO animals 
A-B) Representative immunoblots of total and phosphorylated Ca2+/calmodulin-dependent protein 
kinase IIα (CaMKIIα) protein levels (A) in Gastrocnemius muscle of ad-libitum fed or 24 h fasted mice 
and corresponding quantifications (B) (n=5-6). As a loading control eukaryotic elongation factor 2 
(eEF2) was used. 
C) ISMARA predictions of enriched transcription factor binding motifs like the top target nuclear factor 
of activated T-cells, cytoplasmic 1 (Nfatc1) in Gastrocnemius muscle of 24 h fasted WT and MKO mice 
(n=3-5). 
D) Gene expression of predicted Nfatc1 target genes PGC-1α, protein-O-mannose kinase (Pomk), 
membrane associated ring-CH-type finger 1 (March1), SH3 domain containing kinase binding protein 
1 (Sh3kbp1), methyltransferase like 11B (Mettl11b) and nitric oxide synthase 1 (Nos1) relative to 18S 
in Gastrocnemius muscle of ad-libitum fed or 24 h fasted mice (n=5-6). 
* indicating significant differences between WT and MKO mice; # indicating significant differences 
between fed and fasted conditions.  
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Figure 7. Proposed working model 
In a WT setting, PGC-1β functions as an inhibitor for Nfatc1 transcriptional activity, which prevents 
expression of target genes such as PGC-1α. Ablation of PGC-1β in skeletal muscle results in the 
translocation of Nfatc1 into the nucleus leading to the induction of target genes and the blunted 
response to energy deprivation.  
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Supplemental Figure 1. PGC-1β is necessary for the fasting-induced fiber atrophy 
A-D) Minimal fiber ferrets (minFerret) of oxidative (A and B) and glycolytic (C and D) Gastrocnemius 
muscle cross-sections of ad-libitum fed or 24 h fasted WT (A and C) and MKO (B and D) mice (n=4-6). 
E) Quantification of type I, IIa and IIb/x fibers in Gastrocnemius muscle cross-sections of ad-libitum fed 
or 24 h fasted mice (n=4-6). 
* indicating significant differences between fed and fasted conditions. 
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Supplemental Figure 2. Fasted MKO mice show reduced induction of myostatin and atrophy markers 
gene expression 
Gene ontology (GO) analysis of differentially expressed (DE) genes between fasted MKO vs. fasted WT 
mice and associated genes (n=3-5). 
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Discussion 
Skeletal muscle atrophy can be induced by a variety of different stimuli such as disuse, aging, starvation 
or diseases (e.g. cancer cachexia). Regardless of the primary cause, muscle atrophy is always 
characterized by protein catabolism and reduced fiber diameter, which results in a loss of mass and 
functionality. Indeed, 24 h of fasting resulted in a substantial loss of muscle mass characterized by 
significantly elevated Mstn, MuRF-1 and MAFbx mRNA levels (McPherron, Lawler et al. 1997, Bodine, 
Latres et al. 2001, McFarlane, Plummer et al. 2006, Mendias, Gumucio et al. 2012) and increased 
activities of AMPK and PKA in WT animals. Importantly, all of these changes were blunted or even 
absent in MKO animals suggesting that PGC-1β substantially contributes to muscle atrophy at least 
under fasting conditions. Thus, the model we propose is that in a WT setting PGC-1β acts as an inhibitor 
for Nfatc1 transcriptional activity, which prevents it from binding to target promoters to induce 
transcription of target genes such as PGC-1α (Fig. 7). However, in the MKO animals, Nfatc1 activity 
cannot be repressed by PGC-1β leading to the induction of target genes including PGC-1α (Fig. 7). It is 
important to note that the increased PGC-1α levels in MKO animals were not just due to compensation 
of PGC-1β, but rather a result of the increased Nfatc1 activity specifically in fasted MKO animals, since 
PGC-1α mRNA levels were not different between fed WT and MKO animals. Interestingly, PGC-1α has 
been implicated to protect from muscle atrophy by decreasing FoxO3 transcriptional activity leading 
to a reduction in atrophy-specific gene transcription (Sandri, Sandri et al. 2004, Sandri, Lin et al. 2006). 
The increased PGC-1α mRNA levels in MKO animals could thus explain the blunted induction of MuRF-
1 and MAFbx expression. Furthermore, elevated levels of PGC-1α are known to contribute to increased 
glycogen stores suggesting that MKO animals displayed higher muscle glycogen due to increased PGC-
1α transcription (Wende, Schaeffer et al. 2007). This provides further evidence that the repressed 
activity of AMPK might have been caused by the increase in muscle glycogen levels (Wojtaszewski, 
Jorgensen et al. 2002, Wojtaszewski, MacDonald et al. 2003). Finally, all of these changes possibly 
contributed to the protection of muscle mass suggesting that the reduced Mstn expression levels were 
a cumulative, secondary result of the blunted fasting response in MKO animals.  
Our results suggest that PGC-1β possibly acts as a transcriptional inhibitor for Nfatc1 activity under 
fasting conditions, probably as PGC-1α for FoxO3 (Sandri, Lin et al. 2006). At first sight this seems to 
be paradoxical, since PGC-1β expression in WT animals is itself reduced upon fasting and 
overexpression of PGC-1β has been shown to protect from protein degradation, induction of ubiquitin 
ligases and disuse atrophy (Brault, Jespersen et al. 2010). However, it is feasible that the reduction in 
PGC-1β expression in WT animals might serve as a protective mechanism to reduce its inhibitory effect 
on Nfatc1 and would therefore explain why MKO mice suffer less from an actual fasting stimulus. 
Interestingly, increased transcriptional activity of the calcineurin target protein Nfatc1 has previously 
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been implicated to mediate hypertrophy in skeletal muscle (Semsarian, Wu et al. 1999). Our data 
would thus indicate that Nfatc1 is not only involved in muscle hypertrophy but also in muscle atrophy, 
which could be limited or even prevented by increasing Nfatc1 transcriptional activity, for example by 
reducing PGC-1β expression. As we showed in the beginning, PGC-1β expression could be targeted by 
increasing intracellular cAMP levels. However, we did not investigate how cAMP signaling reduces 
PGC-1β mRNA levels. So far, no cAMP response element (CRE) has been identified on the PGC-1β gene 
as it is the case for PGC-1α, which is known to harbor a CRE around 100 base pairs upstream of its 
transcriptional start site (Herzig, Long et al. 2001, Handschin, Rhee et al. 2003). Thus, it is conceivable 
that PGC-1β is indirectly regulated by cAMP signaling contrary to PGC-1α, which might also explain the 
different expression profiles of the two PGC-1 family members upon increased cAMP levels.  
To conclude, we identified PGC-1β as a new important player in the response to fasting-induced muscle 
atrophy. Muscle-specific ablation of PGC-1β resulted in a Nfatc1-dependent increase in PGC-1α 
expression, which resulted in a blunted fasting response and reduced muscle mass loss. Thus, our 
results shed new light on the complex regulation of muscle metabolism after energy deprivation and 
revealed PGC-1β and Nfatc1 as new possible target candidates for the treatment of different muscle 
wasting diseases.  
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Supplemental Experimental Procedures 
Table 1. Acclimatization protocol for treadmill running at an incline of 5°. 
Day 1 
5 min  
0 m/min 
5 min  
5 m/min 
5 min  
8 m/min 
10 min  
10 m/min     
Day 2 
5 min  
0 m/min 
5 min  
5 m/min 
5 min  
8 m/min 
15 min  
10 m/min 
5 min  
12 m/min   
Day 3 
5 min  
0 m/min 
5 min  
5 m/min 
5 min  
8 m/min 
15 min  
10 m/min 
5 min  
12 m/min 
2 min  
14 m/min 
Day 4 
5 min  
0 m/min 
5 min  
5 m/min 
5 min  
8 m/min 
15 min  
10 m/min 
10 min  
12 m/min 
2 min  
14 m/min 
Day 5 
5 min  
0 m/min 
5 min  
5 m/min 
5 min  
8 m/min 
15 min  
10 m/min 
10 min  
12 m/min 
5 min  
14 m/min 
 
Single fiber isolation and primary cell culture 
Before the isolation of single fibers, all dishes were coated with horse serum (HS, 16050122, Thermo 
Scientific) in order to prevent sticking of the fibers. Single fibers were isolated from Extensor digitorum 
longus (EDL) muscles of 3 weeks old male WT mice by microdissection. Muscles were digested in 0.2% 
collagenase A (10103586001, Roche) in DMEM Glutamax (31966021, Thermo Scientific) supplemented 
with 1% Penicillin/Streptomycin (P/S, 15140122, Thermo Scientific) for 1.5 h at 37 °C. Then EDLs were 
transferred to a new dish without collagenase for another 30 min. Single fibers were isolated by 
triturating the muscles with fire polished glass pipettes (pre-coated with HS) and distributed on 
matrigel coated plates (354234, BD Biosience). After incubation for 1 h at 37 °C fresh seeding medium 
was slowly added (DMEM Glutamax, 10% HS, 1% P/S, 0.5% chicken embryo extract (CEE, C3999, US 
Biological Life Sciences), 0.004% FGF-Basic Recombinant Human Protein (PHG0024, Thermo 
Scientific)).  
After two days of incubation, the medium was changed to proliferation medium (DMEM Glutamax, 
20% FetalClone Serum (FCS, SH30066.03, GE Healthcare Life Sciences), 10% HS, 1% P/S, 1% CEE, 
0.005% FGF). Two days after proliferation, cells were washed with PBS and trypsinized (25300054, 
Thermo Scientific) for 5-10 min at 37°C. The reaction was stopped by the addition of HyClone medium 
(HyClone (SH30262.01, Thermo Scientific), 20% FetalClone Serum (FCS, SH30066.03, GE Healthcare 
Life Sciences), 10% HS, 1% P/S, 1% CEE, 1% L-glutamine (G7513, Sigma), 0.005% FGF). All cells were put 
on a non-coated dish for 1 h at 37 °C to let fibroblasts adhere. After incubation, floating primary 
myoblasts were carefully removed, counted and re-plated on new matrigel coated plates in HyClone 
medium.  
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Fiber Typing and minFeret determination  
Sections were blocked in blocking solution (PBS + 0.4% Triton X-100 (93426, Sigma) + 10% goat serum 
(G9023, Sigma)) for 30 min. After washing with PBS sections were exposed to primary antibodies for 1 
h at room temperature. Primary antibodies used were mouse IgG b2 MHC type 1 (BA-F8, DSHB), mouse 
IgG 1 MHC type 2a (SC-71, DSHB) and laminin (ab11575, Abcam). After washing with PBS slides were 
incubated with the appropriate secondary antibodies AF647 IgG 2b goat-anti-mouse (A-21242, Life 
Technologies), AF568 IgG1 goat-anti-mouse (A-21124, Life Technologies) and AF488 IgG goat-anti-
rabbit (A-11008, Life Technologies) for 1 h at room temperature. Finally, sections were washed with 
PBS, dehydrated with ethanol and mounted with ProLong Gold Antifade reagent (P36930, Life 
Technologies). 
Fiji script for minFeret determination: 
- run("3D Hysteresis Thresholding", "high=5 low=5"); 
- run("Analyze Particles...", "size=150-Infinity pixel circularity=0-1 show=Masks"); 
- run("Invert LUT"); 
- run("Dilate"); 
- run("Dilate"); 
- run("Dilate"); 
- run("Dilate"); 
- run("Skeletonize"); 
- run("Dilate"); 
- run("Invert LUT"); 
- run("Analyze Particles...", "size=500-Infinity pixel circularity=0.30-1.00 show=Overlay display 
exclude clear record add"); 
- drawAllFeretsDiameters(); 
- function drawAllFeretsDiameters() {for (i=0; i<nResults; i++) {x = getResult('XStart', i); y = 
getResult('YStart', i); doWand(x,y); drawFeretsDiameter(); if (i%5==0) 
showProgress(i/nResults);  } run("Select None"); } function drawFeretsDiameter() 
{requires("1.29n"); run("Line Width...", "line=1"); diameter = 0.0; 
getSelectionCoordinates(xCoordinates, yCoordinates); n = xCoordinates.length; for (i=0; i<n; 
i++) {for (j=i; j<n; j++) {dx = xCoordinates[i] - xCoordinates[j];             dy = yCoordinates[i] - 
yCoordinates[j]; d = sqrt(dx*dx + dy*dy); if (d>diameter) {diameter = d;                 i1 = i; i2 = j; 
}}} setForegroundColor(255,0,0); drawLine(xCoordinates[i1], yCoordinates[i1], 
xCoordinates[i2],yCoordinates[i2]);} 
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mRNAseq library preparation and sequencing 
Polyadenylated mRNA was isolated from around 10 mg of powdered Gastrocnemius muscle using the 
dynabeads mRNA direct kit (61012, Thermo Scientific). Fragmentation of mRNA was carried out by 
alkaline hydrolysis (50 mM sodium carbonate pH 9.2, 1 mM EDTA) at 95 °C for 5 min. mRNA was 
cleaned and purified using the RNeasy MinElute Cleanup kit (74204, Qiagen). 3’- and 5’-ends were 
dephosphorylated by alkaline phosphatase treatment (FastAP, EF0651, Thermo Scientific) to prevent 
re-ligation of the mRNA fragments. Before mRNA was cleaned and purified as described above, 5’-OH-
ends were re-phosphorylated by the usage of a T4 polynucleotide kinase (EK0032, Thermo Scientific) 
for 1 h at 37 °C. Addition of the 3’-adapter (5‘-(5rApp)-TGGAATTCTCGGGTGCCAAGG-(3SpC3)-3‘, 1 
µmol, Integrated DNA Technologies) was carried out using a truncated and mutated T4 RNA ligase 
(M0351L, BioLabs) overnight at 4 °C. mRNA was cleaned and purified as described above before 
addition of the 5’-adapter (5’-GUUCAGAGUUCUACAGUCCGACGAUC, 1 µmol, Microsynth) by the 
action of a T4 RNA ligase (AM2141, Thermo Scientific) overnight at 4 °C. mRNA was cleaned and 
purified as described above before reverse transcription using a reverse transcription primer (5’-
GCCTTGGCACCCGAGAATTCCA, 1 µmol, Microsynth) and SuperScript II reverse transcriptase 
(18064022, Thermo Scientific). cDNA was amplified and labelled by the addition of a 5’-RNA PCR primer 
(5’-AATGATACGGCGACCACCGAGATCTACACGTTCAGAGTTCTACAGTCCGA, 1 µmol, Microsynth) and 3’-
indexed RNA PCR primers (TruSeq Small RNA PCR primer sequences from Illumina, 0.2 µmol, 
Microsynth) using Taq DNA polymerase (D1806, Sigma). Finally, PCR product was purified by the 
Agencourt AMPure XP system (A63880, Beckman Coulter) and send for sequencing. Single read 
sequencing was performed with a GFB NextSeq 500 (R2D2) machine (81 cycles, Illumina RTA Version 
2.4.6). 
 
Primary antibodies for Western blot analysis 
MitoProfile (ab110413, Mitosciences, Abcam), mono- and polyubiquitinylated conjugates monoclonal 
antibody (BML-PW8810, Enzo Life Sciences), FoxO3a (9467, Cell Signaling), p-FoxO3a (9464, Cell 
Signaling), AMPKα (2532, Cell Signaling), p-AMPKα (2531, Cell Signaling), PKA-Cα (4782, Cell Signaling), 
p-PKA C (4781, Cell Signaling), Creb (9104, Cell Signaling), p-Creb (9191, Cell Signaling), CaMKIIα (3362, 
Cell Signaling) and pCaMKIIα (12716, Cell Signaling). As a loading control eEF2 (2332, Cell Signaling) 
was used. 
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Table 2. qPCR primer sequences 
Gene Name Forward primer Reverse primer 
18S AGTCCCTGCCCTTTGTACACA CGATCCGAGGGCCTCACTA 
Cox4i1 TACTTCGGTGTGCCTTCGA TGACATGGGCCACATCAG 
Cox5B CTTCAGGCACCAAGGAAGAC TTCACAGATGCAGCCCACTA 
CytC TGCCCAGTGCCACACTGT  CTGTCTTCCGCCCGAACA  
FoxO1 AATCCAGCATGAGCCCTTTG CGTAACTTGATTTGCTGTCCTGAA 
FoxO3 CCGGACAAACGGCTCACT GGCACACAGCGCACCAT 
FoxO4 CCACGAAGCAGTTCAAATGCT TCAGACTCCGGCCTCATTG 
MAFbx CCAAAACTCAGTACTTCCATCAAG CTATCAGCTCCAACAGCCTTAC 
March1 GGCCTACAACCGTGTGATCT GCATCCTTGATTTCCGTGTT 
Mettl11b CCAGACAAGCGTCCTTTCTC CAACGGGATCTAAAGGCAAA 
Mstn GCTGGCCCAGTGGATCTAAA GCCCCTCTTTTTCCACATTTT 
MuRF-1 AGGCAGCCACCCGATGT TCACACGTGAGACAGTAGATGTTGA 
Nos1 CAAGCCAAAGGGTAGCAGAG ACCTCAGACCCAGCTCAAGA 
PGC‐1α TGATGTGAATGACTTGGATACAGACA GCTCATTGTTGTACTGGTTGGATATG 
PGC-1β ATGCTTCCCTCACACCTCAG GCTTTTGCCTTGTAGGCTTG 
Pomk CTCCAGAGGCCAGAAGACAC CAGTGACCTGCTTGGTTCAA 
Sh3kbp1 AGCACAGAAGGAAAGCCAAA AGCTCACGGACTTGCATCTT 
TBP TGCTGTTGGTGATTGTTGGT CTGGCTTGTGTGGGAAAGAT 
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Abstract 
Podocytes are highly specialized kidney cells contributing to the glomerular filtration barrier, which 
prevents the loss of proteins from the filtered blood. Emerging evidence suggests that mitochondrial 
dysfunction might lead to podocyte injury contributing to the development of chronic kidney disease. 
However, the complex regulation of mitochondrial homeostasis in podocyte function is still poorly 
understood. Thus, we assessed the role of the peroxisome proliferator-activated receptor γ 
coactivator-1α (PGC-1α) in podocytes of male wild type control (WT) and PGC-1α podocyte specific 
knockout (PKO) mice. Interestingly, only the glomerular basement membrane thickness mildly 
increased upon the ablation of PGC-1α, which did not result in any functional abnormalities. 
Furthermore, young and aged PKO animals showed normal kidney and podocyte function under basal 
and stress-induced conditions. These results clearly demonstrate that PGC-1α is not required for 
normal podocyte function and question the role of PGC-1α in podocyte metabolism in this context.  
 
Abbreviations 
ACR, albumin to creatinine ratio; BSA, bovine serum albumin; FACS, fluorescence-activated cell sorting; 
GBM, glomerular basement membrane; HBSS, Hank’s balanced salt solution; HFD, high fat diet; PAS, 
periodic acid-Schiff; PBS, phosphate buffered saline; PC-R, protein to creatinine ratio; PGC-1, 
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peroxisome proliferator-activated receptor γ coactivator 1; PKO, PGC-1α podocyte-specific knockout 
mice; ROS, reactive oxygen species; SEM, standard errors of the means; TBP, TATA binding protein; 
WT, wild type; WT1, Wilms tumor 1 
 
Introduction 
The kidneys are bean-shaped organs at the back of the abdominal cavity filtering waste products from 
the blood and controlling body fluid and salt as well as blood pressure homeostasis. The filtration of 
blood takes place in the glomerulus, which is composed of a ball of capillaries surrounded by the 
Bowman’s capsule into which urine is filtered. Glomerular epithelial cells, also called podocytes, are 
highly specialized kidney cells lining the outer aspect of the glomerular basement membrane (GBM). 
They are composed of a cell body, major processes and foot processes. Neighboring foot processes are 
connected by the slit diaphragm, a continuous membrane-like structure. Podocytes form the final 
barrier to protein loss, which explains why podocyte injury leads to proteinuria and occurs in many 
glomerular diseases that finally progress to chronic kidney diseases (Shankland 2006, Cheng and Harris 
2010, Imasawa and Rossignol 2013). Recent studies have shown that mitochondrial dysfunction is 
associated with many types of kidney diseases (Hagiwara, Yamagata et al. 2006, Hall and Unwin 2007, 
Schiffer and Friederich-Persson 2017). Moreover, podocytes also contribute to the progression of the 
diseases by showing abnormalities in their mitochondria as well as reduced expression of mtDNA and 
its encoded proteins (Gucer, Talim et al. 2005, Hagiwara, Yamagata et al. 2006, Reidy, Kang et al. 2014). 
The peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) is a major regulator of 
mitochondrial biogenesis and oxidative metabolism (Lin, Handschin et al. 2005, Schnyder, Kupr et al. 
2017). PGC-1α muscle-specific transgenic mice show increased exercise performance and 
mitochondrial density while PGC-1α muscle-specific knockout mice suffer from impaired mitochondrial 
respiratory function and reduced exercise capacity (Lin, Wu et al. 2002, Handschin, Choi et al. 2007, 
Wende, Schaeffer et al. 2007, Calvo, Daniels et al. 2008). Even though PGC-1α is highly expressed in 
kidneys, its role in renal physiology and podocyte function is largely unexplored (Puigserver, Wu et al. 
1998). Nevertheless, PGC-1α in renal tubules has been shown to be important for age-related sodium 
excretion and transcriptional regulation of mitochondrial metabolism under high fat diet (HFD) 
conditions (Svensson, Schnyder et al. 2016). Moreover, endogenous PGC-1α levels seem to be essential 
for podocyte maintenance and mitochondrial function under basal conditions. Aldosterone-induced 
podocyte injury suppressed PGC-1α and caused mitochondrial damage in podocytes, which could be 
attenuated by a SIRT1 activator by increasing PGC-1α expression (Yuan, Huang et al. 2012). 
Furthermore, overexpression of PGC-1α protects from aldosterone- and adriamycin-induced podocyte 
injury and mitochondrial dysfunction (Zhu, Xuan et al. 2014, Zhao, Yuan et al. 2016). Thus, 
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mitochondrial energy metabolism by PGC-1α may play an important role not only in renal tubular but 
also in podocyte function. Our study was designed to elucidate if endogenous PGC-1α is important and 
required for proper podocyte metabolism. For that purpose, PGC-1α podocyte-specific knockout mice 
(PKO) were generated and characterized. PKO animals showed a minor increase in the GBM width, 
which had no effect on normal podocyte function. Furthermore, bovine serum albumin (BSA) overload 
and HFD treatment did not lead to any functional differences between wild type (WT) and PKO mice. 
These results demonstrate that PGC-1α is dispensable for normal and stress-induced podocyte 
function in-vivo and suggest that PGC-1α might not be that important in podocyte metabolism as 
previously believed.  
 
Material and Methods 
Animal housing and PGC-1α podocyte-specific knockout mouse generation 
Experiments were performed with the approval of the Swiss authorities on adult male mice. Animals 
were housed in a conventional facility with a 12 h light/12 h dark cycle and had free access to food and 
water. Mice were killed by CO2 inhalation.  
PKO mice were generated by crossing PGC-1αloxP/loxP mice (Lin, Wu et al. 2004) with Podocin-Cre 
transgenic mice (Moeller, Sanden et al. 2003, Huber, Hartleben et al. 2009), generously provided by 
Prof. Dr. Tobias Huber. PGC-1αloxP/loxP animals without Cre expression were used as wild type control 
(WT) mice. Specific primer pairs were used to detect the presence of the loxP sites, which resulted in 
amplicons of ~400 bp (WT allele, 650 bp). Specific primer pairs to detect Cre recombinase resulted in 
amplicons of 100 bp in PKO mice.  
 
In-vivo and urine analysis 
All mice were fed a normal chow diet. For HFD treatment, mice were fed a 60% kcal % fat HFD for two 
months (2127, Provimi Kliba AG).   
For urine collection, mice were housed in single mouse metabolic cages (3600M021, Tecniplast) for 24 
h. Water consumption was recorded and urine was collected for further analysis. Levels of creatinine 
(enzymatic method) in urine were determined using an automated biochemical analyzer (Cobas c111 
analyzer, Roche). Protein content in the urine was determined with the Bradford assay (Bio-Rad) and 
albumin levels were measured with a mouse albumin ELISA Kit (ab108792, Abcam) according to the 
manufacturer’s instructions.  
Body composition of the mice was determined before and after HFD treatment using an EchoMRI-
100TM analyzer (EchoMRI Medical Systems).  
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Glucose tolerance tests were performed before and after the HFD treatment. Mice were fasted 
overnight for 16 h and blood glucose was measured from tail blood using a glucose meter (ACCU-CHEK 
Aviva). Subsequently, mice were injected intraperitoneally with a 20% glucose solution normalized to 
their body weight (2 g glucose/kg body weight) and blood glucose was measured at 0’, 15’, 30’, 45’, 
60’, 90’, 120’ and 180’ after the injection from tail blood.  
Fatty acid free BSA (A8806, Sigma) in 0.9% sodium chloride solution (B. Braun) was injected 
intraperitoneally for 7 consecutive days with increasing dosages (2, 4, 6, 8 and 3x10 g/kg body weight). 
Mice were put in metabolic cages before and after the treatment period for 24 h.  
 
Primary glomeruli isolation and podocyte culture 
Mice were anesthetized with 450 mg/kg pentobarbital (50 mg/mL Ketalar, Parke-Davis) and perfused 
through the aorta. First, 10 mL Hank’s balanced salt solution (HBSS) was administered before adding 
35 mL of dynabeads M-450 tosylactivated in HBSS (14013, Thermo Scientific). Kidneys were removed, 
minced and treated with 1 mg/mL collagenase A (10103586001, Roche) and 100 U/mL DNase I 
(18047019, Thermo Scientific) at 37 °C for 30 min with gentle agitation. Digested tissue was filtered 
through a 100 µm cell strainer (352360, BD Falcon) and centrifuged at 1700 rpm for 5 min. Pellet was 
re-suspended in 4 mL of HBSS and distributed in four Eppendorf tubes for magnetic concentration 
(A13346, Thermo Scientific) of the dynabeads. Primary glomeruli were either used for RNA extraction 
as described below or primary podocyte culture. For this purpose, glomeruli were plated on collagen 
coated plates (354400, Becton Dickinson) in proliferation medium (RPMI-1640 (R0883, Sigma), 5% 
FetalClone Serum (SH30066.03, GE Healthcare Life Sciences) and 1% Penicillin/Streptomycin 
(15140122, Thermo Scientific)) for 10 days. Medium was changed every second day. Primary 
podocytes were trypsinized (25300054, Thermo Scientific) for 5 min at 37 °C, passed through a 40 µm 
cell strainer (352340, BD Falcon) and spun down at 1200 rpm for 5 min. Pellet was used for RNA 
isolation as described below.  
For the knockout confirmation, mice were anesthetized as described above and both kidneys, still 
connected to the vasculature, removed and placed in HBSS. First, kidneys were perfused with a mixture 
of dynabeads (M-450 tosylactivated (14013, Thermo Scientific) and M-450 Epoxy (14011, Thermo 
Scientific)) in HBSS and then with a digest solution containing dynabeads mixture, 300 U/mL 
collagenase type II (17101015, Thermo Scientific), 5 U/mL pronase E (7433, EM Millipore) and 100 
U/mL DNase I (18047019, Thermo Scientific). Kidneys were minced and digested in digest solution for 
20 min at 37 °C on a rotor (100 rpm). Primary glomeruli were isolated as described above. Single cells 
were obtained by digesting primary glomeruli for 40 min at 37 °C in a thermomixer (1400 rpm). Beads 
were removed by magnetic concentration and cell suspension centrifuged for 5 min at 2000 rpm at 4 
°C. Single cells were re-suspended in 4% paraformaldehyde, washed and permeabilized with 0.5% 
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triton (X100, Sigma) for 10 min. After washing, cells were blocked in 5% BSA and incubated with an 
anti-podocin antibody (P0372, Sigma) coupled to Alexa Fluor 488 (Z25302, Thermo Scientific) for 1 h 
in the dark. Finally, cells were washed and sorted by fluorescence-activated cell sorting (FACS) in FACS 
buffer (0.1% BSA in phosphate buffered saline (PBS)).  
 
DNA isolation and PCR reaction 
Total DNA was isolated from two pooled samples of FACS sorted podocytes by phenol chloroform DNA 
purification using phenol:chloroform:isoamyl alcohol (15593031, Thermo Scientific) and glycogen 
(10814010, Thermo Scientific) according to the manufacturer’s instructions. The knockout was 
confirmed by PCR amplification using specific primer pairs to detect the knockout or WT band. Primers 
used are listed in Table 1.  
Table 1. PCR primers for knockout confirmation.  
Gene Name Forward primer Reverse primer 
PGC‐1α WT ACCTGTCTTTGCCTATGATTC CCAGTTTCTTCATTGGTGTG  
PGC‐1α PKO TCCAGTAGGCAGAGATTTATGAC CCAACTGTCTATAATTCCAGTTC 
 
RNA isolation and real-time qPCR 
Total RNA was isolated from crushed whole kidney with FastPrep tubes (116913500, MP Biomedicals) 
and TRI reagent (T9424, Sigma) according to the manufacturer’s instructions. Total RNA from primary 
glomeruli and podocytes was isolated using the RNeasy Micro Kit (74004, Qiagen) according to the 
manufacturer’s instructions. RNA concentration was measured with a NanoDrop OneC 
spectrophotometer (Thermo Scientific). RNA from whole kidney was treated with DNase I (18068015, 
Thermo Scientific) and then reverse transcribed using hexanucleotide mix (11277081001, Sigma) and 
SuperScript II reverse transcriptase (18064022, Thermo Scientific). RNA from primary glomeruli and 
podocytes was reverse transcribed using hexanucleotide mix (11277081001, Sigma) and SuperScript 
III reverse transcriptase (18080093, Thermo Scientific). The level of relative mRNA was quantified by 
real-time qPCR on a StepOnePlus system (Applied Biosystems) using Fast SYBR green PCR master mix 
(4385612, Thermo Scientific). The analysis of the mRNA was performed by the comparative CT method 
using TATA binding protein (TBP) as endogenous control. Table 2 lists the primer sequences used. 
Table 2. qPCR primer list 
Gene Name Forward primer Reverse primer 
PGC‐1α AGCCGTGACCACTGACAACGAG  GCTGCATGGTTCTGAGTGCTAAG 
Podocin GTGAGGAGGGCACGGAAG AGGGAGGCGAGGACAAGA 
TBP TGCTGTTGGTGATTGTTGGT CTGGCTTGTGTGGGAAAGAT 
WT1 ATCCTCTGTGGTGCCCAGTA GTTGGGGCCACTCCAGATAC 
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Kidney staining  
Freshly isolated kidney was cut in half and fixed in 4% paraformaldehyde in PBS overnight at 4 °C. Fixed 
tissue was washed twice in water, processed and dehydrated for 25 h (Shandon Pathcentre, Thermo 
Scientific). Then paraffin blocks (107337, Merck Millipore) were made (Microm EC 350-1, Histocom-
AG) and 5 µm sections cut using a microtom (Microm cool cut HM360, Histocom-AG). Slides were dried 
overnight at 37 °C.  
For periodic acid-Schiff (PAS) staining slides were de-paraffinized and stained with periodic acid 
solution (3951, Sigma) for 5 min. After washing with water slides were stained with Schiff’s reagent 
(3952, Sigma) for 15 min, again washed and counter-stained with hematoxylin solution, Gill No. 3 
(GHS3, Sigma) for 1.5 min. Then, slides were dehydrated and mounted with histomount (008030, 
Thermo Scientific). Per sample 20-30 glomeruli were quantified and glomerular area was measured 
with the ImageJ software. 
 
Transmission electron microscopy  
Two small pieces of the cortex region of a freshly isolated kidney were fixed in 3% paraformaldehyde 
and 0.5% glutaraldehyde for 4 h. Then, tissue was further fixed in 1% osmium tetroxide and embedded 
in Epon. 60–70 nm sections were cut, and pictures were taken with a Morgagni 268(D) transmission 
electron microscope (FEI). Per sample, 10 independent measurements of the GBM thickness were 
quantified in 5 different pictures with the ImageJ software. 
 
Statistical analysis 
Values are expressed as means ± standard errors of the means (SEM). Statistical significance was 
determined with unpaired two tailed t-tests using Excel software. Significant differences (p < 0.05) 
between WT and PKO mice are indicated by an asterisk (*). Significant differences between young and 
old or before and after BSA or HFD treatments, respectively, are indicated by a hashtag (#). 
 
Results 
Confirmation of the podocyte-specific PGC-1α knockout 
PKO mice were generated by crossing PGC-1αloxP/loxP mice (Lin, Wu et al. 2004) with Podocin-Cre 
transgenic mice (Moeller, Sanden et al. 2003, Huber, Hartleben et al. 2009). Gross kidney morphology 
and relative kidney weights did not differ between the genotypes (Fig. 1A). In order to confirm the 
successful and specific knockout of PGC-1α in podocytes, we performed qPCR on whole kidney, 
primary glomeruli and primary podocytes samples to determine the expression levels of PGC-1α. On 
whole kidney level we could not detect any differences in PGC-1α expression between WT and PKO 
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animals indicating that the knockout was presumably podocyte-specific (Fig. 1B). However, also in 
primary glomeruli and podocytes mRNA levels of PGC-1α did not differ comparing WT and PKO animals 
(Fig. 1C and D). Furthermore, expression levels of the podocyte-specific markers, podocin and Wilms 
tumor 1 (WT1), were not different between WT and PKO animals in all of the tissue fractions (Fig. 1B-
D). These results indicate that either the recombination of the floxed construct was not successful or 
that the basal expression of PGC-1α was so low that no differences between WT and PKO animals could 
be observed. Thus, we verified the recombination of the floxed construct by PCR with specific primer 
pairs detecting the presence of either the WT or the PKO PCR product. As expected, we only observed 
the WT band in WT animals, however, in the PKO samples we detected the knockout but also the WT 
band (Fig. 1E). In whole kidney and primary glomeruli samples this result could be expected since both 
samples contained a lot of other cell types with intact PGC-1α expression. Furthermore, primary 
podocyte cultures seemed to be a mixture of WT and PKO cells suggesting some contamination from 
other glomerular cell types, which explains why we saw no differences in gene expression levels 
between WT an PKO animals (Fig. 1D). Thus, we pooled two mice of each genotype together and 
isolated primary podocytes by FACS to obtain a pure podocyte culture. With this approach we were 
finally able to confirm the successful recombination of the floxed construct in PKO mice (Fig. 1F).  
 
Basal characterization of young and old PKO mice 
After the confirmation of the PGC-1α knockout in podocytes, we characterized the phenotype of young 
(3 months of age) and old (22 months of age) WT and PKO mice. First, animals were put into metabolic 
cages to monitor their drinking behavior and to collect urine samples. We did not observe any 
genotype differences in young and old mice, however, drinking volume was significantly reduced and 
urine volume increased in old WT and PKO mice (Fig. 2A and B). Albuminuria and proteinuria are 
markers of kidney function and injury and are measured by the ratio of albumin or protein to the 
amount of creatinine in the urine (Biljak, Honovic et al. 2017). The loss of PGC-1α in podocytes did not 
result in any differences in the albumin to creatinine (ACR) or protein to creatinine ratios (PC-R) 
between WT and PKO animals at either age (Fig. 2C and D). Old mice showed an increase in the ACR 
and a decrease in the PC-R suggesting reduced kidney function with age. Histological analysis of kidney 
cross-sections was carried out by periodic acid-Schiff (PAS) stainings and revealed a significant increase 
in the glomerular area with age but no differences between genotypes (Fig. 2E). Moreover, podocyte 
structure was examined by transmission electron microscopy of kidney cortex regions. Basal lamina 
width was significantly increased in young PKO mice compared to their WT counterparts (Fig. 2F). 
Furthermore, old animals showed a massive increase in the width of the basal lamina in relation to 
young mice (Fig. 2F). These results suggest that young PKO animals show a mild pre-aging phenotype 
with a small but significant increase in the basal lamina width.  
6. PGC-1α is dispensable for normal and stress-induced podocyte function in-vivo 
104 
 
BSA-induced podocyte stress leads to albuminuria and proteinuria independently of PGC-1α 
Since PKO animals showed only a very mild pre-aging phenotype under basal conditions we examined 
podocyte function under stress conditions. Thus, we induced albuminuria and proteinuria with 
increasing dosages of intraperitoneal BSA injections in WT and PKO animals (Chen, Wei et al. 1995). 
BSA injections led to no differences in drinking volume (Fig. 3A) while urine volume (Fig. 3B) was 
significantly higher after the treatment but not different between the genotypes. Furthermore, total 
albumin (Fig. 3C) and ACR (Fig. 3D) as well as total protein (Fig. 3E) and PC-R (Fig. 3F) levels all 
significantly increased after BSA treatment, which was independent of PGC-1α. These results indicate 
that PKO animals are able to cope with an increased protein loading to the same extend as WT mice 
and suggest that PGC-1α might not be required for proper podocyte function under basal and stress-
induced conditions in-vivo.  
 
HFD treatment leads to metabolic syndrome and albuminuria in WT mice 
To further test if PGC-1α is indeed dispensable for stress-induced podocyte function, we induced 
proteinuria by HFD treatment, which has been shown to provoke the metabolic syndrome as well as 
renal injury and albuminuria (Deji, Kume et al. 2009). Body weight (Fig. 4A) and fat mass (Fig. 4B) were 
significantly increased while lean mass (Fig. 4C) was reduced after two months of HFD treatment 
independently of PGC-1α. Furthermore, glucose tolerance was lower (Fig. 4D) and concomitantly the 
area under the curve (Fig. 4E) increased in HFD-treated mice. These results demonstrate that the HFD 
treatment successfully induced hallmarks of the metabolic syndrome like increased fat mass and 
glucose intolerance. Surprisingly, WT animals showed an induction of the ACR indicative of 
albuminuria, which we did not observe in PKO mice (Fig. 4F). However, the excretion of proteins in the 
urine was not different between the conditions or the genotypes (Fig. 4G). These data suggest that the 
ablation of PGC-1α in podocytes protected mice from developing albuminuria after HFD treatment and 
confirms that PGC-1α is dispensable for BSA and HFD stress-induced podocyte function.  
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Figure 1. Confirmation of the podocyte-specific PGC-1α knockout 
A) Left and right kidney weights of WT and PKO animals relative to their body weight (n=4).  
B-D) Gene expression of PGC-1α, podocin and Wilms tumor 1 (WT1) relative to TATA-box binding 
protein (TBP) in whole kidney (B), primary glomeruli (C) and primary podocytes (D) of WT and PKO 
mice (n=3-5).   
E) Representative PCR gel of whole kidney, primary glomeruli and primary podocytes samples from 
WT and PKO animals (n=3).  
F) Representative PCR gel of FACS sorted primary podocytes from WT and PKO animals (n=4).  
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Figure 2. Basal characterization of young and old PKO mice 
A-B) Drinking (A) and urine (B) volumes of young and old WT and PKO animals measured over a period 
of 24 h (n=6-10). 
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C-D) Albumin to creatinine (ACR) (C) and protein to creatinine ratios (PC-R) (D) in urine of young and 
old WT and PKO animals (n=6-10). 
E) Representative periodic acid-Schiff (PAS) stainings of kidney cross-sections of young and old WT and 
PKO animals and corresponding quantification (n=4-5). 
F) Representative transmission electron microscopy pictures of kidney cortex regions of young and old 
WT and PKO animals and corresponding quantification (n=4). 
* indicating significant differences between WT and PKO mice; # indicating significant differences 
between young and old mice 
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Figure 3. BSA-induced podocyte stress leads to albuminuria and proteinuria independently of PGC-
1α 
A-B) Drinking (A) and urine (B) volumes of WT and PKO animals before and after intraperitoneal 
injections of BSA for 7 consecutive days (n=6). 
C-F) Total albumin (C), albumin to creatinine (ACR) (D), total protein (E) and protein to creatinine (PC-
R) (F) levels in urine of WT and PKO animals before and after intraperitoneal injections of BSA for 7 
consecutive days (n=6). 
# indicating significant differences before and after BSA treatment 
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Figure 4. HFD treatment leads to metabolic syndrome and albuminuria in WT mice 
A-C) Body weight (A), relative fat mass (B) and relative lean mass (C) of WT and PKO mice before and 
after 2 months of HFD treatment (n=6). 
D-E) Intraperitoneal glucose tolerance test after 16 h of fasting of WT and PKO mice before and after 
2 months of HFD treatment. The adjacent bar graph represents the average area under the curve (n=6). 
F-G) Albumin to creatinine (ACR) (F) and protein to creatinine ratios (PC-R) (G) of WT and PKO mice 
before and after 2 months of HFD treatment (n=6). 
* indicating significant differences between WT and PKO mice; # indicating significant differences 
between CHOW and HFD treatments 
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Discussion 
The study of podocyte biology has gained more and more interest in the past view years and emerging 
data suggest that podocyte injury occurs in many glomerular pathologies that finally progress to 
chronic kidney diseases (Shankland 2006, Cheng and Harris 2010, Imasawa and Rossignol 2013). 
Furthermore, mitochondrial metabolism seems to play an important role in the development of 
podocyte injury and kidney diseases (Hagiwara, Yamagata et al. 2006, Hall and Unwin 2007, Schiffer 
and Friederich-Persson 2017). Activation and overexpression of PGC-1α, a key protein in the regulation 
of oxidative metabolism and mitochondrial homeostasis, has been suggested to protect from 
aldosterone- and adriamycin-induced podocyte injury and mitochondrial dysfunction (Yuan, Huang et 
al. 2012, Zhu, Xuan et al. 2014, Zhao, Yuan et al. 2016). Thus, we evaluated if PGC-1α is required for 
basal and stress-induced podocyte function by ablating PGC-1α specifically in podocytes. Our results 
clearly demonstrate that PGC-1α is not important for normal podocyte metabolism in young and old 
mice and even dispensable for BSA- and HFD-induced podocyte stress.  
Given the important role of PGC-1α in mitochondrial homeostasis (Lin, Handschin et al. 2005, 
Schnyder, Kupr et al. 2017) and the current literature showing that mitochondrial metabolism is 
essential for proper podocyte function (Muller-Deile and Schiffer 2014), our data seem to be 
paradoxical. Mitochondrial respiration in a mouse transformed podocyte cell line has been proposed 
to account for about 50-75% of cellular respiration (Abe, Sakairi et al. 2010, Ozawa, Ueda et al. 2015), 
however, these results might not be true for podocytes in-vivo. Interestingly, a recent study elucidated 
that mitochondria are located in the cytosol around the nucleus but not in the cortical area of cultured 
differentiated podocytes and moreover that mitochondria were not present in foot processes in mouse 
podocytes (Ozawa, Ueda et al. 2015). Thus, energy metabolism in foot processes seems to be 
supported by glycolysis rather than mitochondrial respiration. Furthermore, glycolysis was found to 
contribute to apoptosis regulation, cell motility, lamellipodia formation and local ATP production in 
the cortical area of podocytes (Ozawa, Ueda et al. 2015). Thus, it is conceivable that PGC-1α is 
dispensable for energy metabolism in cortical areas of podocytes (e.g. foot processes), which might 
explain why structural damages of podocytes by BSA or HFD treatments did not lead to any functional 
differences between WT and PKO animals. Furthermore, ablation of PGC-1α in podocytes protected 
mice from developing albuminuria upon HFD treatment. In muscle tissue it is well established that 
PGC-1α knockout mice show a shift from oxidative to more glycolytic muscle fibers (Handschin, Chin 
et al. 2007) suggesting that the loss of PGC-1α in podocytes could have led to a similar switch in 
metabolism that seems to be beneficial under HFD conditions. Thus, glycolysis might indeed be more 
important and crucial for podocyte function in cortical areas and foot processes. Nevertheless, 
overexpression of PGC-1α seems to be protective against aldosterone- and adriamycin-induced 
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podocyte injury (Zhu, Xuan et al. 2014, Zhao, Yuan et al. 2016). Both treatments are proposed to 
increase intracellular levels of reactive oxygen species (ROS) leading to mitochondrial dysfunction and 
podocyte damage. Ablation of PGC-1α in podocytes does not lead to podocyte damage suggesting that 
ROS levels and mitochondrial function were normal in PKO mice. Furthermore, this suggests that either 
PGC-1α is not that important for mitochondrial function in podocytes in-vivo, as previously believed, 
or that the loss of PGC-1α was compensated by other proteins. Indeed, the closely related family 
member PGC-1β could be a likely candidate compensating for the loss of PGC-1α. For example, 
dysregulation of PGC-1 coactivators has been associated with the development of skeletal muscle 
insulin resistance (Mootha, Lindgren et al. 2003, Patti, Butte et al. 2003), however, single knockout 
models of either PGC-1α or –β did principally not result in insulin resistant or glucose intolerant 
phenotypes (Lin, Wu et al. 2004, Leone, Lehman et al. 2005, Lelliott, Medina-Gomez et al. 2006, Vianna, 
Huntgeburth et al. 2006, Handschin, Choi et al. 2007, Sonoda, Mehl et al. 2007, Gali Ramamoorthy, 
Laverny et al. 2015). Moreover, a large subset of genes seems to be controlled by both PGC-1 
coactivators, at least in skeletal muscle (Zechner, Lai et al. 2010). Thus, it may be assumed that the loss 
of PGC-1α in podocytes could have also resulted in a compensatory increase in PGC-1β expression, 
which might be another reason why PKO animals did not show any functional abnormalities.  
To conclude, our results unraveled that basal PGC-1α expression might not be a key player for normal 
podocyte function and shed new light on the complex biology of podocyte metabolism. Moreover, 
glycolysis and mitochondrial respiration might be of equal importance for podocyte energy 
homeostasis, which possibly opens new avenues for the future development of therapeutic strategies 
to counteract podocyte injury and chronic kidney diseases.  
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7. Discussion 
 
The two PGC-1 family members PGC-1α and PGC-1β are coactivator proteins with pleiotropic functions 
in tissue-specific and whole body metabolism. During the course of this thesis, we focused on the study 
of these two coactivators in skeletal muscle physiology as well as of PGC-1α in kidney metabolism. 
Thereby, we identified new functions and regulatory pathways of PGC-1α and –β in these tissues, 
which will be discussed in greater detail in the following sections. 
 
Skeletal muscle is a highly metabolically active organ with a tremendous capacity to adapt its activity 
to different stimuli in order to meet the required tissue and whole body energy needs. Physical activity 
substantially contributes to skeletal muscle metabolism and whole body energy expenditure and is 
widely accepted as a tool for the treatment of many different metabolic disorders and other diseases 
(Haskell, Lee et al. 2007, Colberg, Sigal et al. 2010, Egan and Zierath 2013). But also dietary 
interventions, for example ketogenic diets (KD), have gained more and more popularity in the use as 
therapeutic strategies (Paoli, Rubini et al. 2013). KDs are known to induce a fasting-like state, also 
referred to as ketosis, due to the low amount of carbohydrates and the high amount of fatty acids, 
respectively (Krebs 1966). The concomitant increase in circulating ketone bodies has been proposed 
to increase fatty acid oxidation, mitochondrial biogenesis and ATP production, however, the exact 
mode of action is still unclear (Bough and Rho 2007, Tagliabue, Bertoli et al. 2012). Since PGC-1α is an 
important regulator of all of these processes and furthermore, is involved in ketolysis in skeletal 
muscle, we explored its role in mediating the local and systemic effects of a long-term KD in the first 
study of this thesis (Austin and St-Pierre 2012, Svensson, Albert et al. 2016). We demonstrated that 
PGC-1α affects exercise performance and oxygen consumption and was involved in the induction of 
genes important for fatty acid oxidation in skeletal muscle upon KD feeding (Schnyder, Svensson et al. 
2017). To our surprise, increased circulating ketone bodies did not affect mitochondrial biogenesis and 
moreover, ATP production was even reduced in skeletal muscle, contrary to what has been shown in 
brain tissue (Bough and Rho 2007). These discrepancies could be due to different compositions of the 
administered diet or could indicate that ketone bodies exert different actions depending on the target 
organ. In fact, ketone bodies have been identified as signaling metabolites that can activate 
extracellular receptors (Newman and Verdin 2014). β-OHB has been shown to bind two GPRs, 
hydroxycarboxylic acid receptor 2 (HCAR2) in adipocytes and free fatty acid receptor 3 (FFAR3) in 
sympathetic ganglions, respectively, to reduce lipolysis and lower the metabolic rate (Taggart, Kero et 
al. 2005, Kimura, Inoue et al. 2011). Furthermore, β-OHB also binds to and inhibits class I histone 
deacetylases (HDAC) that protects mice from renal oxidative stress (Shimazu, Hirschey et al. 2013). It 
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is conceivable that the increase in mitochondrial biogenesis and ATP production in the brain might also 
be a result of direct β-OHB binding to specific receptors rather than a passive consequence due to the 
oxidation of ketone bodies. Since GPRs and HDACs are important players in skeletal muscle 
metabolism, particularly in the regulation of muscle mass, it would be interesting to study the role of 
β-OHB as signaling metabolite in skeletal muscle (Jean-Baptiste, Yang et al. 2005, Moresi, Williams et 
al. 2010). First, this could be done in different cell culture settings in-vitro using C2C12 or primary 
myotubes and second, osmotic pumps could be implanted subcutaneously or intraperitoneally to 
constantly increase circulating β-OHB levels in-vivo. These settings would also be of interest in light of 
PGC-1α, which is known to be regulated by β-adrenergic signaling and HDAC5 (Miura, Kawanaka et al. 
2007, Akimoto, Li et al. 2008). Furthermore, direct delivery of β-OHB could also prevent the adverse 
effects of KD feeding including increased fat mass, cholesterol and liver stress markers (Schnyder, 
Svensson et al. 2017). 
Another point to consider when studying the effects of ketone bodies on whole body metabolism is 
their acidic nature. Diabetic ketoacidosis is a severe life-threatening complication in type 1 diabetes 
patients that results from insulin deficiency leading to marked hyperketonemia with plasma ketone 
body levels exceeding 25 mM (Laffel 1999). Even though KDs only induce a mild hyperketonemia as 
during caloric starvation (2-6 mM), several studies have shown an association between KDs and 
metabolic acidosis (Millichap and Jones 1964, Takeoka, Riviello et al. 2002, Yancy, Olsen et al. 2007). 
This acidosis could induce many adverse effects including gastrointestinal disturbances, nausea, 
growth retardation in children or cardiometabolic complications (Yuen, Walcutt et al. 2017). However, 
direct correlations between KDs, increased metabolic acidosis and all of these adverse effects are still 
missing. Nevertheless, these associations, together with the above mentioned detrimental effects of 
KD feeding, raise the questions about the usage of KDs as therapeutic strategies and their compatibility 
with exercise. The latter is still under debate and various studies show different results ranging from 
positive effects on maximal VO2 and lactate threshold to no negative effects on aerobic endurance 
capacity or explosive and strength performance (Phinney, Bistrian et al. 1983, Paoli, Grimaldi et al. 
2012, Zajac, Poprzecki et al. 2014). Furthermore, a recent study in healthy non-athlete adults showed 
that six weeks of KD feeding on one hand led to reduced body weight due to loss in fat and lean mass, 
decreased VO2peak and peak power and increased total cholesterol and low density lipoprotein levels 
(Urbain, Strom et al. 2017). On the other hand, it slightly increased handgrip strength (Urbain, Strom 
et al. 2017). These data show that KD feeding can result in positive and negative effects on exercise 
performance and suggest that it would not impair daily activities or aerobic exercise training, however, 
it might have detrimental effects on training and competition performance in elite athletes (Urbain, 
Strom et al. 2017). Finally, these inconclusive results strongly emphasize the need of future studies 
aimed at elucidating the mechanisms and molecular pathways induced by KD feeding.  
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In the second study, we focused on the acute time-course and chronic exercise responses and the 
dependence of PGC-1α in these contexts. PGC-1α is an important mediator of exercise-induced 
molecular responses functioning as metabolic sensor and effector protein (Kupr and Handschin 2015). 
We now showed that PGC-1α is furthermore required for the timely expression of target genes and 
defined the PGC-1α-dependent acute core exercise response, which involved stress- and heat-
responsive genes. Importantly, PGC-1α muscle-specific knockout mice (PGC-1α MKO) displayed a 
different time-course expression pattern of exercise-induced gene transcripts and showed a much 
smaller acute core exercise response. Gene ontology (GO) analysis of the wildtype (WT) acute core 
exercise response revealed “cellular response to calcium ion” as top category with associated genes of 
the Fos and Jun gene families. Fos and Jun belong to the immediate-early genes and are known to be 
induced by exercise and calcium (Curran 1992, Puntschart, Wey et al. 1998, Carrasco, Riveros et al. 
2003). Thus, the first acute transcriptional response seems to be initiated to cope with an increase in 
cytosolic calcium levels (Miledi, Parker et al. 1983). In fact, prolonged increases in cytosolic calcium 
concentrations pose a major stress factor for any kind of cell and can result in dysfunction, injury and 
apoptosis (Trump and Berezesky 1992). The importance of cellular calcium homeostasis is also 
reflected in the severe and life-threatening phenotype of the disease malignant hyperthermia (MH) 
(MacLennan and Phillips 1992). MH is an inherited syndrome caused by a mutated ryanodine receptor 
that leads to hypersensitive gating and results in a sustained release of calcium from the sarcoplasmic 
reticulum (Joffe, Savage et al. 1992). Inhalation anesthetics have been identified as the main triggers 
of the syndrome and patients experience different symptoms including high fever, skeletal muscle 
rigidity, lactic acidosis, increased production of CO2 and organ dysfunction and failure that eventually 
lead to death (Ohta, Endo et al. 1989, Hopkins 2011). Thus, the severe clinical picture of MH clearly 
demonstrates the importance of the regulation of calcium homeostasis in skeletal muscle. 
Furthermore, our results suggest that each bout of exercise poses an enormous stress on skeletal 
muscle cells that leads to the induction of immediate-early genes such as Fos and Jun. In addition, it is 
important to note that increases in cytosolic calcium concentrations lead to hyperthermia since the 
acute core exercise response also included the GO term “response to stress” in which heat shock 
protein (Hsp) family members clustered. Thus, it might be interesting to study the effect of elevated 
cytosolic calcium concentrations on the expression of Hsps. In fact, the heat shock transcription factor 
(HSF) has been shown to be activated by calcium in-vitro (Mosser, Kotzbauer et al. 1990). Furthermore, 
calcium induces Hsp72 and Hsp60 in human cultured keratinocytes and is involved in the induction of 
Hsp70 upon Hsp90 inhibition in human non-small cell lung cancer H460 cells (Wakita, Tokura et al. 
1994, Chang, Lee et al. 2006). Thus, the study of Hsp regulation by increases in cytosolic calcium might 
also be of interest in skeletal muscle and exercise physiology. However, this would need to be done in 
a temperature controlled system to avoid confounding effects through mechanical-induced 
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overheating of the muscle. This could for example be achieved by swimming or treadmill running in a 
temperature controlled pool or room, respectively (Ishihara, Yamada et al. 2009). Furthermore, it 
would be interesting to elucidate the role of skeletal muscle PGC-1α in this context, which is known to 
be regulated by calcium and has been shown to associate with HSF to induce the transcription of Hsps 
(Wu, Puigserver et al. 1999, Wu, Kanatous et al. 2002, Handschin, Rhee et al. 2003).   
To our surprise, the overlap between the acute and the chronic exercise-induced transcriptional 
responses was almost completely missing. Since chronically trained mice exerted major improvements 
in exercise performance and oxygen consumption, we suggest that protein rather than transcriptional 
adaptations in skeletal muscle metabolism occurred. To confirm this, we are currently performing mass 
spectrometry analysis. Since the chronic exercise samples have been harvested 18 h after the last 
training session our results indicate that each exercise bout elicited only a transient rather than a 
continuous increase in mRNA expression levels. Thus, it could be speculated that the acute and the 
chronic-acute transcriptional responses would show a similar expression pattern of exercise-
responsive genes. To evaluate this hypothesis, we plan to repeat the chronic exercise training and 
harvest samples after the last training session according to the acute time-course. Thereby we will be 
able to compare the acute and chronic-acute transcriptional responses upon exercise and their 
dependence on skeletal muscle PGC-1α.  
A follow-up study of this second project of the thesis will be the comparison of transcriptional changes 
elicited by acute exercise and cold exposure in skeletal muscle. Recently, three PGC-1α- and exercise-
dependent myokines termed irisin, meteorin-like and β-aminoisobutyric acid have been identified 
promoting browning of white adipose tissue and thereby increasing energy expenditure (Bostrom, Wu 
et al. 2012, Rao, Long et al. 2014, Roberts, Bostrom et al. 2014). Even though it seems paradoxical that 
exercise triggers the release of myokines to induce thermogenesis and energy expenditure, the 
authors claim that this could just be an evolutionary consequence of muscle shivering, however, direct 
correlations are missing. This hypothesis suggests that there might be substantial overlap between the 
responses to exercise and cold exposure in skeletal muscle. Interestingly, PGC-1α expression in skeletal 
muscle can be induced by physical activity and cold exposure indicating that PGC-1α might also play 
an important role in shivering thermogenesis (Puigserver, Wu et al. 1998, Wu, Kanatous et al. 2002, 
Handschin, Rhee et al. 2003). Thus, we started this follow-up study with exposing WT and PGC-1α MKO 
mice to 4 °C or room temperature for 6 h and harvesting Quadriceps muscles immediately after the 
intervention. We could confirm that PGC-1α together with PPARα and the two uncoupling proteins 2 
and 3 were significantly upregulated after 6 h of cold exposure (data not shown). These samples will 
now be subjected to RNA sequencing. The aim of this follow-up project is to define the PGC-1α-
dependent and –independent transcriptional adaptations in response to acute cold exposure and to 
compare these changes to the ones induced by acute exercise. This study will elucidate how much 
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overlap these two stress conditions elicit on the transcriptome of skeletal muscle and will give new 
insights in the regulation of muscle metabolism and the involvement of PGC-1α as a metabolic sensor 
and effector protein.  
 
The third study of this thesis was aimed at elucidating the role and regulation of PGC-1β in the response 
to energy deprivation. We were able to demonstrate that PGC-1β expression is regulated and 
suppressed by increased cAMP levels in-vitro and by fasting in-vivo. Due to low specificity of 
commercially available PGC-1β antibodies and protein abundance in mass spectrometry experiments, 
we did not succeed in having a closer look at the protein levels of PGC-1β under basal and fasted 
conditions in-vivo. Therefore, we claimed that the reduction in PGC-1β mRNA levels is due to a 
protective mechanism in order to reduce its inhibitory effects on the nuclear factor of activated T-cells, 
cytoplasmic 1 (Nfatc1) to limit muscle mass loss. However, one could also speculate that the observed 
reduced PGC-1β expression in WT animals could be the result of a negative feedback loop of increased 
PGC-1β protein stability and content on its own transcription. Interestingly, cAMP has been shown to 
stabilize the PGC-1β protein most likely through the action of cAMP-dependent protein kinase (PKA) 
without affecting its expression levels in primary human melanocytes (Shoag, Haq et al. 2013). Thus, it 
is conceivable that PGC-1β protein stability in skeletal muscle is also increased in response to cAMP 
and fasting. To test this hypothesis, cell culture models (e.g. C2C12 myotubes) with for example flag-
tagged PGC-1β overexpression could be used to circumvent the non-specificity of commercially 
available antibodies and the low abundance of endogenous PGC-1β protein. These cells could be 
treated with compounds that are known to induce cAMP such as forskolin or 8-(4-
chlorophenylthio)adenosine 3',5'-cyclic monophosphate and protein content could be evaluated over 
time by Western blotting, which would indicate if the half-life of the PGC-1β protein is changed 
(Bartsch, Zorn-Kruppa et al. 2003). Furthermore, the human PGC-1α protein has been shown to 
possess several serine PKA binding sites important for its stabilization by cAMP (Shoag, Haq et al. 2013). 
Mutation of these sites to alanine resulted in abolished protein stability after activation by cAMP 
(Shoag, Haq et al. 2013). These experiments could also be carried out for PGC-1β and would elucidate 
if cAMP stabilizes its protein structure through phosphorylation by PKA. If all of these results would be 
positive, one could conclude that PGC-1β actively participates in the fasting response and most likely 
contributes to skeletal muscle atrophy. Contrary to this assumption, overexpression of PGC-1β has 
been shown to protect from muscle wasting through inhibiting FoxO-induced transcription and NF-κB 
activity during denervation atrophy (Brault, Jespersen et al. 2010). Nevertheless, our results suggest 
that PGC-1β is required for the induction of muscle atrophy, at least during energy deprivation. This 
conflicting results could originate from the different stimuli, e.g. fasting versus denervation. Fasting, 
on one hand, is a continuous progressive response that involves all organs of the body and that triggers 
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muscle mass loss in the need for amino acids to sustain hepatic gluconeogenesis (Longo and Mattson 
2014). Denervation, on the other hand, induces an immediate loss of voluntary contractile activity that 
results in disuse-atrophy (Batt and Bain 2013). In fact, the regulation of PGC-1β gene expression in 
these two conditions seems to be distinct. While denervation-induced atrophy leads to a ∼80% drop 
in PGC-1β mRNA levels within the first day, fasting for 24 h only reduces the expression by 30-40% 
(Sacheck, Hyatt et al. 2007). Conceivably, the regulation of PGC-1β in these two conditions might be 
different, even though the induction of atrophy markers such as the two E3 ubiquitin ligases MuRF-1 
and MAFbx are common during denervation and fasting (Bodine, Latres et al. 2001, Gomes, Lecker et 
al. 2001, Sacheck, Hyatt et al. 2007). Thus, it might be interesting to compare different atrophy models, 
e.g. denervation, fasting and cancer cachexia, in terms of PGC-1β regulation.  
As we propose in our study, PGC-1β could function as an inhibitor and possible corepressor for Nfatc1 
transcriptional activity. However, this hypothesis is just based on predictions obtained from the 
integrated motif activity response analysis (ISMARA) tool as well as of RNA sequencing and qPCR 
results. Thus, to solidify these data additional experiments should be carried out. For example, the 
expression of Nfatc1 target genes could be analyzed after overexpression and knockdown of PGC-1β 
in C2C12 or primary myotubes. If PGC-1β indeed functions as a corepressor for Nfatc1 activity, target 
genes would be suppressed in the overexpressed and induced in the knockdown condition, 
respectively. Accordingly, these effects of PGC-1β should be abolished when Nfatc1 is knocked down. 
Ultimately, this experiment could be repeated in-vivo using WT and PGC-1β MKO mice. Knockdown of 
Nfatc1 should render PGC-1β MKO mice as susceptible to fasting-induced muscle atrophy as WT 
animals, which would prove that the blunted fasting response in PGC-1β MKO mice resulted from 
increased Nfatc1 activity. Thus, it might also be interesting to study the role of Nfatc1 in the 
maintenance of skeletal muscle mass. Nfatc1 has been shown to be important for the determination 
of skeletal muscle fiber type and muscle-specific Nfatc1 knockout mice display a lower percentage of 
slow fibers and lack fiber type switching following a seven-day voluntary exercise training in Soleus 
muscle (Ehlers, Celona et al. 2014). Furthermore, another report suggests that Nfatc1 is involved in the 
signaling of IGF-1-induced skeletal myocyte hypertrophy to activate target gene programs (Musaro, 
McCullagh et al. 1999). These results indicate that Nfatc1 might indeed be involved in the regulation 
of muscle mass and increased Nfatc1 activity might protect from fasting-induced muscle atrophy.  
 
In the fourth and last study of this thesis, we focused on the role of PGC-1α in podocyte function and 
its contribution to renal physiology. In fact, we are the first group that generated podocyte-specific 
PGC-1α knockout (PGC-1α PKO) mice to elucidate its function in podocyte metabolism in-vivo. PGC-1α 
ablation in podocytes only resulted in a mild increase in the GBM, which had no negative effects on 
basal or stress-induced podocyte function. These results were quite surprising considering the current 
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literature on the importance of mitochondrial function in podocyte and kidney metabolism. Oxidative 
stress and mitochondrial dysfunction have been indicated to be major contributors in the development 
of podocyte injury and the progression to CKD (Hagiwara, Yamagata et al. 2006, Hall and Unwin 2007, 
Schiffer and Friederich-Persson 2017). Podocyte injury is often associated with mitochondrial 
abnormalities and reduced expression of mtDNA and its encoded proteins (Gucer, Talim et al. 2005, 
Hagiwara, Yamagata et al. 2006, Reidy, Kang et al. 2014).  Thus, activation or overexpression of PGC-
1α in different experimental settings has been shown to protect from mitochondrial dysfunction and 
renal disorders (Chung, Lim et al. 2012, Yuan, Huang et al. 2012, Kim, Lim et al. 2013, Hong, Lim et al. 
2014, Tran, Zsengeller et al. 2016). Conversely, global- or kidney-specific PGC-1α knockout mice display 
difficulties in the response to different stressors such as sepsis, HFD feeding or ischemia (Tran, Tam et 
al. 2011, Svensson, Schnyder et al. 2016, Tran, Zsengeller et al. 2016). Contrary to these results, our 
data revealed that PGC-1α is not required for basal or stress-induced podocyte function in-vivo. This 
could be due to two different reasons: either podocytes are not that dependent on oxidative 
metabolism and mitochondrial function as previously believed or the applied stresses were too mild 
to trigger a possible phenotype in PGC-1α PKO mice. Indeed, it has recently been shown that foot 
processes, the actual barrier-forming units of podocytes, mainly rely on glycolysis to produce ATP 
rather than on mitochondrial respiration (Ozawa, Ueda et al. 2015). This suggests that the loss of PGC-
1α in podocytes did not lead to any structural defects in podocyte architecture and foot processes, 
which might explain why bovine serum albumin- and HFD-induced albuminuria was not different 
between WT and PGC-1α PKO mice. Conceivably, other stressors such as sepsis, ischemia or 
aldosterone could have led to different results. In fact, aldosterone seems to be a potent mediator of 
podocyte injury and its inhibition has recently been implicated to lower proteinuria and to slow the 
progression of CKD (Fourkiotis, Hanslik et al. 2012, Buglioni, Cannone et al. 2015, Buglioni, Cannone et 
al. 2015). Thus, future experiments could include the use of subcutaneously implanted mini-pumps to 
chronically administrate a constant dose of aldosterone followed by the assessment of albuminuria 
and the study of glomerular and podocyte function in WT and PGC-1α PKO mice. These experiments 
could clarify if PGC-1α is indeed dispensable for basal and stress-induced podocyte function or if its 
required to protect from aldosterone-induced podocyte injury and might thus be involved in the 
development and progression of CKD.   
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8. Outlook   
 
To conclude, PGC-1α and PGC-1β are coactivator proteins with pleiotropic functions in tissue-specific 
and whole body metabolism.  
Our results in the first study of this thesis revealed that PGC-1α in skeletal muscle is involved in the 
response to chronic ketogenic diet feeding being essential for the maintenance of adequate energy 
levels during exhaustive endurance exercise. In the second project, we identified PGC-1α to be 
important for the timely expression of target genes upon acute exercise and defined the PGC-1α-
dependent acute core exercise response. The third study was aimed at elucidating the role of skeletal 
muscle PGC-1β in the response to fasting. We demonstrated that PGC-1β is substantially involved in 
fasting-induced muscle atrophy, most likely by inhibiting Nfatc1 transcriptional activity. Finally, we 
showed that PGC-1α is dispensable for normal and stress-induced podocyte and kidney function in-
vivo in the fourth and last study of this thesis.  
Taken all together, we contributed important new aspects to the current knowledge of the function 
and role of the two PGC-1 coactivators in skeletal muscle and of PGC-1α in kidney metabolism. 
Nevertheless, many new questions regarding the regulation and role of the two PGC-1s arose that have 
been discussed in the previous section. In addition, there is still limited knowledge about PGC-1 protein 
regulation in different physiological and pathophysiological settings, in particular in the case of PGC-
1β. Thus, future studies should focus on the control of PGC-1 protein modifications and their 
contributions to cellular homeostasis and whole body metabolism. Furthermore, PGC-1 coactivators 
have been implicated to possess therapeutic potential for the treatment of different pathological 
states. Therefore, intervention strategies should be developed to target and activate PGC-1s in disease 
situations to exert their beneficial effects on tissue-specific and whole body metabolism.   
 
                                                                                                                                                                                 References 
123 
 
References 
  
Abe, Y., T. Sakairi, H. Kajiyama, S. Shrivastav, C. Beeson and J. B. Kopp (2010). "Bioenergetic 
characterization of mouse podocytes." Am J Physiol Cell Physiol 299(2): C464-476. 
 
Adams, G. R., B. M. Hather, K. M. Baldwin and G. A. Dudley (1993). "Skeletal muscle myosin heavy chain 
composition and resistance training." J Appl Physiol (1985) 74(2): 911-915. 
 
Akimoto, T., P. Li and Z. Yan (2008). "Functional interaction of regulatory factors with the Pgc-1alpha 
promoter in response to exercise by in vivo imaging." Am J Physiol Cell Physiol 295(1): C288-292. 
 
Akimoto, T., S. C. Pohnert, P. Li, M. Zhang, C. Gumbs, P. B. Rosenberg, R. S. Williams and Z. Yan (2005). 
"Exercise stimulates Pgc-1alpha transcription in skeletal muscle through activation of the p38 MAPK 
pathway." J Biol Chem 280(20): 19587-19593. 
 
Andersson, U. and R. C. Scarpulla (2001). "Pgc-1-related coactivator, a novel, serum-inducible 
coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells." Mol Cell Biol 
21(11): 3738-3749. 
 
Arany, Z., S. Y. Foo, Y. Ma, J. L. Ruas, A. Bommi-Reddy, G. Girnun, M. Cooper, D. Laznik, J. Chinsomboon, 
S. M. Rangwala, K. H. Baek, A. Rosenzweig and B. M. Spiegelman (2008). "HIF-independent regulation 
of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha." Nature 451(7181): 1008-
1012. 
 
Arany, Z., N. Lebrasseur, C. Morris, E. Smith, W. Yang, Y. Ma, S. Chin and B. M. Spiegelman (2007). "The 
transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal 
muscle." Cell Metab 5(1): 35-46. 
 
Aronson, P. S. and B. Sacktor (1975). "The Na+ gradient-dependent transport of D-glucose in renal 
brush border membranes." J Biol Chem 250(15): 6032-6039. 
 
Austin, S. and J. St-Pierre (2012). "PGC1alpha and mitochondrial metabolism--emerging concepts and 
relevance in ageing and neurodegenerative disorders." J Cell Sci 125(Pt 21): 4963-4971. 
 
Bagnasco, S., D. Good, R. Balaban and M. Burg (1985). "Lactate production in isolated segments of the 
rat nephron." Am J Physiol 248(4 Pt 2): F522-526. 
 
Balwierz, P. J., M. Pachkov, P. Arnold, A. J. Gruber, M. Zavolan and E. van Nimwegen (2014). "ISMARA: 
automated modeling of genomic signals as a democracy of regulatory motifs." Genome Res 24(5): 869-
884. 
 
Baresic, M., S. Salatino, B. Kupr, E. van Nimwegen and C. Handschin (2014). "Transcriptional network 
analysis in muscle reveals AP-1 as a partner of PGC-1alpha in the regulation of the hypoxic gene 
program." Mol Cell Biol 34(16): 2996-3012. 
 
Barres, R., J. Yan, B. Egan, J. T. Treebak, M. Rasmussen, T. Fritz, K. Caidahl, A. Krook, D. J. O'Gorman 
and J. R. Zierath (2012). "Acute exercise remodels promoter methylation in human skeletal muscle." 
Cell Metab 15(3): 405-411. 
                                                                                                                                                                                 References 
124 
 
Bartsch, M., M. Zorn-Kruppa, N. Kuhl, H. G. Genieser, F. Schwede and B. Jastorff (2003). "Bioactivatable, 
membrane-permeant analogs of cyclic nucleotides as biological tools for growth control of C6 glioma 
cells." Biol Chem 384(9): 1321-1326. 
 
Batt, J. A. and J. R. Bain (2013). "Tibial nerve transection - a standardized model for denervation-
induced skeletal muscle atrophy in mice." J Vis Exp(81): e50657. 
 
Benziane, B., T. J. Burton, B. Scanlan, D. Galuska, B. J. Canny, A. V. Chibalin, J. R. Zierath and N. K. Stepto 
(2008). "Divergent cell signaling after short-term intensified endurance training in human skeletal 
muscle." Am J Physiol Endocrinol Metab 295(6): E1427-1438. 
 
Bertram, J. F., R. N. Douglas-Denton, B. Diouf, M. D. Hughson and W. E. Hoy (2011). "Human nephron 
number: implications for health and disease." Pediatr Nephrol 26(9): 1529-1533. 
 
Biljak, V. R., L. Honovic, J. Matica, B. Kresic and S. S. Vojak (2017). "The role of laboratory testing in 
detection and classification of chronic kidney disease: national recommendations." Biochem Med 
(Zagreb) 27(1): 153-176. 
 
Bishop, J. S. and J. Larner (1969). "Presence in liver of a 3':5'-cyclic AMP stimulated kinase for the I form 
of UDPG-glycogen glucosyltransferase." Biochim Biophys Acta 171(2): 374-377. 
 
Bobulescu, I. A. and O. W. Moe (2006). "Na+/H+ exchangers in renal regulation of acid-base balance." 
Semin Nephrol 26(5): 334-344. 
 
Bodine, S. C., E. Latres, S. Baumhueter, V. K. Lai, L. Nunez, B. A. Clarke, W. T. Poueymirou, F. J. Panaro, 
E. Na, K. Dharmarajan, Z. Q. Pan, D. M. Valenzuela, T. M. DeChiara, T. N. Stitt, G. D. Yancopoulos and 
D. J. Glass (2001). "Identification of ubiquitin ligases required for skeletal muscle atrophy." Science 
294(5547): 1704-1708. 
 
Bonaldo, P. and M. Sandri (2013). "Cellular and molecular mechanisms of muscle atrophy." Dis Model 
Mech 6(1): 25-39. 
 
Boron, W. F. and E. L. Boulpaep (1983). "Intracellular pH regulation in the renal proximal tubule of the 
salamander. Basolateral HCO3- transport." J Gen Physiol 81(1): 53-94. 
 
Bostrom, P., J. Wu, M. P. Jedrychowski, A. Korde, L. Ye, J. C. Lo, K. A. Rasbach, E. A. Bostrom, J. H. Choi, 
J. Z. Long, S. Kajimura, M. C. Zingaretti, B. F. Vind, H. Tu, S. Cinti, K. Hojlund, S. P. Gygi and B. M. 
Spiegelman (2012). "A PGC1-alpha-dependent myokine that drives brown-fat-like development of 
white fat and thermogenesis." Nature 481(7382): 463-468. 
 
Bough, K. J. and J. M. Rho (2007). "Anticonvulsant mechanisms of the ketogenic diet." Epilepsia 48(1): 
43-58. 
 
Brault, J. J., J. G. Jespersen and A. L. Goldberg (2010). "Peroxisome proliferator-activated receptor 
gamma coactivator 1alpha or 1beta overexpression inhibits muscle protein degradation, induction of 
ubiquitin ligases, and disuse atrophy." J Biol Chem 285(25): 19460-19471. 
 
Brewster, U. C. and M. A. Perazella (2004). "The renin-angiotensin-aldosterone system and the kidney: 
effects on kidney disease." Am J Med 116(4): 263-272. 
 
Briant, L., A. Salehi, E. Vergari, Q. Zhang and P. Rorsman (2016). "Glucagon secretion from pancreatic 
alpha-cells." Ups J Med Sci 121(2): 113-119. 
                                                                                                                                                                                 References 
125 
 
Buglioni, A., V. Cannone, A. Cataliotti, S. J. Sangaralingham, D. M. Heublein, C. G. Scott, K. R. Bailey, R. 
J. Rodeheffer, P. Dessi-Fulgheri, R. Sarzani and J. C. Burnett, Jr. (2015). "Circulating aldosterone and 
natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease." 
Hypertension 65(1): 45-53. 
 
Buglioni, A., V. Cannone, S. J. Sangaralingham, D. M. Heublein, C. G. Scott, K. R. Bailey, R. J. Rodeheffer, 
R. Sarzani and J. C. Burnett (2015). "Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease 
in the General Community: A 4-Year Follow-Up." J Am Heart Assoc 4(12). 
 
Calvo, J. A., T. G. Daniels, X. Wang, A. Paul, J. Lin, B. M. Spiegelman, S. C. Stevenson and S. M. Rangwala 
(2008). "Muscle-specific expression of PPARgamma coactivator-1alpha improves exercise 
performance and increases peak oxygen uptake." J Appl Physiol (1985) 104(5): 1304-1312. 
 
Canto, C., Z. Gerhart-Hines, J. N. Feige, M. Lagouge, L. Noriega, J. C. Milne, P. J. Elliott, P. Puigserver 
and J. Auwerx (2009). "AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 
activity." Nature 458(7241): 1056-1060. 
 
Carmona-Saez, P., M. Chagoyen, F. Tirado, J. M. Carazo and A. Pascual-Montano (2007). "GENECODIS: 
a web-based tool for finding significant concurrent annotations in gene lists." Genome Biol 8(1): R3. 
 
Carrasco, M. A., N. Riveros, J. Rios, M. Muller, F. Torres, J. Pineda, S. Lantadilla and E. Jaimovich (2003). 
"Depolarization-induced slow calcium transients activate early genes in skeletal muscle cells." Am J 
Physiol Cell Physiol 284(6): C1438-1447. 
 
Catoire, M., M. Mensink, M. V. Boekschoten, R. Hangelbroek, M. Muller, P. Schrauwen and S. Kersten 
(2012). "Pronounced effects of acute endurance exercise on gene expression in resting and exercising 
human skeletal muscle." PLoS One 7(11): e51066. 
 
Chai, J. and A. S. Tarnawski (2002). "Serum response factor: discovery, biochemistry, biological roles 
and implications for tissue injury healing." J Physiol Pharmacol 53(2): 147-157. 
 
Chambers, K. T., Z. Chen, P. A. Crawford, X. Fu, S. C. Burgess, L. Lai, T. C. Leone, D. P. Kelly and B. N. 
Finck (2012). "Liver-specific PGC-1beta deficiency leads to impaired mitochondrial function and 
lipogenic response to fasting-refeeding." PLoS One 7(12): e52645. 
 
Chang, Y. S., L. C. Lee, F. C. Sun, C. C. Chao, H. W. Fu and Y. K. Lai (2006). "Involvement of calcium in 
the differential induction of heat shock protein 70 by heat shock protein 90 inhibitors, geldanamycin 
and radicicol, in human non-small cell lung cancer H460 cells." J Cell Biochem 97(1): 156-165. 
 
Che, R., Y. Yuan, S. Huang and A. Zhang (2014). "Mitochondrial dysfunction in the pathophysiology of 
renal diseases." Am J Physiol Renal Physiol 306(4): F367-378. 
 
Chen, A., C. H. Wei, L. F. Sheu, S. L. Ding and W. H. Lee (1995). "Induction of proteinuria by adriamycin 
or bovine serum albumin in the mouse." Nephron 69(3): 293-300. 
 
Chen, Y., J. Ye, L. Cao, Y. Zhang, W. Xia and D. Zhu (2010). "Myostatin regulates glucose metabolism via 
the AMP-activated protein kinase pathway in skeletal muscle cells." Int J Biochem Cell Biol 42(12): 
2072-2081. 
 
Cheng, H. and R. C. Harris (2010). "The glomerulus--a view from the outside--the podocyte." The 
international journal of biochemistry & cell biology 42(9): 1380-1387. 
                                                                                                                                                                                 References 
126 
 
Chinsomboon, J., J. Ruas, R. K. Gupta, R. Thom, J. Shoag, G. C. Rowe, N. Sawada, S. Raghuram and Z. 
Arany (2009). "The transcriptional coactivator PGC-1alpha mediates exercise-induced angiogenesis in 
skeletal muscle." Proc Natl Acad Sci U S A 106(50): 21401-21406. 
 
Chung, H. W., J. H. Lim, M. Y. Kim, S. J. Shin, S. Chung, B. S. Choi, H. W. Kim, Y. S. Kim, C. W. Park and Y. 
S. Chang (2012). "High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously 
hypertensive rat are ameliorated by fenofibrate through the PPARalpha-FoxO3a-PGC-1alpha 
pathway." Nephrol Dial Transplant 27(6): 2213-2225. 
 
Coffey, V. G., A. Shield, B. J. Canny, K. A. Carey, D. Cameron-Smith and J. A. Hawley (2006). "Interaction 
of contractile activity and training history on mRNA abundance in skeletal muscle from trained 
athletes." Am J Physiol Endocrinol Metab 290(5): E849-855. 
 
Coffey, V. G., Z. Zhong, A. Shield, B. J. Canny, A. V. Chibalin, J. R. Zierath and J. A. Hawley (2006). "Early 
signaling responses to divergent exercise stimuli in skeletal muscle from well-trained humans." FASEB 
J 20(1): 190-192. 
 
Colberg, S. R., R. J. Sigal, B. Fernhall, J. G. Regensteiner, B. J. Blissmer, R. R. Rubin, L. Chasan-Taber, A. 
L. Albright, B. Braun, M. American College of Sports and A. American Diabetes (2010). "Exercise and 
type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint 
position statement." Diabetes Care 33(12): e147-167. 
 
Collier, J. B., R. M. Whitaker, S. T. Eblen and R. G. Schnellmann (2016). "Rapid Renal Regulation of 
Peroxisome Proliferator-activated Receptor gamma Coactivator-1alpha by Extracellular Signal-
Regulated Kinase 1/2 in Physiological and Pathological Conditions." J Biol Chem 291(52): 26850-26859. 
 
Correia, J. C., D. M. Ferreira and J. L. Ruas (2015). "Intercellular: local and systemic actions of skeletal 
muscle PGC-1s." Trends Endocrinol Metab 26(6): 305-314. 
 
Costill, D. L., J. Daniels, W. Evans, W. Fink, G. Krahenbuhl and B. Saltin (1976). "Skeletal muscle enzymes 
and fiber composition in male and female track athletes." J Appl Physiol 40(2): 149-154. 
 
Curran, T. (1992). "Fos and Jun: oncogenic transcription factors." Tohoku J Exp Med 168(2): 169-174. 
 
Curthoys, N. P. and O. W. Moe (2014). "Proximal tubule function and response to acidosis." Clin J Am 
Soc Nephrol 9(9): 1627-1638. 
 
Davidson, L. E., R. Hudson, K. Kilpatrick, J. L. Kuk, K. McMillan, P. M. Janiszewski, S. Lee, M. Lam and R. 
Ross (2009). "Effects of exercise modality on insulin resistance and functional limitation in older adults: 
a randomized controlled trial." Arch Intern Med 169(2): 122-131. 
 
de Lange, P., P. Farina, M. Moreno, M. Ragni, A. Lombardi, E. Silvestri, L. Burrone, A. Lanni and F. Goglia 
(2006). "Sequential changes in the signal transduction responses of skeletal muscle following food 
deprivation." FASEB J 20(14): 2579-2581. 
 
de Lange, P., M. Moreno, E. Silvestri, A. Lombardi, F. Goglia and A. Lanni (2007). "Fuel economy in food-
deprived skeletal muscle: signaling pathways and regulatory mechanisms." FASEB J 21(13): 3431-3441. 
 
Deji, N., S. Kume, S. Araki, M. Soumura, T. Sugimoto, K. Isshiki, M. Chin-Kanasaki, M. Sakaguchi, D. 
Koya, M. Haneda, A. Kashiwagi and T. Uzu (2009). "Structural and functional changes in the kidneys of 
high-fat diet-induced obese mice." Am J Physiol Renal Physiol 296(1): F118-126. 
                                                                                                                                                                                 References 
127 
 
Egan, B., J. A. Hawley and J. R. Zierath (2016). "SnapShot: Exercise Metabolism." Cell Metab 24(2): 342-
342 e341. 
 
Egan, B. and J. R. Zierath (2013). "Exercise metabolism and the molecular regulation of skeletal muscle 
adaptation." Cell Metab 17(2): 162-184. 
 
Egerman, M. A. and D. J. Glass (2014). "Signaling pathways controlling skeletal muscle mass." Crit Rev 
Biochem Mol Biol 49(1): 59-68. 
 
Ehlers, M. L., B. Celona and B. L. Black (2014). "NFATc1 controls skeletal muscle fiber type and is a 
negative regulator of MyoD activity." Cell Rep 8(6): 1639-1648. 
 
El-Nahas, A. M. (2003). "Plasticity of kidney cells: role in kidney remodeling and scarring." Kidney Int 
64(5): 1553-1563. 
 
El Nahas, M. (2003). "Kidney remodelling and scarring: the plasticity of cells." Nephrol Dial Transplant 
18(10): 1959-1962. 
 
Elsayed, E. T., R. A. Nassra and Y. S. Naga (2017). "Peroxisome proliferator-activated receptor-gamma-
coactivator 1alpha (PGC-1alpha) gene expression in chronic kidney disease patients on hemodialysis: 
relation to hemodialysis-related cardiovascular morbidity and mortality." Int Urol Nephrol. 
 
Fernandez-Marcos, P. J. and J. Auwerx (2011). "Regulation of PGC-1alpha, a nodal regulator of 
mitochondrial biogenesis." Am J Clin Nutr 93(4): 884S-890. 
 
Fink, W. J., D. L. Costill and M. L. Pollock (1977). "Submaximal and maximal working capacity of elite 
distance runners. Part II. Muscle fiber composition and enzyme activities." Ann N Y Acad Sci 301: 323-
327. 
 
Fluck, M., F. W. Booth and M. N. Waxham (2000). "Skeletal muscle CaMKII enriches in nuclei and 
phosphorylates myogenic factor SRF at multiple sites." Biochem Biophys Res Commun 270(2): 488-
494. 
 
Foley, R. N. (2008). "Erythropoietin: physiology and molecular mechanisms." Heart Fail Rev 13(4): 405-
414. 
 
Fong, Y., L. L. Moldawer, M. A. Marano, H. Wei, A. Barber, D. A. Fischman and S. F. Lowry (1989). 
"Starvation leads to decreased levels of mRNA for myofibrillar proteins." J Surg Res 46(5): 457-461. 
 
Fourkiotis, V. G., G. Hanslik, F. Hanusch, J. Lepenies and M. Quinkler (2012). "Aldosterone and the 
kidney." Horm Metab Res 44(3): 194-201. 
 
Gabriel, B. M. and J. R. Zierath (2017). "The Limits of Exercise Physiology: From Performance to Health." 
Cell Metab 25(5): 1000-1011. 
 
Gali Ramamoorthy, T., G. Laverny, A. I. Schlagowski, J. Zoll, N. Messaddeq, J. M. Bornert, S. Panza, A. 
Ferry, B. Geny and D. Metzger (2015). "The transcriptional coregulator PGC-1beta controls 
mitochondrial function and anti-oxidant defence in skeletal muscles." Nat Commun 6: 10210. 
 
Gehlert, S., W. Bloch and F. Suhr (2015). "Ca2+-dependent regulations and signaling in skeletal muscle: 
from electro-mechanical coupling to adaptation." Int J Mol Sci 16(1): 1066-1095. 
                                                                                                                                                                                 References 
128 
 
Gerich, J. E. (2010). "Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of 
diabetes mellitus: therapeutic implications." Diabet Med 27(2): 136-142. 
 
Giebisch, G. (1998). "Renal potassium transport: mechanisms and regulation." Am J Physiol 274(5 Pt 
2): F817-833. 
 
Glass, D. and R. Roubenoff (2010). "Recent advances in the biology and therapy of muscle wasting." 
Ann N Y Acad Sci 1211: 25-36. 
 
Gleyzer, N. and R. C. Scarpulla (2013). "Activation of a PGC-1-related coactivator (PRC)-dependent 
inflammatory stress program linked to apoptosis and premature senescence." J Biol Chem 288(12): 
8004-8015. 
 
Gomes, M. D., S. H. Lecker, R. T. Jagoe, A. Navon and A. L. Goldberg (2001). "Atrogin-1, a muscle-specific 
F-box protein highly expressed during muscle atrophy." Proc Natl Acad Sci U S A 98(25): 14440-14445. 
 
Granata, S., A. Dalla Gassa, P. Tomei, A. Lupo and G. Zaza (2015). "Mitochondria: a new therapeutic 
target in chronic kidney disease." Nutr Metab (Lond) 12: 49. 
 
Granata, S., G. Zaza, S. Simone, G. Villani, D. Latorre, P. Pontrelli, M. Carella, F. P. Schena, G. 
Grandaliano and G. Pertosa (2009). "Mitochondrial dysregulation and oxidative stress in patients with 
chronic kidney disease." BMC Genomics 10: 388. 
 
Green, H. J., R. Helyar, M. Ball-Burnett, N. Kowalchuk, S. Symon and B. Farrance (1992). "Metabolic 
adaptations to training precede changes in muscle mitochondrial capacity." J Appl Physiol (1985) 72(2): 
484-491. 
 
Gucer, S., B. Talim, E. Asan, P. Korkusuz, S. Ozen, S. Unal, S. H. Kalkanoglu, G. Kale and M. Caglar (2005). 
"Focal segmental glomerulosclerosis associated with mitochondrial cytopathy: report of two cases 
with special emphasis on podocytes." Pediatric and developmental pathology : the official journal of 
the Society for Pediatric Pathology and the Paediatric Pathology Society 8(6): 710-717. 
 
Hagiwara, M., K. Yamagata, R. A. Capaldi and A. Koyama (2006). "Mitochondrial dysfunction in focal 
segmental glomerulosclerosis of puromycin aminonucleoside nephrosis." Kidney international 69(7): 
1146-1152. 
 
Halagappa, V. K., Z. Guo, M. Pearson, Y. Matsuoka, R. G. Cutler, F. M. Laferla and M. P. Mattson (2007). 
"Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-
transgenic mouse model of Alzheimer's disease." Neurobiol Dis 26(1): 212-220. 
 
Hall, A. M. and R. J. Unwin (2007). "The not so 'mighty chondrion': emergence of renal diseases due to 
mitochondrial dysfunction." Nephron. Physiology 105(1): p1-10. 
 
Handschin, C., S. Chin, P. Li, F. Liu, E. Maratos-Flier, N. K. Lebrasseur, Z. Yan and B. M. Spiegelman 
(2007). "Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha 
muscle-specific knock-out animals." J Biol Chem 282(41): 30014-30021. 
 
Handschin, C., C. S. Choi, S. Chin, S. Kim, D. Kawamori, A. J. Kurpad, N. Neubauer, J. Hu, V. K. Mootha, 
Y. B. Kim, R. N. Kulkarni, G. I. Shulman and B. M. Spiegelman (2007). "Abnormal glucose homeostasis 
in skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell 
crosstalk." J Clin Invest 117(11): 3463-3474. 
                                                                                                                                                                                 References 
129 
 
Handschin, C., J. Rhee, J. Lin, P. T. Tarr and B. M. Spiegelman (2003). "An autoregulatory loop controls 
peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle." Proc Natl 
Acad Sci U S A 100(12): 7111-7116. 
 
Hardie, D. G. (2007). "AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy." 
Nat Rev Mol Cell Biol 8(10): 774-785. 
 
Harvie, M. N., M. Pegington, M. P. Mattson, J. Frystyk, B. Dillon, G. Evans, J. Cuzick, S. A. Jebb, B. Martin, 
R. G. Cutler, T. G. Son, S. Maudsley, O. D. Carlson, J. M. Egan, A. Flyvbjerg and A. Howell (2011). "The 
effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk 
markers: a randomized trial in young overweight women." Int J Obes (Lond) 35(5): 714-727. 
 
Haskell, W. L., I. M. Lee, R. R. Pate, K. E. Powell, S. N. Blair, B. A. Franklin, C. A. Macera, G. W. Heath, P. 
D. Thompson and A. Bauman (2007). "Physical activity and public health: updated recommendation 
for adults from the American College of Sports Medicine and the American Heart Association." Med 
Sci Sports Exerc 39(8): 1423-1434. 
 
Haskell, W. L., I. M. Lee, R. R. Pate, K. E. Powell, S. N. Blair, B. A. Franklin, C. A. Macera, G. W. Heath, P. 
D. Thompson, A. Bauman, M. American College of Sports and A. American Heart (2007). "Physical 
activity and public health: updated recommendation for adults from the American College of Sports 
Medicine and the American Heart Association." Circulation 116(9): 1081-1093. 
 
Heberle, H., G. V. Meirelles, F. R. da Silva, G. P. Telles and R. Minghim (2015). "InteractiVenn: a web-
based tool for the analysis of sets through Venn diagrams." BMC Bioinformatics 16: 169. 
 
Henstridge, D. C., M. A. Febbraio and M. Hargreaves (2016). "Heat shock proteins and exercise 
adaptations. Our knowledge thus far and the road still ahead." J Appl Physiol (1985) 120(6): 683-691. 
 
Herzig, S., F. Long, U. S. Jhala, S. Hedrick, R. Quinn, A. Bauer, D. Rudolph, G. Schutz, C. Yoon, P. 
Puigserver, B. Spiegelman and M. Montminy (2001). "CREB regulates hepatic gluconeogenesis through 
the coactivator PGC-1." Nature 413(6852): 179-183. 
 
Higgins, G. C. and M. T. Coughlan (2014). "Mitochondrial dysfunction and mitophagy: the beginning 
and end to diabetic nephropathy?" Br J Pharmacol 171(8): 1917-1942. 
 
Hildebrandt, A. L. and P. D. Neufer (2000). "Exercise attenuates the fasting-induced transcriptional 
activation of metabolic genes in skeletal muscle." Am J Physiol Endocrinol Metab 278(6): E1078-1086. 
 
Hindi, S. M., V. Mishra, S. Bhatnagar, M. M. Tajrishi, Y. Ogura, Z. Yan, L. C. Burkly, T. S. Zheng and A. 
Kumar (2014). "Regulatory circuitry of TWEAK-Fn14 system and PGC-1alpha in skeletal muscle atrophy 
program." FASEB J 28(3): 1398-1411. 
 
Ho, K. K., S. S. Myatt and E. W. Lam (2008). "Many forks in the path: cycling with FoxO." Oncogene 
27(16): 2300-2311. 
 
Holness, M. J. and M. C. Sugden (1990). "Glucose utilization in heart, diaphragm and skeletal muscle 
during the fed-to-starved transition." Biochem J 270(1): 245-249. 
 
Hong, Y. A., J. H. Lim, M. Y. Kim, T. W. Kim, Y. Kim, K. S. Yang, H. S. Park, S. R. Choi, S. Chung, H. W. Kim, 
H. W. Kim, B. S. Choi, Y. S. Chang and C. W. Park (2014). "Fenofibrate improves renal lipotoxicity 
through activation of AMPK-PGC-1alpha in db/db mice." PLoS One 9(5): e96147. 
                                                                                                                                                                                 References 
130 
 
Hopkins, P. M. (2011). "Malignant hyperthermia: pharmacology of triggering." Br J Anaesth 107(1): 48-
56. 
 
Huber, T. B., B. Hartleben, K. Winkelmann, L. Schneider, J. U. Becker, M. Leitges, G. Walz, H. Haller and 
M. Schiffer (2009). "Loss of podocyte aPKClambda/iota causes polarity defects and nephrotic 
syndrome." J Am Soc Nephrol 20(4): 798-806. 
 
Hudson, E. R., D. A. Pan, J. James, J. M. Lucocq, S. A. Hawley, K. A. Green, O. Baba, T. Terashima and D. 
G. Hardie (2003). "A novel domain in AMP-activated protein kinase causes glycogen storage bodies 
similar to those seen in hereditary cardiac arrhythmias." Curr Biol 13(10): 861-866. 
 
Imasawa, T. and R. Rossignol (2013). "Podocyte energy metabolism and glomerular diseases." Int J 
Biochem Cell Biol 45(9): 2109-2118. 
 
Ishihara, K., A. Yamada, Y. Mita, A. Goto, T. Ishimi, H. Mabuchi, K. Inoue, T. Fushiki and K. Yasumoto 
(2009). "Improved swimming pool achieves higher reproducibility and sensitivity to effect of food 
components as ergogenic AIDS." J Nutr Sci Vitaminol (Tokyo) 55(3): 301-308. 
 
Jacobson, L. O., E. Goldwasser, W. Fried and L. Plzak (2000). "Role of the kidney in erythropoiesis. 
1957." J Am Soc Nephrol 11(3): 589-590; discussion 589-591. 
 
Jager, S., C. Handschin, J. St-Pierre and B. M. Spiegelman (2007). "AMP-activated protein kinase (AMPK) 
action in skeletal muscle via direct phosphorylation of PGC-1alpha." Proc Natl Acad Sci U S A 104(29): 
12017-12022. 
 
Jagoe, R. T., S. H. Lecker, M. Gomes and A. L. Goldberg (2002). "Patterns of gene expression in 
atrophying skeletal muscles: response to food deprivation." FASEB J 16(13): 1697-1712. 
 
Jean-Baptiste, G., Z. Yang, C. Khoury, S. Gaudio and M. T. Greenwood (2005). "Peptide and non-peptide 
G-protein coupled receptors (GPCRs) in skeletal muscle." Peptides 26(8): 1528-1536. 
 
Joffe, M., N. Savage and M. Silove (1992). "The biochemistry of malignant hyperthermia: recent 
concepts." Int J Biochem 24(3): 387-398. 
 
Johnson, L. N. (2009). "The regulation of protein phosphorylation." Biochem Soc Trans 37(Pt 4): 627-
641. 
 
Kazancioglu, R. (2013). "Risk factors for chronic kidney disease: an update." Kidney Int Suppl (2011) 
3(4): 368-371. 
 
Kdoqi (2007). "KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes 
and Chronic Kidney Disease." Am J Kidney Dis 49(2 Suppl 2): S12-154. 
 
Kim, M. Y., J. H. Lim, H. H. Youn, Y. A. Hong, K. S. Yang, H. S. Park, S. Chung, S. H. Ko, S. J. Shin, B. S. Choi, 
H. W. Kim, Y. S. Kim, J. H. Lee, Y. S. Chang and C. W. Park (2013). "Resveratrol prevents renal lipotoxicity 
and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1alpha axis in 
db/db mice." Diabetologia 56(1): 204-217. 
 
Kimura, I., D. Inoue, T. Maeda, T. Hara, A. Ichimura, S. Miyauchi, M. Kobayashi, A. Hirasawa and G. 
Tsujimoto (2011). "Short-chain fatty acids and ketones directly regulate sympathetic nervous system 
via G protein-coupled receptor 41 (GPR41)." Proc Natl Acad Sci U S A 108(19): 8030-8035. 
                                                                                                                                                                                 References 
131 
 
Koves, T. R., P. Li, J. An, T. Akimoto, D. Slentz, O. Ilkayeva, G. L. Dohm, Z. Yan, C. B. Newgard and D. M. 
Muoio (2005). "Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated 
metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced 
mitochondrial inefficiency." J Biol Chem 280(39): 33588-33598. 
 
Krebs, H. A. (1966). "The regulation of the release of ketone bodies by the liver." Adv Enzyme Regul 4: 
339-354. 
 
Kregel, K. C. (2002). "Heat shock proteins: modifying factors in physiological stress responses and 
acquired thermotolerance." J Appl Physiol (1985) 92(5): 2177-2186. 
 
Kressler, D., S. N. Schreiber, D. Knutti and A. Kralli (2002). "The PGC-1-related protein PERC is a selective 
coactivator of estrogen receptor alpha." J Biol Chem 277(16): 13918-13925. 
 
Kupr, B. and C. Handschin (2015). "Complex Coordination of Cell Plasticity by a PGC-1alpha-controlled 
Transcriptional Network in Skeletal Muscle." Front Physiol 6: 325. 
 
Kupr, B., S. Schnyder and C. Handschin (2017). "Role of Nuclear Receptors in Exercise-Induced Muscle 
Adaptations." Cold Spring Harb Perspect Med 7(6). 
 
Laffel, L. (1999). "Ketone bodies: a review of physiology, pathophysiology and application of 
monitoring to diabetes." Diabetes Metab Res Rev 15(6): 412-426. 
 
Lai, L., T. C. Leone, C. Zechner, P. J. Schaeffer, S. M. Kelly, D. P. Flanagan, D. M. Medeiros, A. Kovacs and 
D. P. Kelly (2008). "Transcriptional coactivators PGC-1alpha and PGC-lbeta control overlapping 
programs required for perinatal maturation of the heart." Genes Dev 22(14): 1948-1961. 
 
Larrouy, D., H. Vidal, F. Andreelli, M. Laville and D. Langin (1999). "Cloning and mRNA tissue distribution 
of human PPARgamma coactivator-1." Int J Obes Relat Metab Disord 23(12): 1327-1332. 
 
Lee, C., L. Raffaghello, S. Brandhorst, F. M. Safdie, G. Bianchi, A. Martin-Montalvo, V. Pistoia, M. Wei, 
S. Hwang, A. Merlino, L. Emionite, R. de Cabo and V. D. Longo (2012). "Fasting cycles retard growth of 
tumors and sensitize a range of cancer cell types to chemotherapy." Sci Transl Med 4(124): 124ra127. 
 
Lee, S., T. C. Leone, L. Rogosa, J. Rumsey, J. Ayala, P. M. Coen, R. H. Fitts, R. B. Vega and D. P. Kelly 
(2017). "Skeletal muscle PGC-1beta signaling is sufficient to drive an endurance exercise phenotype 
and to counteract components of detraining in mice." Am J Physiol Endocrinol Metab 312(5): E394-
E406. 
 
Leeuwis, J. W., T. Q. Nguyen, A. Dendooven, R. J. Kok and R. Goldschmeding (2010). "Targeting 
podocyte-associated diseases." Adv Drug Deliv Rev 62(14): 1325-1336. 
 
Lelliott, C. J., G. Medina-Gomez, N. Petrovic, A. Kis, H. M. Feldmann, M. Bjursell, N. Parker, K. Curtis, 
M. Campbell, P. Hu, D. Zhang, S. E. Litwin, V. G. Zaha, K. T. Fountain, S. Boudina, M. Jimenez-Linan, M. 
Blount, M. Lopez, A. Meirhaeghe, Y. M. Bohlooly, L. Storlien, M. Stromstedt, M. Snaith, M. Oresic, E. D. 
Abel, B. Cannon and A. Vidal-Puig (2006). "Ablation of PGC-1beta results in defective mitochondrial 
activity, thermogenesis, hepatic function, and cardiac performance." PLoS Biol 4(11): e369. 
 
Lemon, P. W. and J. P. Mullin (1980). "Effect of initial muscle glycogen levels on protein catabolism 
during exercise." J Appl Physiol Respir Environ Exerc Physiol 48(4): 624-629. 
 
                                                                                                                                                                                 References 
132 
 
Leone, T. C., J. J. Lehman, B. N. Finck, P. J. Schaeffer, A. R. Wende, S. Boudina, M. Courtois, D. F. 
Wozniak, N. Sambandam, C. Bernal-Mizrachi, Z. Chen, J. O. Holloszy, D. M. Medeiros, R. E. Schmidt, J. 
E. Saffitz, E. D. Abel, C. F. Semenkovich and D. P. Kelly (2005). "PGC-1alpha deficiency causes multi-
system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic 
steatosis." PLoS Biol 3(4): e101. 
 
Lerin, C., J. T. Rodgers, D. E. Kalume, S. H. Kim, A. Pandey and P. Puigserver (2006). "GCN5 
acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-
1alpha." Cell Metab 3(6): 429-438. 
 
Levey, A. S., J. Coresh, E. Balk, A. T. Kausz, A. Levin, M. W. Steffes, R. J. Hogg, R. D. Perrone, J. Lau, G. 
Eknoyan and F. National Kidney (2003). "National Kidney Foundation practice guidelines for chronic 
kidney disease: evaluation, classification, and stratification." Ann Intern Med 139(2): 137-147. 
 
Lin, J., C. Handschin and B. M. Spiegelman (2005). "Metabolic control through the PGC-1 family of 
transcription coactivators." Cell Metab 1(6): 361-370. 
 
Lin, J., P. Puigserver, J. Donovan, P. Tarr and B. M. Spiegelman (2002). "Peroxisome proliferator-
activated receptor gamma coactivator 1beta (PGC-1beta ), a novel PGC-1-related transcription 
coactivator associated with host cell factor." J Biol Chem 277(3): 1645-1648. 
 
Lin, J., P. T. Tarr, R. Yang, J. Rhee, P. Puigserver, C. B. Newgard and B. M. Spiegelman (2003). "PGC-
1beta in the regulation of hepatic glucose and energy metabolism." J Biol Chem 278(33): 30843-30848. 
 
Lin, J., H. Wu, P. T. Tarr, C. Y. Zhang, Z. Wu, O. Boss, L. F. Michael, P. Puigserver, E. Isotani, E. N. Olson, 
B. B. Lowell, R. Bassel-Duby and B. M. Spiegelman (2002). "Transcriptional co-activator PGC-1 alpha 
drives the formation of slow-twitch muscle fibres." Nature 418(6899): 797-801. 
 
Lin, J., P. H. Wu, P. T. Tarr, K. S. Lindenberg, J. St-Pierre, C. Y. Zhang, V. K. Mootha, S. Jager, C. R. Vianna, 
R. M. Reznick, L. Cui, M. Manieri, M. X. Donovan, Z. Wu, M. P. Cooper, M. C. Fan, L. M. Rohas, A. M. 
Zavacki, S. Cinti, G. I. Shulman, B. B. Lowell, D. Krainc and B. M. Spiegelman (2004). "Defects in adaptive 
energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice." Cell 119(1): 121-135. 
 
Lin, J., R. Yang, P. T. Tarr, P. H. Wu, C. Handschin, S. Li, W. Yang, L. Pei, M. Uldry, P. Tontonoz, C. B. 
Newgard and B. M. Spiegelman (2005). "Hyperlipidemic effects of dietary saturated fats mediated 
through PGC-1beta coactivation of SREBP." Cell 120(2): 261-273. 
 
Lonard, D. M. and W. O'Malley B (2007). "Nuclear receptor coregulators: judges, juries, and 
executioners of cellular regulation." Mol Cell 27(5): 691-700. 
 
Longo, V. D. and M. P. Mattson (2014). "Fasting: molecular mechanisms and clinical applications." Cell 
Metab 19(2): 181-192. 
 
MacLennan, D. H. and M. S. Phillips (1992). "Malignant hyperthermia." Science 256(5058): 789-794. 
 
Malovannaya, A., R. B. Lanz, S. Y. Jung, Y. Bulynko, N. T. Le, D. W. Chan, C. Ding, Y. Shi, N. Yucer, G. 
Krenciute, B. J. Kim, C. Li, R. Chen, W. Li, Y. Wang, B. W. O'Malley and J. Qin (2011). "Analysis of the 
human endogenous coregulator complexome." Cell 145(5): 787-799. 
 
McFarlane, C., E. Plummer, M. Thomas, A. Hennebry, M. Ashby, N. Ling, H. Smith, M. Sharma and R. 
Kambadur (2006). "Myostatin induces cachexia by activating the ubiquitin proteolytic system through 
an NF-kappaB-independent, FoxO1-dependent mechanism." J Cell Physiol 209(2): 501-514. 
                                                                                                                                                                                 References 
133 
 
McPherron, A. C., A. M. Lawler and S. J. Lee (1997). "Regulation of skeletal muscle mass in mice by a 
new TGF-beta superfamily member." Nature 387(6628): 83-90. 
 
Mehta, R. L., J. A. Kellum, S. V. Shah, B. A. Molitoris, C. Ronco, D. G. Warnock, A. Levin and N. Acute 
Kidney Injury (2007). "Acute Kidney Injury Network: report of an initiative to improve outcomes in 
acute kidney injury." Crit Care 11(2): R31. 
 
Meirhaeghe, A., V. Crowley, C. Lenaghan, C. Lelliott, K. Green, A. Stewart, K. Hart, S. Schinner, J. K. 
Sethi, G. Yeo, M. D. Brand, R. N. Cortright, S. O'Rahilly, C. Montague and A. J. Vidal-Puig (2003). 
"Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated 
receptor-gamma co-activator 1 beta) gene in vitro and in vivo." Biochem J 373(Pt 1): 155-165. 
 
Mendias, C. L., J. P. Gumucio, M. E. Davis, C. W. Bromley, C. S. Davis and S. V. Brooks (2012). 
"Transforming growth factor-beta induces skeletal muscle atrophy and fibrosis through the induction 
of atrogin-1 and scleraxis." Muscle Nerve 45(1): 55-59. 
 
Micallef, L. and P. Rodgers (2014). "eulerAPE: drawing area-proportional 3-Venn diagrams using 
ellipses." PLoS One 9(7): e101717. 
 
Miledi, R., I. Parker and P. H. Zhu (1983). "Calcium transients in frog skeletal muscle fibres following 
conditioning stimuli." J Physiol 339: 223-242. 
 
Millichap, J. G. and J. D. Jones (1964). "Acid-Base, Electrolyte, and Amino-Acid Metabolism in Children 
with Petit Mal. Etiologic Significance and Modification by Anticonvulsant Drugs and the Ketogenic 
Diet." Epilepsia 5: 239-255. 
 
Miner, J. H. (2012). "The glomerular basement membrane." Exp Cell Res 318(9): 973-978. 
 
Mitch, W. E. and A. L. Goldberg (1996). "Mechanisms of muscle wasting. The role of the ubiquitin-
proteasome pathway." N Engl J Med 335(25): 1897-1905. 
 
Miura, S., Y. Kai, Y. Kamei and O. Ezaki (2008). "Isoform-specific increases in murine skeletal muscle 
peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in 
response to beta2-adrenergic receptor activation and exercise." Endocrinology 149(9): 4527-4533. 
 
Miura, S., K. Kawanaka, Y. Kai, M. Tamura, M. Goto, T. Shiuchi, Y. Minokoshi and O. Ezaki (2007). "An 
increase in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-
1alpha (PGC-1alpha) mRNA in response to exercise is mediated by beta-adrenergic receptor 
activation." Endocrinology 148(7): 3441-3448. 
 
Moeller, M. J., S. K. Sanden, A. Soofi, R. C. Wiggins and L. B. Holzman (2003). "Podocyte-specific 
expression of cre recombinase in transgenic mice." Genesis 35(1): 39-42. 
 
Mootha, V. K., C. M. Lindgren, K. F. Eriksson, A. Subramanian, S. Sihag, J. Lehar, P. Puigserver, E. 
Carlsson, M. Ridderstrale, E. Laurila, N. Houstis, M. J. Daly, N. Patterson, J. P. Mesirov, T. R. Golub, P. 
Tamayo, B. Spiegelman, E. S. Lander, J. N. Hirschhorn, D. Altshuler and L. C. Groop (2003). "PGC-1alpha-
responsive genes involved in oxidative phosphorylation are coordinately downregulated in human 
diabetes." Nat Genet 34(3): 267-273. 
 
Moresi, V., A. H. Williams, E. Meadows, J. M. Flynn, M. J. Potthoff, J. McAnally, J. M. Shelton, J. Backs, 
W. H. Klein, J. A. Richardson, R. Bassel-Duby and E. N. Olson (2010). "Myogenin and class II HDACs 
control neurogenic muscle atrophy by inducing E3 ubiquitin ligases." Cell 143(1): 35-45. 
                                                                                                                                                                                 References 
134 
 
Mortensen, O. H., P. Plomgaard, C. P. Fischer, A. K. Hansen, H. Pilegaard and B. K. Pedersen (2007). 
"PGC-1beta is downregulated by training in human skeletal muscle: no effect of training twice every 
second day vs. once daily on expression of the PGC-1 family." J Appl Physiol (1985) 103(5): 1536-1542. 
 
Mosser, D. D., P. T. Kotzbauer, K. D. Sarge and R. I. Morimoto (1990). "In vitro activation of heat shock 
transcription factor DNA-binding by calcium and biochemical conditions that affect protein 
conformation." Proc Natl Acad Sci U S A 87(10): 3748-3752. 
 
Mouchiroud, L., L. J. Eichner, R. J. Shaw and J. Auwerx (2014). "Transcriptional coregulators: fine-tuning 
metabolism." Cell Metab 20(1): 26-40. 
 
Muller-Deile, J. and M. Schiffer (2014). "The podocyte power-plant disaster and its contribution to 
glomerulopathy." Front Endocrinol (Lausanne) 5: 209. 
 
Musaro, A., K. J. McCullagh, F. J. Naya, E. N. Olson and N. Rosenthal (1999). "IGF-1 induces skeletal 
myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1." Nature 400(6744): 
581-585. 
 
Nangaku, M. (2004). "Mechanisms of tubulointerstitial injury in the kidney: final common pathways to 
end-stage renal failure." Intern Med 43(1): 9-17. 
 
Newman, J. C. and E. Verdin (2014). "Ketone bodies as signaling metabolites." Trends Endocrinol 
Metab 25(1): 42-52. 
 
Nielsen, S., S. R. DiGiovanni, E. I. Christensen, M. A. Knepper and H. W. Harris (1993). "Cellular and 
subcellular immunolocalization of vasopressin-regulated water channel in rat kidney." Proc Natl Acad 
Sci U S A 90(24): 11663-11667. 
 
Nogales-Cadenas, R., P. Carmona-Saez, M. Vazquez, C. Vicente, X. Yang, F. Tirado, J. M. Carazo and A. 
Pascual-Montano (2009). "GeneCodis: interpreting gene lists through enrichment analysis and 
integration of diverse biological information." Nucleic Acids Res 37(Web Server issue): W317-322. 
 
O'Connor, P. M. (2006). "Renal oxygen delivery: matching delivery to metabolic demand." Clin Exp 
Pharmacol Physiol 33(10): 961-967. 
 
Ohta, T., M. Endo, T. Nakano, Y. Morohoshi, K. Wanikawa and A. Ohga (1989). "Ca-induced Ca release 
in malignant hyperthermia-susceptible pig skeletal muscle." Am J Physiol 256(2 Pt 1): C358-367. 
 
Ozawa, S., S. Ueda, H. Imamura, K. Mori, K. Asanuma, M. Yanagita and T. Nakagawa (2015). "Glycolysis, 
but not Mitochondria, responsible for intracellular ATP distribution in cortical area of podocytes." Sci 
Rep 5: 18575. 
 
Paoli, A., K. Grimaldi, D. D'Agostino, L. Cenci, T. Moro, A. Bianco and A. Palma (2012). "Ketogenic diet 
does not affect strength performance in elite artistic gymnasts." J Int Soc Sports Nutr 9(1): 34. 
 
Paoli, A., A. Rubini, J. S. Volek and K. A. Grimaldi (2013). "Beyond weight loss: a review of the 
therapeutic uses of very-low-carbohydrate (ketogenic) diets." Eur J Clin Nutr 67(8): 789-796. 
 
Parikh, S. M., Y. Yang, L. He, C. Tang, M. Zhan and Z. Dong (2015). "Mitochondrial function and 
disturbances in the septic kidney." Semin Nephrol 35(1): 108-119. 
 
                                                                                                                                                                                 References 
135 
 
Parsons, W. J., V. Ramkumar and G. L. Stiles (1988). "Isobutylmethylxanthine stimulates adenylate 
cyclase by blocking the inhibitory regulatory protein, Gi." Mol Pharmacol 34(1): 37-41. 
 
Patti, M. E., A. J. Butte, S. Crunkhorn, K. Cusi, R. Berria, S. Kashyap, Y. Miyazaki, I. Kohane, M. Costello, 
R. Saccone, E. J. Landaker, A. B. Goldfine, E. Mun, R. DeFronzo, J. Finlayson, C. R. Kahn and L. J. 
Mandarino (2003). "Coordinated reduction of genes of oxidative metabolism in humans with insulin 
resistance and diabetes: Potential role of PGC1 and NRF1." Proc Natl Acad Sci U S A 100(14): 8466-
8471. 
 
Pedersen, C. R., I. Hagemann, T. Bock and K. Buschard (1999). "Intermittent feeding and fasting reduces 
diabetes incidence in BB rats." Autoimmunity 30(4): 243-250. 
 
Philp, A., M. Y. Belew, A. Evans, D. Pham, I. Sivia, A. Chen, S. Schenk and K. Baar (2011). "The PGC-
1alpha-related coactivator promotes mitochondrial and myogenic adaptations in C2C12 myotubes." 
Am J Physiol Regul Integr Comp Physiol 301(4): R864-872. 
 
Phinney, S. D., B. R. Bistrian, W. J. Evans, E. Gervino and G. L. Blackburn (1983). "The human metabolic 
response to chronic ketosis without caloric restriction: preservation of submaximal exercise capability 
with reduced carbohydrate oxidation." Metabolism 32(8): 769-776. 
 
Pilegaard, H., B. Saltin and P. D. Neufer (2003). "Exercise induces transient transcriptional activation of 
the PGC-1alpha gene in human skeletal muscle." J Physiol 546(Pt 3): 851-858. 
 
Polekhina, G., A. Gupta, B. J. Michell, B. van Denderen, S. Murthy, S. C. Feil, I. G. Jennings, D. J. 
Campbell, L. A. Witters, M. W. Parker, B. E. Kemp and D. Stapleton (2003). "AMPK beta subunit targets 
metabolic stress sensing to glycogen." Curr Biol 13(10): 867-871. 
 
Puigserver, P., G. Adelmant, Z. Wu, M. Fan, J. Xu, B. O'Malley and B. M. Spiegelman (1999). "Activation 
of PPARgamma coactivator-1 through transcription factor docking." Science 286(5443): 1368-1371. 
 
Puigserver, P., J. Rhee, J. Lin, Z. Wu, J. C. Yoon, C. Y. Zhang, S. Krauss, V. K. Mootha, B. B. Lowell and B. 
M. Spiegelman (2001). "Cytokine stimulation of energy expenditure through p38 MAP kinase activation 
of PPARgamma coactivator-1." Mol Cell 8(5): 971-982. 
 
Puigserver, P., Z. Wu, C. W. Park, R. Graves, M. Wright and B. M. Spiegelman (1998). "A cold-inducible 
coactivator of nuclear receptors linked to adaptive thermogenesis." Cell 92(6): 829-839. 
 
Puntschart, A., E. Wey, K. Jostarndt, M. Vogt, M. Wittwer, H. R. Widmer, H. Hoppeler and R. Billeter 
(1998). "Expression of fos and jun genes in human skeletal muscle after exercise." Am J Physiol 274(1 
Pt 1): C129-137. 
 
Ramaswamy, S., N. Nakamura, I. Sansal, L. Bergeron and W. R. Sellers (2002). "A novel mechanism of 
gene regulation and tumor suppression by the transcription factor FKHR." Cancer Cell 2(1): 81-91. 
 
Rao, R. R., J. Z. Long, J. P. White, K. J. Svensson, J. Lou, I. Lokurkar, M. P. Jedrychowski, J. L. Ruas, C. D. 
Wrann, J. C. Lo, D. M. Camera, J. Lachey, S. Gygi, J. Seehra, J. A. Hawley and B. M. Spiegelman (2014). 
"Meteorin-like Is a Hormone that Regulates Immune-Adipose Interactions to Increase Beige Fat 
Thermogenesis." Cell 157(6): 1279-1291. 
 
Rayego-Mateos, S., J. L. Morgado-Pascual, A. B. Sanz, A. M. Ramos, S. Eguchi, D. Batlle, J. Pato, G. Keri, 
J. Egido, A. Ortiz and M. Ruiz-Ortega (2013). "TWEAK transactivation of the epidermal growth factor 
receptor mediates renal inflammation." J Pathol 231(4): 480-494. 
                                                                                                                                                                                 References 
136 
 
Reidy, K., H. M. Kang, T. Hostetter and K. Susztak (2014). "Molecular mechanisms of diabetic kidney 
disease." J Clin Invest 124(6): 2333-2340. 
 
Rhee, J., Y. Inoue, J. C. Yoon, P. Puigserver, M. Fan, F. J. Gonzalez and B. M. Spiegelman (2003). 
"Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for 
hepatocyte nuclear factor 4alpha in gluconeogenesis." Proc Natl Acad Sci U S A 100(7): 4012-4017. 
 
Roberts, L. D., P. Bostrom, J. F. O'Sullivan, R. T. Schinzel, G. D. Lewis, A. Dejam, Y. K. Lee, M. J. Palma, 
S. Calhoun, A. Georgiadi, M. H. Chen, V. S. Ramachandran, M. G. Larson, C. Bouchard, T. Rankinen, A. 
L. Souza, C. B. Clish, T. J. Wang, J. L. Estall, A. A. Soukas, C. A. Cowan, B. M. Spiegelman and R. E. Gerszten 
(2014). "beta-Aminoisobutyric Acid Induces Browning of White Fat and Hepatic beta-Oxidation and Is 
Inversely Correlated with Cardiometabolic Risk Factors." Cell Metabolism 19(1): 96-108. 
 
Robinson, M. M., S. Dasari, A. R. Konopka, M. L. Johnson, S. Manjunatha, R. R. Esponda, R. E. Carter, I. 
R. Lanza and K. S. Nair (2017). "Enhanced Protein Translation Underlies Improved Metabolic and 
Physical Adaptations to Different Exercise Training Modes in Young and Old Humans." Cell Metab 
25(3): 581-592. 
 
Rose, A. J., B. Kiens and E. A. Richter (2006). "Ca2+-calmodulin-dependent protein kinase expression 
and signalling in skeletal muscle during exercise." J Physiol 574(Pt 3): 889-903. 
 
Rowe, G. C., C. Jang, I. S. Patten and Z. Arany (2011). "PGC-1beta regulates angiogenesis in skeletal 
muscle." Am J Physiol Endocrinol Metab 301(1): E155-163. 
 
Rowe, G. C., I. S. Patten, Z. K. Zsengeller, R. El-Khoury, M. Okutsu, S. Bampoh, N. Koulisis, C. Farrell, M. 
F. Hirshman, Z. Yan, L. J. Goodyear, P. Rustin and Z. Arany (2013). "Disconnecting mitochondrial content 
from respiratory chain capacity in PGC-1-deficient skeletal muscle." Cell Rep 3(5): 1449-1456. 
 
Ruas, J. L., J. P. White, R. R. Rao, S. Kleiner, K. T. Brannan, B. C. Harrison, N. P. Greene, J. Wu, J. L. Estall, 
B. A. Irving, I. R. Lanza, K. A. Rasbach, M. Okutsu, K. S. Nair, Z. Yan, L. A. Leinwand and B. M. Spiegelman 
(2012). "A PGC-1alpha isoform induced by resistance training regulates skeletal muscle hypertrophy." 
Cell 151(6): 1319-1331. 
 
Ruiz-Andres, O., B. Suarez-Alvarez, C. Sanchez-Ramos, M. Monsalve, M. D. Sanchez-Nino, M. Ruiz-
Ortega, J. Egido, A. Ortiz and A. B. Sanz (2016). "The inflammatory cytokine TWEAK decreases PGC-
1alpha expression and mitochondrial function in acute kidney injury." Kidney Int 89(2): 399-410. 
 
Sacheck, J. M., J. P. Hyatt, A. Raffaello, R. T. Jagoe, R. R. Roy, V. R. Edgerton, S. H. Lecker and A. L. 
Goldberg (2007). "Rapid disuse and denervation atrophy involve transcriptional changes similar to 
those of muscle wasting during systemic diseases." FASEB J 21(1): 140-155. 
 
Sahay, M., S. Kalra and T. Bandgar (2012). "Renal endocrinology: The new frontier." Indian J Endocrinol 
Metab 16(2): 154-155. 
 
Sahlin, K. (1986). "Metabolic changes limiting muscle performance." Int. Series Sport Sci. 162: 261-266. 
 
Sahlin, K., M. Tonkonogi and K. Soderlund (1998). "Energy supply and muscle fatigue in humans." Acta 
Physiol Scand 162(3): 261-266. 
 
Salamin, O., T. Kuuranne, M. Saugy and N. Leuenberger (2017). "Erythropoietin as a performance-
enhancing drug: Its mechanistic basis, detection, and potential adverse effects." Mol Cell Endocrinol. 
                                                                                                                                                                                 References 
137 
 
Salo, D. C., C. M. Donovan and K. J. Davies (1991). "HSP70 and other possible heat shock or oxidative 
stress proteins are induced in skeletal muscle, heart, and liver during exercise." Free Radic Biol Med 
11(3): 239-246. 
 
Saltin, B., J. Henriksson, E. Nygaard, P. Andersen and E. Jansson (1977). "Fiber types and metabolic 
potentials of skeletal muscles in sedentary man and endurance runners." Ann N Y Acad Sci 301: 3-29. 
 
Sandri, M., J. Lin, C. Handschin, W. Yang, Z. P. Arany, S. H. Lecker, A. L. Goldberg and B. M. Spiegelman 
(2006). "PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-
specific gene transcription." Proc Natl Acad Sci U S A 103(44): 16260-16265. 
 
Sandri, M., C. Sandri, A. Gilbert, C. Skurk, E. Calabria, A. Picard, K. Walsh, S. Schiaffino, S. H. Lecker and 
A. L. Goldberg (2004). "Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-
1 and cause skeletal muscle atrophy." Cell 117(3): 399-412. 
 
Schiaffino, S. and C. Reggiani (2011). "Fiber types in mammalian skeletal muscles." Physiol Rev 91(4): 
1447-1531. 
 
Schiffer, T. A. and M. Friederich-Persson (2017). "Mitochondrial Reactive Oxygen Species and Kidney 
Hypoxia in the Development of Diabetic Nephropathy." Front Physiol 8: 211. 
 
Schmitt, B. M., D. Biemesderfer, M. F. Romero, E. L. Boulpaep and W. F. Boron (1999). 
"Immunolocalization of the electrogenic Na+-HCO-3 cotransporter in mammalian and amphibian 
kidney." Am J Physiol 276(1 Pt 2): F27-38. 
 
Schnyder, S., B. Kupr and C. Handschin (2017). "Coregulator-mediated control of skeletal muscle 
plasticity - A mini-review." Biochimie. 
 
Schnyder, S., B. Kupr and C. Handschin (2017). "Coregulator-mediated control of skeletal muscle 
plasticity - A mini-review." Biochimie 136: 49-54. 
 
Schnyder, S., K. Svensson, B. Cardel and C. Handschin (2017). "Muscle PGC-1alpha is required for long-
term systemic and local adaptations to a ketogenic diet in mice." Am J Physiol Endocrinol Metab 312(5): 
E437-E446. 
 
Semsarian, C., M. J. Wu, Y. K. Ju, T. Marciniec, T. Yeoh, D. G. Allen, R. P. Harvey and R. M. Graham 
(1999). "Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling 
pathway." Nature 400(6744): 576-581. 
 
Shankland, S. J. (2006). "The podocyte's response to injury: role in proteinuria and glomerulosclerosis." 
Kidney international 69(12): 2131-2147. 
 
Shaulian, E. and M. Karin (2002). "AP-1 as a regulator of cell life and death." Nat Cell Biol 4(5): E131-
136. 
 
Shaywitz, A. J. and M. E. Greenberg (1999). "CREB: a stimulus-induced transcription factor activated by 
a diverse array of extracellular signals." Annu Rev Biochem 68: 821-861. 
 
Shimazu, T., M. D. Hirschey, J. Newman, W. He, K. Shirakawa, N. Le Moan, C. A. Grueter, H. Lim, L. R. 
Saunders, R. D. Stevens, C. B. Newgard, R. V. Farese, Jr., R. de Cabo, S. Ulrich, K. Akassoglou and E. 
Verdin (2013). "Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone 
deacetylase inhibitor." Science 339(6116): 211-214. 
                                                                                                                                                                                 References 
138 
 
Shoag, J., R. Haq, M. Zhang, L. Liu, G. C. Rowe, A. Jiang, N. Koulisis, C. Farrel, C. I. Amos, Q. Wei, J. E. 
Lee, J. Zhang, T. S. Kupper, A. A. Qureshi, R. Cui, J. Han, D. E. Fisher and Z. Arany (2013). "PGC-1 
coactivators regulate MITF and the tanning response." Mol Cell 49(1): 145-157. 
 
Sigal, R. J., G. P. Kenny, N. G. Boule, G. A. Wells, D. Prud'homme, M. Fortier, R. D. Reid, H. Tulloch, D. 
Coyle, P. Phillips, A. Jennings and J. Jaffey (2007). "Effects of aerobic training, resistance training, or 
both on glycemic control in type 2 diabetes: a randomized trial." Ann Intern Med 147(6): 357-369. 
 
Small, D. M., J. S. Coombes, N. Bennett, D. W. Johnson and G. C. Gobe (2012). "Oxidative stress, anti-
oxidant therapies and chronic kidney disease." Nephrology (Carlton) 17(4): 311-321. 
 
Snyder, S. and B. Pendergraph (2005). "Detection and evaluation of chronic kidney disease." Am Fam 
Physician 72(9): 1723-1732. 
 
Soltoff, S. P. (1986). "ATP and the regulation of renal cell function." Annu Rev Physiol 48: 9-31. 
 
Sonoda, J., I. R. Mehl, L. W. Chong, R. R. Nofsinger and R. M. Evans (2007). "PGC-1beta controls 
mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic 
steatosis." Proc Natl Acad Sci U S A 104(12): 5223-5228. 
 
Spiegelman, B. M. and R. Heinrich (2004). "Biological control through regulated transcriptional 
coactivators." Cell 119(2): 157-167. 
 
Spina, R. J., M. M. Chi, M. G. Hopkins, P. M. Nemeth, O. H. Lowry and J. O. Holloszy (1996). 
"Mitochondrial enzymes increase in muscle in response to 7-10 days of cycle exercise." J Appl Physiol 
(1985) 80(6): 2250-2254. 
 
St-Pierre, J., J. Lin, S. Krauss, P. T. Tarr, R. Yang, C. B. Newgard and B. M. Spiegelman (2003). 
"Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 
1beta (PGC-1alpha and PGC-1beta) in muscle cells." J Biol Chem 278(29): 26597-26603. 
 
Stitt, T. N., D. Drujan, B. A. Clarke, F. Panaro, Y. Timofeyva, W. O. Kline, M. Gonzalez, G. D. Yancopoulos 
and D. J. Glass (2004). "The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced 
ubiquitin ligases by inhibiting FOXO transcription factors." Mol Cell 14(3): 395-403. 
 
Su, M., A. R. Dhoopun, Y. Yuan, S. Huang, C. Zhu, G. Ding, B. Liu, T. Yang and A. Zhang (2013). 
"Mitochondrial dysfunction is an early event in aldosterone-induced podocyte injury." Am J Physiol 
Renal Physiol 305(4): F520-531. 
 
Suetta, C., U. Frandsen, L. Jensen, M. M. Jensen, J. G. Jespersen, L. G. Hvid, M. Bayer, S. J. Petersson, 
H. D. Schroder, J. L. Andersen, K. M. Heinemeier, P. Aagaard, P. Schjerling and M. Kjaer (2012). "Aging 
affects the transcriptional regulation of human skeletal muscle disuse atrophy." PLoS One 7(12): 
e51238. 
 
Suh, J. H. and J. H. Miner (2013). "The glomerular basement membrane as a barrier to albumin." Nat 
Rev Nephrol 9(8): 470-477. 
 
Summermatter, S., O. Baum, G. Santos, H. Hoppeler and C. Handschin (2010). "Peroxisome 
proliferator-activated receptor {gamma} coactivator 1{alpha} (PGC-1{alpha}) promotes skeletal muscle 
lipid refueling in vivo by activating de novo lipogenesis and the pentose phosphate pathway." J Biol 
Chem 285(43): 32793-32800. 
                                                                                                                                                                                 References 
139 
 
Summermatter, S., G. Santos, J. Perez-Schindler and C. Handschin (2013). "Skeletal muscle PGC-1alpha 
controls whole-body lactate homeostasis through estrogen-related receptor alpha-dependent 
activation of LDH B and repression of LDH A." Proc Natl Acad Sci U S A 110(21): 8738-8743. 
 
Summermatter, S., R. Thurnheer, G. Santos, B. Mosca, O. Baum, S. Treves, H. Hoppeler, F. Zorzato and 
C. Handschin (2012). "Remodeling of calcium handling in skeletal muscle through PGC-1alpha: impact 
on force, fatigability, and fiber type." Am J Physiol Cell Physiol 302(1): C88-99. 
 
Supek, F., M. Bosnjak, N. Skunca and T. Smuc (2011). "REVIGO summarizes and visualizes long lists of 
gene ontology terms." PLoS One 6(7): e21800. 
 
Svensson, K., V. Albert, B. Cardel, S. Salatino and C. Handschin (2016). "Skeletal muscle PGC-1alpha 
modulates systemic ketone body homeostasis and ameliorates diabetic hyperketonemia in mice." 
FASEB J 30(5): 1976-1986. 
 
Svensson, K., S. Schnyder, B. Cardel and C. Handschin (2016). "Loss of Renal Tubular PGC-1alpha 
Exacerbates Diet-Induced Renal Steatosis and Age-Related Urinary Sodium Excretion in Mice." PLoS 
One 11(7): e0158716. 
 
Tabas-Madrid, D., R. Nogales-Cadenas and A. Pascual-Montano (2012). "GeneCodis3: a non-redundant 
and modular enrichment analysis tool for functional genomics." Nucleic Acids Res 40(Web Server 
issue): W478-483. 
 
Taggart, A. K., J. Kero, X. Gan, T. Q. Cai, K. Cheng, M. Ippolito, N. Ren, R. Kaplan, K. Wu, T. J. Wu, L. Jin, 
C. Liaw, R. Chen, J. Richman, D. Connolly, S. Offermanns, S. D. Wright and M. G. Waters (2005). "(D)-
beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G." J Biol Chem 
280(29): 26649-26652. 
 
Tagliabue, A., S. Bertoli, C. Trentani, P. Borrelli and P. Veggiotti (2012). "Effects of the ketogenic diet 
on nutritional status, resting energy expenditure, and substrate oxidation in patients with medically 
refractory epilepsy: a 6-month prospective observational study." Clin Nutr 31(2): 246-249. 
 
Takeoka, M., J. J. Riviello, Jr., H. Pfeifer and E. A. Thiele (2002). "Concomitant treatment with 
topiramate and ketogenic diet in pediatric epilepsy." Epilepsia 43(9): 1072-1075. 
 
Tiraby, C., G. Tavernier, C. Lefort, D. Larrouy, F. Bouillaud, D. Ricquier and D. Langin (2003). 
"Acquirement of brown fat cell features by human white adipocytes." J Biol Chem 278(35): 33370-
33376. 
 
Totsuka, Y., M. S. Ferdows, T. B. Nielsen and J. B. Field (1983). "Effects of forskolin on adenylate cyclase, 
cyclic AMP, protein kinase and intermediary metabolism of the thyroid gland." Biochim Biophys Acta 
756(3): 319-327. 
 
Tran, M., D. Tam, A. Bardia, M. Bhasin, G. C. Rowe, A. Kher, Z. K. Zsengeller, M. R. Akhavan-Sharif, E. V. 
Khankin, M. Saintgeniez, S. David, D. Burstein, S. A. Karumanchi, I. E. Stillman, Z. Arany and S. M. Parikh 
(2011). "PGC-1alpha promotes recovery after acute kidney injury during systemic inflammation in 
mice." J Clin Invest 121(10): 4003-4014. 
 
Tran, M. T., Z. K. Zsengeller, A. H. Berg, E. V. Khankin, M. K. Bhasin, W. Kim, C. B. Clish, I. E. Stillman, S. 
A. Karumanchi, E. P. Rhee and S. M. Parikh (2016). "PGC1alpha drives NAD biosynthesis linking 
oxidative metabolism to renal protection." Nature 531(7595): 528-532. 
                                                                                                                                                                                 References 
140 
 
Trump, B. F. and I. K. Berezesky (1992). "The role of cytosolic Ca2+ in cell injury, necrosis and 
apoptosis." Curr Opin Cell Biol 4(2): 227-232. 
 
Urbain, P., L. Strom, L. Morawski, A. Wehrle, P. Deibert and H. Bertz (2017). "Impact of a 6-week non-
energy-restricted ketogenic diet on physical fitness, body composition and biochemical parameters in 
healthy adults." Nutr Metab (Lond) 14: 17. 
 
Vandewalle, A., G. Wirthensohn, H. G. Heidrich and W. G. Guder (1981). "Distribution of hexokinase 
and phosphoenolpyruvate carboxykinase along the rabbit nephron." Am J Physiol 240(6): F492-500. 
 
Varady, K. A. and M. K. Hellerstein (2007). "Alternate-day fasting and chronic disease prevention: a 
review of human and animal trials." Am J Clin Nutr 86(1): 7-13. 
 
Vercauteren, K., N. Gleyzer and R. C. Scarpulla (2009). "Short hairpin RNA-mediated silencing of PRC 
(PGC-1-related coactivator) results in a severe respiratory chain deficiency associated with the 
proliferation of aberrant mitochondria." J Biol Chem 284(4): 2307-2319. 
 
Vercauteren, K., R. A. Pasko, N. Gleyzer, V. M. Marino and R. C. Scarpulla (2006). "PGC-1-related 
coactivator: immediate early expression and characterization of a CREB/NRF-1 binding domain 
associated with cytochrome c promoter occupancy and respiratory growth." Mol Cell Biol 26(20): 
7409-7419. 
 
Vianna, C. R., M. Huntgeburth, R. Coppari, C. S. Choi, J. Lin, S. Krauss, G. Barbatelli, I. Tzameli, Y. B. Kim, 
S. Cinti, G. I. Shulman, B. M. Spiegelman and B. B. Lowell (2006). "Hypomorphic mutation of PGC-1beta 
causes mitochondrial dysfunction and liver insulin resistance." Cell Metab 4(6): 453-464. 
 
Wakita, H., Y. Tokura, F. Furukawa and M. Takigawa (1994). "High calcium induces heat shock proteins 
72 and 60 in cultured human keratinocytes: comparative study with heat shock and sunlamp light 
irradiation." J Dermatol Sci 8(2): 136-144. 
 
Wallberg, A. E., S. Yamamura, S. Malik, B. M. Spiegelman and R. G. Roeder (2003). "Coordination of 
p300-mediated chromatin remodeling and TRAP/mediator function through coactivator PGC-1alpha." 
Mol Cell 12(5): 1137-1149. 
 
Wen, X., J. Wu, J. S. Chang, P. Zhang, J. Wang, Y. Zhang, T. W. Gettys and Y. Zhang (2014). "Effect of 
exercise intensity on isoform-specific expressions of NT-PGC-1 alpha mRNA in mouse skeletal muscle." 
Biomed Res Int 2014: 402175. 
 
Wende, A. R., P. J. Schaeffer, G. J. Parker, C. Zechner, D. H. Han, M. M. Chen, C. R. Hancock, J. J. Lehman, 
J. M. Huss, D. A. McClain, J. O. Holloszy and D. P. Kelly (2007). "A role for the transcriptional coactivator 
PGC-1alpha in muscle refueling." J Biol Chem 282(50): 36642-36651. 
 
Westerblad, H., J. D. Bruton and A. Katz (2010). "Skeletal muscle: energy metabolism, fiber types, 
fatigue and adaptability." Exp Cell Res 316(18): 3093-3099. 
 
White, J. P., C. D. Wrann, R. R. Rao, S. K. Nair, M. P. Jedrychowski, J. S. You, V. Martinez-Redondo, S. P. 
Gygi, J. L. Ruas, T. A. Hornberger, Z. Wu, D. J. Glass, X. Piao and B. M. Spiegelman (2014). "G protein-
coupled receptor 56 regulates mechanical overload-induced muscle hypertrophy." Proc Natl Acad Sci 
U S A 111(44): 15756-15761. 
 
                                                                                                                                                                                 References 
141 
 
Widrick, J. J., J. E. Stelzer, T. C. Shoepe and D. P. Garner (2002). "Functional properties of human muscle 
fibers after short-term resistance exercise training." Am J Physiol Regul Integr Comp Physiol 283(2): 
R408-416. 
 
Wojtaszewski, J. F., S. B. Jorgensen, Y. Hellsten, D. G. Hardie and E. A. Richter (2002). "Glycogen-
dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein 
kinase and glycogen synthase activities in rat skeletal muscle." Diabetes 51(2): 284-292. 
 
Wojtaszewski, J. F., C. MacDonald, J. N. Nielsen, Y. Hellsten, D. G. Hardie, B. E. Kemp, B. Kiens and E. A. 
Richter (2003). "Regulation of 5'AMP-activated protein kinase activity and substrate utilization in 
exercising human skeletal muscle." Am J Physiol Endocrinol Metab 284(4): E813-822. 
 
Wu, H., S. B. Kanatous, F. A. Thurmond, T. Gallardo, E. Isotani, R. Bassel-Duby and R. S. Williams (2002). 
"Regulation of mitochondrial biogenesis in skeletal muscle by CaMK." Science 296(5566): 349-352. 
 
Wu, P., K. Inskeep, M. M. Bowker-Kinley, K. M. Popov and R. A. Harris (1999). "Mechanism responsible 
for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes." 
Diabetes 48(8): 1593-1599. 
 
Wu, Z., P. Puigserver, U. Andersson, C. Zhang, G. Adelmant, V. Mootha, A. Troy, S. Cinti, B. Lowell, R. C. 
Scarpulla and B. M. Spiegelman (1999). "Mechanisms controlling mitochondrial biogenesis and 
respiration through the thermogenic coactivator PGC-1." Cell 98(1): 115-124. 
 
Xu, L., X. Ma, A. Bagattin and E. Mueller (2016). "The transcriptional coactivator PGC1alpha protects 
against hyperthermic stress via cooperation with the heat shock factor HSF1." Cell Death Dis 7: e2102. 
 
Yancy, W. S., Jr., M. K. Olsen, T. Dudley and E. C. Westman (2007). "Acid-base analysis of individuals 
following two weight loss diets." Eur J Clin Nutr 61(12): 1416-1422. 
 
Yang, Y., A. Creer, B. Jemiolo and S. Trappe (2005). "Time course of myogenic and metabolic gene 
expression in response to acute exercise in human skeletal muscle." J Appl Physiol (1985) 98(5): 1745-
1752. 
 
Yoon, J. C., P. Puigserver, G. Chen, J. Donovan, Z. Wu, J. Rhee, G. Adelmant, J. Stafford, C. R. Kahn, D. 
K. Granner, C. B. Newgard and B. M. Spiegelman (2001). "Control of hepatic gluconeogenesis through 
the transcriptional coactivator PGC-1." Nature 413(6852): 131-138. 
 
Yuan, Y., S. Huang, W. Wang, Y. Wang, P. Zhang, C. Zhu, G. Ding, B. Liu, T. Yang and A. Zhang (2012). 
"Activation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha ameliorates 
mitochondrial dysfunction and protects podocytes from aldosterone-induced injury." Kidney Int 82(7): 
771-789. 
 
Yuan, Y., S. Huang, W. Wang, Y. Wang, P. Zhang, C. Zhu, G. Ding, B. Liu, T. Yang and A. Zhang (2012). 
"Activation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha ameliorates 
mitochondrial dysfunction and protects podocytes from aldosterone-induced injury." Kidney 
international 82(7): 771-789. 
 
Yuen, A. W. C., I. A. Walcutt and J. W. Sander (2017). "An acidosis-sparing ketogenic (ASK) diet to 
improve efficacy and reduce adverse effects in the treatment of refractory epilepsy." Epilepsy Behav 
74: 15-21. 
                                                                                                                                                                                 References 
142 
 
Zajac, A., S. Poprzecki, A. Maszczyk, M. Czuba, M. Michalczyk and G. Zydek (2014). "The effects of a 
ketogenic diet on exercise metabolism and physical performance in off-road cyclists." Nutrients 6(7): 
2493-2508. 
 
Zaza, G., S. Granata, V. Masola, C. Rugiu, F. Fantin, L. Gesualdo, F. P. Schena and A. Lupo (2013). 
"Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease 
patients." PLoS One 8(10): e77847. 
 
Zechner, C., L. Lai, J. F. Zechner, T. Geng, Z. Yan, J. W. Rumsey, D. Collia, Z. Chen, D. F. Wozniak, T. C. 
Leone and D. P. Kelly (2010). "Total skeletal muscle PGC-1 deficiency uncouples mitochondrial 
derangements from fiber type determination and insulin sensitivity." Cell Metab 12(6): 633-642. 
 
Zhao, M., Y. Yuan, M. Bai, G. Ding, Z. Jia, S. Huang and A. Zhang (2016). "PGC-1alpha overexpression 
protects against aldosterone-induced podocyte depletion: role of mitochondria." Oncotarget 7(11): 
12150-12162. 
 
Zhu, C., X. Xuan, R. Che, G. Ding, M. Zhao, M. Bai, Z. Jia, S. Huang and A. Zhang (2014). "Dysfunction of 
the PGC-1alpha-mitochondria axis confers adriamycin-induced podocyte injury." Am J Physiol Renal 
Physiol 306(12): F1410-1417. 
 
Zurlo, F., K. Larson, C. Bogardus and E. Ravussin (1990). "Skeletal muscle metabolism is a major 
determinant of resting energy expenditure." J Clin Invest 86(5): 1423-1427. 
 
 
 
 
Appendices 
143 
 
Appendices 
Appendix A 
Appendices 
144 
 
Appendices 
145 
 
Appendices 
146 
 
Appendices 
147 
 
Appendices 
148 
 
Appendices 
149 
 
Appendices 
150 
 
Appendices 
151 
 
Appendices 
152 
 
Appendices 
153 
 
Appendices 
154 
 
Appendices 
155 
 
Appendices 
156 
 
Appendices 
157 
 
Appendices 
158 
 
Appendices 
159 
 
Appendices 
160 
 
Appendices 
161 
 
 
Appendices 
162 
 
Appendix B 
Appendices 
163 
 
Appendices 
164 
 
Appendices 
165 
 
Appendices 
166 
 
Appendices 
167 
 
  
Appendices 
168 
 
Appendix C 
Appendices 
169 
 
Appendices 
170 
 
Appendices 
171 
 
Appendices 
172 
 
Appendices 
173 
 
Appendices 
174 
 
Appendices 
175 
 
Appendices 
176 
 
Appendices 
177 
 
Appendices 
178 
 
 
 
Acknowledgments 
179 
 
Acknowledgments  
 
First of all, I would like to thank Christoph Handschin, my supervisor, for giving me the opportunity of 
doing my PhD in his lab. He allowed me to work very independently and to bring in and follow up my 
own ideas and hypothesis but nevertheless, was always there to support me whenever I had difficulties 
or needed advice.   
 
Furthermore, I want to thank all the members of the Handschin and Rüegg labs for creating such a nice 
working atmosphere and for helping me in different kinds of techniques and experiments.  
 
Special thanks goes to Barbara Kupr, Bettina Karrer and Regula Furrer, who were always there for me 
to discuss any kind of stupid problem and who became friends over the last years.  
 
Last but not least, the biggest thank you goes to my family and especially my boyfriend, Marc Schmid, 
who experienced all the ups and downs and always encouraged and supported me with great patience 
and understanding. 
